Samples	AJCC_Stage_nature2012	Age_at_Initial_Pathologic_Diagnosis_nature2012	CN_Clusters_nature2012	Converted_Stage_nature2012	Days_to_Date_of_Last_Contact_nature2012	Days_to_date_of_Death_nature2012	ER_Status_nature2012	Gender_nature2012	HER2_Final_Status_nature2012	Integrated_Clusters_no_exp__nature2012	Integrated_Clusters_unsup_exp__nature2012	Integrated_Clusters_with_PAM50__nature2012	Metastasis_Coded_nature2012	Metastasis_nature2012	Node_Coded_nature2012	Node_nature2012	OS_Time_nature2012	OS_event_nature2012	PAM50Call_RNAseq	PAM50_mRNA_nature2012	PR_Status_nature2012	RPPA_Clusters_nature2012	SigClust_Intrinsic_mRNA_nature2012	SigClust_Unsupervised_mRNA_nature2012	Survival_Data_Form_nature2012	Tumor_T1_Coded_nature2012	Tumor_nature2012	Vital_Status_nature2012	X_EVENT	X_INTEGRATION	X_OS	X_OS_IND	X_OS_UNIT	X_PANCAN_CNA_PANCAN_K8	X_PANCAN_Cluster_Cluster_PANCAN	X_PANCAN_DNAMethyl_BRCA	X_PANCAN_DNAMethyl_PANCAN	X_PANCAN_RPPA_PANCAN_K8	X_PANCAN_UNC_RNAseq_PANCAN_K16	X_PANCAN_miRNA_PANCAN	X_PANCAN_mirna_BRCA	X_PANCAN_mutation_PANCAN	X_PATIENT	X_RFS	X_RFS_IND	X_RFS_UNIT	X_TIME_TO_EVENT	X_TIME_TO_EVENT_UNIT	X_cohort	X_primary_disease	X_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_surgery_locoregional_procedure	additional_surgery_metastatic_procedure	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	axillary_lymph_node_stage_method_type	axillary_lymph_node_stage_other_method_descriptive_text	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	breast_cancer_surgery_margin_status	breast_carcinoma_estrogen_receptor_status	breast_carcinoma_immunohistochemistry_er_pos_finding_scale	breast_carcinoma_immunohistochemistry_pos_cell_score	breast_carcinoma_immunohistochemistry_prgstrn_rcptr_ps_fndng_scl	breast_carcinoma_primary_surgical_procedure_name	breast_carcinoma_progesterone_receptor_status	breast_carcinoma_surgical_procedure_name	breast_neoplasm_other_surgical_procedure_descriptive_text	cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr	days_to_additional_surgery_locoregional_procedure	days_to_additional_surgery_metastatic_procedure	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	disease_code	distant_metastasis_present_ind2	er_detection_method_text	er_level_cell_percentage_category	fluorescence_in_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng	followup_case_report_form_submission_reason	form_completion_date	gender	her2_and_centromere_17_positive_finding_other_measuremnt_scl_txt	her2_erbb_method_calculation_method_text	her2_erbb_pos_finding_cell_percent_category	her2_erbb_pos_finding_fluorescence_n_st_hybrdztn_clcltn_mthd_txt	her2_immunohistochemistry_level_result	her2_neu_and_centromere_17_copy_number_analysis_npt_ttl_nmbr_cnt	her2_neu_breast_carcinoma_copy_analysis_input_total_number	her2_neu_chromosone_17_signal_ratio_value	her2_neu_metastatic_breast_carcinoma_copy_analysis_inpt_ttl_nmbr	histological_type	histological_type_other	history_of_neoadjuvant_treatment	hr2_n_nd_cntrmr_17_cpy_nmbr_mtsttc_brst_crcnm_nlyss_npt_ttl_nmbr	icd_10	icd_o_3_histology	icd_o_3_site	immunohistochemistry_positive_cell_score	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	initial_weight	is_ffpe	lab_proc_her2_neu_immunohistochemistry_receptor_status	lab_procedure_her2_neu_in_situ_hybrid_outcome_type	lost_follow_up	lymph_node_examined_count	margin_status	menopause_status	metastatic_breast_carcinm_ps_fndng_prgstrn_rcptr_thr_msr_scl_txt	metastatic_breast_carcinom_lb_prc_hr2_n_mmnhstchmstry_rcptr_stts	metastatic_breast_carcinoma_erbb2_immunohistochemistry_levl_rslt	metastatic_breast_carcinoma_estrogen_receptor_detection_mthd_txt	metastatic_breast_carcinoma_estrogen_receptor_status	metastatic_breast_carcinoma_estrogen_receptr_lvl_cll_prcnt_ctgry	metastatic_breast_carcinoma_her2_erbb_method_calculatin_mthd_txt	metastatic_breast_carcinoma_her2_erbb_pos_findng_cll_prcnt_ctgry	metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rat_vl	metastatic_breast_carcinoma_immunhstchmstry_r_pstv_fndng_scl_typ	metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_scr	metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_scr	metastatic_breast_carcinoma_lab_proc_hr2_n_n_st_hybrdztn_tcm_typ	metastatic_breast_carcinoma_pos_finding_hr2_rbb2_thr_msr_scl_txt	metastatic_breast_carcinoma_progestern_rcptr_lvl_cll_prcnt_ctgry	metastatic_breast_carcinoma_progesterone_receptor_dtctn_mthd_txt	metastatic_breast_carcinoma_progesterone_receptor_status	metastatic_site_at_diagnosis	metastatic_site_at_diagnosis_other	methylation_Clusters_nature2012	miRNA_Clusters_nature2012	mtsttc_brst_crcnm_flrscnc_n_st_hybrdztn_dgnstc_prc_cntrmr_17_sgn	mtsttc_brst_crcnm_hr2_rbb_ps_fndng_flrscnc_n_st_hybrdztn_clcltn	mtsttc_brst_crcnm_mmnhstchmstry_prgstrn_rcptr_pstv_fndng_scl_typ	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	oct_embedded	other_dx	pathologic_M	pathologic_N	pathologic_T	pathologic_stage	pathology_report_file_name	patient_id	person_neoplasm_cancer_status	pgr_detection_method_text	pos_finding_her2_erbb2_other_measurement_scale_text	pos_finding_metastatic_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt	pos_finding_progesterone_receptor_other_measurement_scale_text	positive_finding_estrogen_receptor_other_measurement_scale_text	postoperative_rx_tx	primary_lymph_node_presentation_assessment	progesterone_receptor_level_cell_percent_category	project_code	radiation_therapy	sample_type	sample_type_id	surgical_procedure_purpose_other_text	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_tissue_site	vial_number	vital_status	year_of_initial_pathologic_diagnosis	X_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_exon	X_GENOMIC_ID_TCGA_BRCA_GSNP6noCNV	X_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_PANCAN	X_GENOMIC_ID_TCGA_BRCA_GSNP6raw	X_GENOMIC_ID_TCGA_BRCA_RPPA_RBN	X_GENOMIC_ID_TCGA_BRCA_mutation	X_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_totalRNA_exon	X_GENOMIC_ID_TCGA_BRCA_PDMRNAseq	X_GENOMIC_ID_TCGA_BRCA_hMethyl450	X_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_totalRNA	X_GENOMIC_ID_TCGA_BRCA_RPPA	X_GENOMIC_ID_TCGA_BRCA_PDMRNAseqCNV	X_GENOMIC_ID_TCGA_BRCA_mutation_curated_wustl_gene	X_GENOMIC_ID_TCGA_BRCA_hMethyl27	X_GENOMIC_ID_TCGA_BRCA_PDMarrayCNV	X_GENOMIC_ID_TCGA_BRCA_miRNA_HiSeq	X_GENOMIC_ID_TCGA_BRCA_mutation_wustl_gene	X_GENOMIC_ID_TCGA_BRCA_miRNA_GA	X_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_percentile	X_GENOMIC_ID_data.public.TCGA.BRCA.miRNA_GA_gene	X_GENOMIC_ID_TCGA_BRCA_gistic2thd	X_GENOMIC_ID_data.public.TCGA.BRCA.miRNA_HiSeq_gene	X_GENOMIC_ID_TCGA_BRCA_G4502A_07_3	X_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2	X_GENOMIC_ID_TCGA_BRCA_gistic2	X_GENOMIC_ID_TCGA_BRCA_PDMarray
TCGA.A1.A0SP.01	Stage IIA	40	NA	Stage IIA	583	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	583	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.A1.A0SP.01	584	0	days	High	C4-BRCA/Basal		BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12		mutation cluster 5	TCGA-A1-A0SP	NA	NA	days	584	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right	Axillary lymph node dissection alone			TCGA-A1-A0SP			Negative					Negative	Lumpectomy			NA	NA	-14954	NA	NA	0	584	NA	NA								2010-12-6	FEMALE					0	NA		NA	NA	Infiltrating Ductal Carcinoma			NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	NA		Negative			3	Negative										NA											NA	NA	NA								0	NA		Yes	M0	N0 (i-)	T2	Stage IIA		A0SP	TUMOR FREE											Primary Tumor	1		6th		NO	YES	A1	Breast		LIVING	2007	f091d050-4847-4d4d-b94c-1efacecdef6b	fda83c5d-bec0-427d-8c6e-e8c06953e58a	f091d050-4847-4d4d-b94c-1efacecdef6b	fda83c5d-bec0-427d-8c6e-e8c06953e58a		TCGA.A1.A0SP.01A-11D-A099-09		TCGA.A1.A0SP.01	TCGA.A1.A0SP.01A-11D-A10P-05			TCGA.A1.A0SP.01	TCGA.A1.A0SP.01A-11D-A099-09		TCGA.A1.A0SP.01		TCGA.A1.A0SP.01A-11D-A099-09	TCGA.A1.A0SP.01	f091d050-4847-4d4d-b94c-1efacecdef6b	TCGA.A1.A0SP.01	TCGA.A1.A0SP.01A-11D-A087-01		TCGA.A1.A0SP.01A-11R-A084-07	f091d050-4847-4d4d-b94c-1efacecdef6b	TCGA.A1.A0SP.01A-11D-A087-01	TCGA.A1.A0SP.01
TCGA.A2.A04T.01	Stage IIA	62	1	Stage IIA	2246	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	2246	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA.A2.A04T.01	2246	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 5		TCGA-A2-A04T	NA	NA	days	2246	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA.A2.A04T.F9343	TCGA-A2-A04T	TCGA.A2.A04T.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-22707	1979	NA	0	2246	NA	NA					<10%			2011-3-17	FEMALE					2+	NA		1.1	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA								0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A04T.24D42292-B875-4FAF-8C3A-9834414C3A01.pdf	A04T	TUMOR FREE								<10%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	79d7a589-60bd-4b4a-89c1-d557fe24c733	9f5d61da-fe30-4975-a3d5-3ba4eab06683	79d7a589-60bd-4b4a-89c1-d557fe24c733	9f5d61da-fe30-4975-a3d5-3ba4eab06683	TCGA.A2.A04T.01A-31-A13A-20			TCGA.A2.A04T.01			2724de89-78e5-4da5-b2d9-350a986a8abb	TCGA.A2.A04T.01	TCGA.A2.A04T.01A-21W-A050-09	TCGA.A2.A04T.01A-21D-A032-05	TCGA.A2.A04T.01			TCGA.A2.A04T.01	79d7a589-60bd-4b4a-89c1-d557fe24c733	TCGA.A2.A04T.01	TCGA.A2.A04T.01A-21D-A036-01		TCGA.A2.A04T.01A-21R-A034-07	79d7a589-60bd-4b4a-89c1-d557fe24c733	TCGA.A2.A04T.01A-21D-A036-01	TCGA.A2.A04T.01
TCGA.A2.A0CM.01	Stage IIA	40	4	Stage IIA	754	754	Negative	FEMALE	Negative	1	1	2	Negative	M0	Negative	N0	754	1	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	DECEASED	1	TCGA.A2.A0CM.01	754	1	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0CM	NA	NA	days	754	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		40	Left	Sentinel node biopsy alone		TCGA.A2.A0CM.F2013	TCGA-A2-A0CM	TCGA.A2.A0CM.01A		Negative		0			Negative	Simple Mastectomy		YES	NA	NA	-14969	2546	754	0	NA	NA	NA	382				<10%			2010-9-6	FEMALE			<10%		0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Excisional Biopsy	300	NO	Negative			1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											4	4	NA								0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0CM.2972AB07-2C29-43B8-96DA-1386C5E248EB.pdf	A0CM	WITH TUMOR								<10%		NO	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	DECEASED	2003	62dd11c2-2271-45e7-b753-d0f0d79fdf23	34e39e63-405b-4eae-a326-163ea06baa81	62dd11c2-2271-45e7-b753-d0f0d79fdf23	34e39e63-405b-4eae-a326-163ea06baa81	TCGA.A2.A0CM.01A-21-A13C-20	TCGA.A2.A0CM.01A-31W-A050-09		TCGA.A2.A0CM.01			bd38e599-aa6d-4349-b7de-630514cc1220	TCGA.A2.A0CM.01	TCGA.A2.A0CM.01A-31W-A050-09	TCGA.A2.A0CM.01A-31D-A032-05	TCGA.A2.A0CM.01		TCGA.A2.A0CM.01A-31W-A050-09	TCGA.A2.A0CM.01	62dd11c2-2271-45e7-b753-d0f0d79fdf23	TCGA.A2.A0CM.01	TCGA.A2.A0CM.01A-31D-A036-01		TCGA.A2.A0CM.01A-31R-A034-07	62dd11c2-2271-45e7-b753-d0f0d79fdf23	TCGA.A2.A0CM.01A-31D-A036-01	TCGA.A2.A0CM.01
TCGA.A2.A0D0.01	Stage IIA	60	1	Stage IIA	643	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	643	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA.A2.A0D0.01	2048	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 5	mutation cluster 5	TCGA-A2-A0D0	2048	0	days	2048	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.A2.A0D0.F59399	TCGA-A2-A0D0	TCGA.A2.A0D0.01A		Negative		0			Negative	Simple Mastectomy		NO	NA	NA	-22115	720	NA	0	2048	NA	NA					<10%		Scheduled Follow-up Submission	2014-5-12	FEMALE					0	NA		1.17	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Core needle biopsy	500	NO	Negative	Negative	NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA							NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0D0.D8B44020-EC34-4788-B7FB-790B9C12D886.pdf	A0D0	TUMOR FREE						YES		<10%		NO	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	ad8186c8-9dc3-40dd-92ea-4a952ddbad11	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	ad8186c8-9dc3-40dd-92ea-4a952ddbad11	TCGA.A2.A0D0.01A-21-A13C-20	TCGA.A2.A0D0.01A-11W-A019-09		TCGA.A2.A0D0.01			980c774a-c662-489e-82a3-212d0a45f759	TCGA.A2.A0D0.01	TCGA.A2.A0D0.01A-11W-A019-09	TCGA.A2.A0D0.01A-11D-A00Y-05	TCGA.A2.A0D0.01		TCGA.A2.A0D0.01A-11W-A019-09	TCGA.A2.A0D0.01	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	TCGA.A2.A0D0.01	TCGA.A2.A0D0.01A-11D-A011-01		TCGA.A2.A0D0.01A-11R-A00Z-07	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	TCGA.A2.A0D0.01A-11D-A011-01	TCGA.A2.A0D0.01
TCGA.A2.A0D2.01	Stage IIB	45	3	Stage IIA	1027	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1027	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA.A2.A0D2.01	1027	0	days	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-A2-A0D2	1027	0	days	1027	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA.A2.A0D2.F14458	TCGA-A2-A0D2	TCGA.A2.A0D2.01A		Negative		0			Negative	Simple Mastectomy		YES	NA	NA	-16623	614	NA	0	1027	NA	NA					<10%		Scheduled Follow-up Submission	2011-6-9	FEMALE					0	NA		1.05	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Core needle biopsy	330	NO	Negative	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	4	NA							NO	0	4	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0D2.B0DE3388-7826-40D3-ADEE-0B25FE201F4A.pdf	A0D2	TUMOR FREE								<10%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	2ad8d416-08a4-4e6f-947e-d74269d02ab1	3da4a808-275c-45fd-b9e4-81183ebeb0c9	2ad8d416-08a4-4e6f-947e-d74269d02ab1	3da4a808-275c-45fd-b9e4-81183ebeb0c9	TCGA.A2.A0D2.01A-11-A13C-20	TCGA.A2.A0D2.01A-21W-A050-09		TCGA.A2.A0D2.01			74c3c43d-b3f1-4846-be03-3b65098774c7	TCGA.A2.A0D2.01	TCGA.A2.A0D2.01A-21W-A050-09	TCGA.A2.A0D2.01A-21D-A032-05	TCGA.A2.A0D2.01		TCGA.A2.A0D2.01A-21W-A050-09	TCGA.A2.A0D2.01	2ad8d416-08a4-4e6f-947e-d74269d02ab1	TCGA.A2.A0D2.01	TCGA.A2.A0D2.01A-21D-A036-01		TCGA.A2.A0D2.01A-21R-A034-07	2ad8d416-08a4-4e6f-947e-d74269d02ab1	TCGA.A2.A0D2.01A-21D-A036-01	TCGA.A2.A0D2.01
TCGA.A2.A0YM.01	Stage IIA	67	3	Stage IIA	964	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	964	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA.A2.A0YM.01	965	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	OV-like c4	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-A2-A0YM	965	0	days	965	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Left Upper Outer Quadrant	Other (specify)	Sentinel lymph node biopsy and non-sentinel lymph node biopsy	TCGA.A2.A0YM.F15767	TCGA-A2-A0YM	TCGA.A2.A0YM.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-24831	691	NA	0	965	NA	NA					<10%		Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; ratio of HER2/Centromere >=2.1 is amplified		60		1.08	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO		Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA							NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0YM.E1D8F2CB-25F1-49E0-92D3-132DCA8FD533.pdf	A0YM	TUMOR FREE								<10%		YES	Primary Tumor	1			NO	NO	YES	A2	Breast	A	LIVING	2008	1e59ea3f-36fa-4860-8c28-87b4b09075ec	356ec0ad-a065-44db-8a4d-218efff4c3b4	1e59ea3f-36fa-4860-8c28-87b4b09075ec	356ec0ad-a065-44db-8a4d-218efff4c3b4	TCGA.A2.A0YM.01A-21-A13D-20	TCGA.A2.A0YM.01A-11D-A10G-09		TCGA.A2.A0YM.01	TCGA.A2.A0YM.01A-11D-A10A-05		a55195f2-8c4d-40ab-a452-8424a0403d03	TCGA.A2.A0YM.01	TCGA.A2.A0YM.01A-11D-A10G-09		TCGA.A2.A0YM.01		TCGA.A2.A0YM.01A-11D-A10G-09	TCGA.A2.A0YM.01	1e59ea3f-36fa-4860-8c28-87b4b09075ec	TCGA.A2.A0YM.01	TCGA.A2.A0YM.01A-11D-A107-01		TCGA.A2.A0YM.01A-11R-A109-07	1e59ea3f-36fa-4860-8c28-87b4b09075ec	TCGA.A2.A0YM.01A-11D-A107-01	TCGA.A2.A0YM.01
TCGA.A2.A3XS.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					1	TCGA.A2.A3XS.01	1032	1	days							miRNA cluster 4			TCGA-A2-A3XS	682	1	days	1032	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.A2.A3XS.F34446	TCGA-A2-A3XS	TCGA.A2.A3XS.01A	Negative	Negative				Mastectomy NOS	Negative	Lumpectomy		YES	NA	NA	-23000	3355	1032	0	NA	NA	NA	682		YES				Additional New Tumor Event	2012-8-15	FEMALE						NA		1.3	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	40	NO		Negative		19	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA			Lung	Distant Metastasis			YES	9	0	true	No	M0	N2a	T1	Stage IIIA	TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652.pdf	A3XS	WITH TUMOR							YES			NO	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	DECEASED	2003	799df122-75f1-46bf-8b5e-ca557cd38d53	b53f403a-449d-4a77-891e-562a0ce6ff75	799df122-75f1-46bf-8b5e-ca557cd38d53	b53f403a-449d-4a77-891e-562a0ce6ff75				TCGA.A2.A3XS.01	TCGA.A2.A3XS.01A-11D-A230-05			TCGA.A2.A3XS.01	TCGA.A2.A3XS.01A-11D-A22X-09			TCGA.A2.A3XS.01			799df122-75f1-46bf-8b5e-ca557cd38d53		TCGA.A2.A3XS.01A-11D-A22W-01	TCGA.A2.A3XS.01		799df122-75f1-46bf-8b5e-ca557cd38d53	TCGA.A2.A3XS.01A-11D-A22W-01	
TCGA.A2.A3XT.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.A2.A3XT.01	2770	0	days					BRCA basal-like c6		miRNA cluster 4			TCGA-A2-A3XT	2770	0	days	2770	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left	Other (specify)	F plus axillary lymph node dissection	TCGA.A2.A3XT.F55841	TCGA-A2-A3XT	TCGA.A2.A3XT.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-16649	2164	NA	0	2770	NA	NA								2014-1-16	FEMALE						NA		1.13	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Excisional Biopsy	340	NO	Negative	Negative	NO	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											NA	NA	NA							NO	1	NA	true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A3XT.A614B6B7-256F-4148-8941-6145B2D9B8B5.pdf	A3XT	TUMOR FREE						YES	YES			YES	Primary Tumor	1		6th		NO	YES	A2	Breast	A	LIVING	2006	e0a10445-6266-4f41-a747-fb19d7182652	bbbed4e0-9f0b-4312-999a-dcd592b8e383	e0a10445-6266-4f41-a747-fb19d7182652	bbbed4e0-9f0b-4312-999a-dcd592b8e383	TCGA.A2.A3XT.01A-21-A24A-20			TCGA.A2.A3XT.01	TCGA.A2.A3XT.01A-11D-A230-05		904a9035-e5e9-4a07-99dd-3a74f66c9145	TCGA.A2.A3XT.01	TCGA.A2.A3XT.01A-11D-A22X-09			TCGA.A2.A3XT.01			e0a10445-6266-4f41-a747-fb19d7182652		TCGA.A2.A3XT.01A-11D-A22W-01	TCGA.A2.A3XT.01		e0a10445-6266-4f41-a747-fb19d7182652	TCGA.A2.A3XT.01A-11D-A22W-01	
TCGA.A2.A3XX.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					1	TCGA.A2.A3XX.01	1439	1	days					KIRC-like c1					TCGA-A2-A3XX	1439	0	days	1439	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA.A2.A3XX.F43310	TCGA-A2-A3XX	TCGA.A2.A3XX.01A		Negative					Negative	Simple Mastectomy		YES	NA	NA	-17981	1143	1439	0	1168	NA	NA			NO					2013-5-16	FEMALE					1+	NA		1.25	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	780	NO	Negative	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C.pdf	A3XX	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th		YES	NO	A2	Breast	A	DECEASED	2009	043d5dcd-1524-402b-939c-984a1dc916a0	1a12cd14-3f98-41bd-b89f-c0fb2848f8d5	043d5dcd-1524-402b-939c-984a1dc916a0	1a12cd14-3f98-41bd-b89f-c0fb2848f8d5	TCGA.A2.A3XX.01A-41-A24A-20			TCGA.A2.A3XX.01	TCGA.A2.A3XX.01A-21D-A23D-05		c4757b28-bb38-49bb-bb06-70fa40ad8298	TCGA.A2.A3XX.01	TCGA.A2.A3XX.01A-21D-A23C-09			TCGA.A2.A3XX.01			043d5dcd-1524-402b-939c-984a1dc916a0		TCGA.A2.A3XX.01A-21D-A238-01	TCGA.A2.A3XX.01		043d5dcd-1524-402b-939c-984a1dc916a0	TCGA.A2.A3XX.01A-21D-A238-01	
TCGA.A8.A07C.01	Stage IIA	57	2	Stage IIA	580	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	580	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.A8.A07C.01	1034	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 14	TCGA-A8-A07C	1034	0	days	1034	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Right Upper Outer Quadrant			TCGA.A8.A07C.F40824	TCGA-A8-A07C	TCGA.A8.A07C.01A		Negative					Negative	Other			NA	NA	-20820	637	NA	0	1034	NA	NA								2013-3-2	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES			80	NO	Negative	Negative	NO	NA	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA							NO	NA	NA	false	No	M0	N0	T2	Stage IIA	TCGA-A8-A07C.DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71.pdf	A07C	TUMOR FREE						YES				YES	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	19d713e8-e754-44a4-9b23-0ef70f5d6b44		19d713e8-e754-44a4-9b23-0ef70f5d6b44			TCGA.A8.A07C.01A-11D-A045-09		TCGA.A8.A07C.01					TCGA.A8.A07C.01A-11D-A045-09	TCGA.A8.A07C.01A-11D-A032-05			TCGA.A8.A07C.01A-11D-A045-09	TCGA.A8.A07C.01	19d713e8-e754-44a4-9b23-0ef70f5d6b44	TCGA.A8.A07C.01			TCGA.A8.A07C.01A-11R-A034-07	19d713e8-e754-44a4-9b23-0ef70f5d6b44		TCGA.A8.A07C.01
TCGA.A8.A07O.01	Stage IIA	51	1	Stage IIA	304	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	304	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.A8.A07O.01	304	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07O	304	0	days	304	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Outer Quadrant			TCGA.A8.A07O.F40831	TCGA-A8-A07O	TCGA.A8.A07O.01A		Negative					Negative	Other			NA	NA	-18870	180	NA	0	304	NA	NA								2013-3-2	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES			220	NO	Negative	Negative	NO	NA	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	4	NA							NO	NA	NA	false	No	M0	N0	T2	Stage IIA	TCGA-A8-A07O.9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE.pdf	A07O	TUMOR FREE						YES				YES	Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	8ed5d79e-3f1b-497f-b9da-fde3a6798c21	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	8ed5d79e-3f1b-497f-b9da-fde3a6798c21	TCGA.A8.A07O.01A-21-A13B-20	TCGA.A8.A07O.01A-11W-A019-09		TCGA.A8.A07O.01			d7dd9819-8523-4dff-8ffb-689d37a73368	TCGA.A8.A07O.01	TCGA.A8.A07O.01A-11W-A019-09	TCGA.A8.A07O.01A-11D-A00Y-05	TCGA.A8.A07O.01		TCGA.A8.A07O.01A-11W-A019-09	TCGA.A8.A07O.01	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	TCGA.A8.A07O.01	TCGA.A8.A07O.01A-11D-A011-01		TCGA.A8.A07O.01A-11R-A00Z-07	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	TCGA.A8.A07O.01A-11D-A011-01	TCGA.A8.A07O.01
TCGA.A8.A07R.01	Stage IIIC	80	3	Stage IIIC	273	NA	Negative	FEMALE	Equivocal	2	2	2	Negative	M0	Positive	N3	273	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.A8.A07R.01	273	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07R	NA	NA	days	273	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left Upper Outer Quadrant				TCGA-A8-A07R			Negative					Negative	Other			NA	NA	-29251	NA	NA	0	273	NA	NA								2011-5-27	FEMALE					2+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES			NA		Positive			NA	Positive										NA											5	4	NA								NA	NA		No	M0	N3a	T2	Stage IIIC		A07R												Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2009	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	b5e9e344-a813-442e-8bd4-504111e98c0b	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	b5e9e344-a813-442e-8bd4-504111e98c0b	TCGA.A8.A07R.01A-12-A13B-20	TCGA.A8.A07R.01A-21W-A050-09		TCGA.A8.A07R.01			f547b351-f375-4f31-970f-40e006020b01	TCGA.A8.A07R.01	TCGA.A8.A07R.01A-21W-A050-09	TCGA.A8.A07R.01A-21D-A032-05	TCGA.A8.A07R.01		TCGA.A8.A07R.01A-21W-A050-09	TCGA.A8.A07R.01	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	TCGA.A8.A07R.01	TCGA.A8.A07R.01A-21D-A036-01		TCGA.A8.A07R.01A-21R-A034-07	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	TCGA.A8.A07R.01A-21D-A036-01	TCGA.A8.A07R.01
TCGA.A8.A08R.01	Stage IIB	52	4	Stage IIB	30	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	30	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.A8.A08R.01	30	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-A8-A08R	NA	NA	days	30	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left				TCGA-A8-A08R	TCGA.A8.A08R.01A		Negative					Negative	Other			NA	NA	-19298	728	NA	0	30	NA	NA								2011-5-27	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES			90	NO	Negative	Negative		NA	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	4	NA								NA	NA	false	No	M0	N1a	T2	Stage IIB	TCGA-A8-A08R.FC0C1BF3-74C3-4DFC-B9B5-2FD1728E287A.pdf	A08R	TUMOR FREE											Primary Tumor	1	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	3a1d8959-f829-4b8a-a65f-70a51845f118	a60f9ab6-65cb-4ef0-89ae-33db4d5546c4	3a1d8959-f829-4b8a-a65f-70a51845f118	a60f9ab6-65cb-4ef0-89ae-33db4d5546c4		TCGA.A8.A08R.01A-11W-A050-09		TCGA.A8.A08R.01				TCGA.A8.A08R.01	TCGA.A8.A08R.01A-11W-A050-09	TCGA.A8.A08R.01A-11D-A032-05	TCGA.A8.A08R.01		TCGA.A8.A08R.01A-11W-A050-09	TCGA.A8.A08R.01	3a1d8959-f829-4b8a-a65f-70a51845f118	TCGA.A8.A08R.01	TCGA.A8.A08R.01A-11D-A036-01		TCGA.A8.A08R.01A-11R-A034-07	3a1d8959-f829-4b8a-a65f-70a51845f118	TCGA.A8.A08R.01A-11D-A036-01	TCGA.A8.A08R.01
TCGA.AC.A6IW.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.AC.A6IW.01	413	0	days										TCGA-AC-A6IW	413	0	days	413	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.AC.A6IW.F64106	TCGA-AC-A6IW	TCGA.AC.A6IW.01A		Negative					Negative	Simple Mastectomy		YES	NA	NA	-26896	74	NA	0	413	NA	NA					<10%			2014-8-26	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	MX	N0 (i-)	T2	Stage IIA	TCGA-AC-A6IW.302E69E0-39F0-4CDB-97F9-A6CDDB3D7233.pdf	A6IW	TUMOR FREE						NO	YES	<10%		NO	Primary Tumor	1		7th		YES	NO	AC	Breast	A	LIVING	2013	fceb1551-4b16-45de-8ba0-7906aa3fe841	fd183f1b-305a-48f9-a42b-a0d2711bcadb	fceb1551-4b16-45de-8ba0-7906aa3fe841	fd183f1b-305a-48f9-a42b-a0d2711bcadb				TCGA.AC.A6IW.01	TCGA.AC.A6IW.01A-12D-A33F-05		7FE7ED52-C8B0-4C86-BE4E-BF31EFBEA9BB	TCGA.AC.A6IW.01				TCGA.AC.A6IW.01			fceb1551-4b16-45de-8ba0-7906aa3fe841		TCGA.AC.A6IW.01A-12D-A33D-01	TCGA.AC.A6IW.01		fceb1551-4b16-45de-8ba0-7906aa3fe841	TCGA.AC.A6IW.01A-12D-A33D-01	
TCGA.AC.A8OQ.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.AC.A8OQ.01	34	0	days										TCGA-AC-A8OQ	34	0	days	34	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-AC-A8OQ	TCGA.AC.A8OQ.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-26535	742	NA	0	34	NA	NA								2014-2-26	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Indeterminate			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	1	NA	false	No	MX	N1a	T2	Stage IIB	TCGA-AC-A8OQ.FFA6F9F3-71C1-4AF9-B9F7-0466550EBC90.pdf	A8OQ	TUMOR FREE							YES				Primary Tumor	1		7th		YES	NO	AC	Breast	A	LIVING	2011	cca6f765-44ff-4540-a961-0a2be4e41f93	9e0a88d5-c42a-4094-a44d-f638243a23f9	cca6f765-44ff-4540-a961-0a2be4e41f93	9e0a88d5-c42a-4094-a44d-f638243a23f9				TCGA.AC.A8OQ.01	TCGA.AC.A8OQ.01A-11D-A41Q-05		4B47C521-A9C2-4CF0-91BB-27DD99200EC7	TCGA.AC.A8OQ.01				TCGA.AC.A8OQ.01			cca6f765-44ff-4540-a961-0a2be4e41f93		TCGA.AC.A8OQ.01A-11D-A41E-01	TCGA.AC.A8OQ.01		cca6f765-44ff-4540-a961-0a2be4e41f93	TCGA.AC.A8OQ.01A-11D-A41E-01	
TCGA.AN.A04D.01	Stage IIB	58	1	No_Conversion	52	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	52	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA.AN.A04D.01	52	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AN-A04D	NA	NA	days	52	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Outer Quadrant	No axillary staging		TCGA.AN.A04D.F68975	TCGA-AN-A04D	TCGA.AN.A04D.01A		Negative		0		Modified radical mastectomy	Negative	Simple Mastectomy		NO	NA	NA	-21426	676	NA	0	52	NA	NA				Allred (Biocare)				2014-12-24	FEMALE		Dako Hercept Test			0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Tumor resection	260	NO	Negative		YES	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA								2	0	true	No	M0	N1	T2	Stage IIB	TCGA-AN-A04D.A3CB59DE-5893-4FA2-B4D5-EDA612480E76.pdf	A04D	TUMOR FREE	Allred (Biocare)			0	0						Primary Tumor	1				NO	YES	AN	Breast	A	LIVING	2008	a09baab9-3eac-4271-9c12-2684642f8869	336a5a76-3373-47ac-85ea-c78ba65cd902	a09baab9-3eac-4271-9c12-2684642f8869	336a5a76-3373-47ac-85ea-c78ba65cd902	TCGA.AN.A04D.01A-31-A13A-20	TCGA.AN.A04D.01A-21W-A050-09		TCGA.AN.A04D.01			e48b250c-b634-4bfb-90e4-c2e1c0069400	TCGA.AN.A04D.01	TCGA.AN.A04D.01A-21W-A050-09	TCGA.AN.A04D.01A-21D-A032-05	TCGA.AN.A04D.01		TCGA.AN.A04D.01A-21W-A050-09	TCGA.AN.A04D.01	a09baab9-3eac-4271-9c12-2684642f8869	TCGA.AN.A04D.01	TCGA.AN.A04D.01A-21D-A036-01		TCGA.AN.A04D.01A-21R-A034-07	a09baab9-3eac-4271-9c12-2684642f8869	TCGA.AN.A04D.01A-21D-A036-01	TCGA.AN.A04D.01
TCGA.AN.A0AT.01	Stage IIA	62	1	No_Conversion	10	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	10	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.AN.A0AT.01	10	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-AN-A0AT	NA	NA	days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Inner Quadrant	No axillary staging		TCGA.AN.A0AT.F68948	TCGA-AN-A0AT	TCGA.AN.A0AT.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-22798	28	NA	0	10	NA	NA								2014-12-23	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative		YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	NA	NA								0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0AT.3E8F2012-A457-4358-9C8B-23292374A743.pdf	A0AT	TUMOR FREE		0		0	0	NO				NO	Primary Tumor	1				NO	YES	AN	Breast	A	LIVING	2010	edda9023-a8d9-45dc-af21-5bba663967e4	170030ae-72f3-46cc-b82a-d23c7f3ad70d	edda9023-a8d9-45dc-af21-5bba663967e4	170030ae-72f3-46cc-b82a-d23c7f3ad70d	TCGA.AN.A0AT.01A-21-A13C-20	TCGA.AN.A0AT.01A-11D-A045-09		TCGA.AN.A0AT.01			d29e84ac-dc3b-4139-950c-fd197d9ca11f	TCGA.AN.A0AT.01	TCGA.AN.A0AT.01A-11D-A045-09	TCGA.AN.A0AT.01A-11D-A032-05	TCGA.AN.A0AT.01	TCGA.AN.A0AT.01	TCGA.AN.A0AT.01A-11D-A045-09		edda9023-a8d9-45dc-af21-5bba663967e4		TCGA.AN.A0AT.01A-11D-A036-01	TCGA.AN.A0AT.01	TCGA.AN.A0AT.01A-11R-A034-07	edda9023-a8d9-45dc-af21-5bba663967e4	TCGA.AN.A0AT.01A-11D-A036-01	TCGA.AN.A0AT.01
TCGA.AO.A0J4.01	Stage IA	41	1	Stage I	294	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	294	0	Basal	Basal-like	Negative		-13	-12	followup	T1	T1	LIVING	0	TCGA.AO.A0J4.01	1587	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AO-A0J4	1587	0	days	1587	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA.AO.A0J4.F15478	TCGA-AO-A0J4	TCGA.AO.A0J4.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-15052	224	NA	0	1587	NA	NA					<10%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%			NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	4	NA							NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-AO-A0J4.846851BE-3D24-46F0-A6BE-CEB22C7D0F62.pdf	A0J4	TUMOR FREE								<10%		YES	Primary Tumor	1			YES	NO	YES	AO	Breast	A	LIVING	2009	4808bc63-000a-4a49-a25b-4b817ca5ea54	4883e039-c3b8-4777-a0fa-765f06006523	4808bc63-000a-4a49-a25b-4b817ca5ea54	4883e039-c3b8-4777-a0fa-765f06006523		TCGA.AO.A0J4.01A-11W-A050-09		TCGA.AO.A0J4.01				TCGA.AO.A0J4.01	TCGA.AO.A0J4.01A-11W-A050-09	TCGA.AO.A0J4.01A-11D-A032-05	TCGA.AO.A0J4.01		TCGA.AO.A0J4.01A-11W-A050-09	TCGA.AO.A0J4.01	4808bc63-000a-4a49-a25b-4b817ca5ea54	TCGA.AO.A0J4.01	TCGA.AO.A0J4.01A-11D-A036-01		TCGA.AO.A0J4.01A-11R-A034-07	4808bc63-000a-4a49-a25b-4b817ca5ea54	TCGA.AO.A0J4.01A-11D-A036-01	TCGA.AO.A0J4.01
TCGA.AO.A0J6.01	Stage IIA	61	1	Stage IIA	775	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	775	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA.AO.A0J6.01	1140	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AO-A0J6	1140	0	days	1140	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA.AO.A0J6.F15479	TCGA-AO-A0J6	TCGA.AO.A0J6.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-22462	748	NA	0	1140	NA	NA					<10%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	390	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	2	NA							NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A0J6.CE2FF4D3-B82C-4435-AE1C-3E2E6F104271.pdf	A0J6	TUMOR FREE								<10%		YES	Primary Tumor	1			YES	NO	YES	AO	Breast	A	LIVING	2008	1fe98b05-6803-4803-83cd-a59e794b956e	6fc05d70-1569-4bfa-bab2-5947d36fd71b	1fe98b05-6803-4803-83cd-a59e794b956e	6fc05d70-1569-4bfa-bab2-5947d36fd71b	TCGA.AO.A0J6.01A-21-A13A-20	TCGA.AO.A0J6.01A-11W-A050-09		TCGA.AO.A0J6.01			13c00c4c-d6c9-4d3f-b63d-780757d0e5e1	TCGA.AO.A0J6.01	TCGA.AO.A0J6.01A-11W-A050-09	TCGA.AO.A0J6.01A-11D-A032-05	TCGA.AO.A0J6.01		TCGA.AO.A0J6.01A-11W-A050-09	TCGA.AO.A0J6.01	1fe98b05-6803-4803-83cd-a59e794b956e	TCGA.AO.A0J6.01	TCGA.AO.A0J6.01A-11D-A036-01		TCGA.AO.A0J6.01A-11R-A034-07	1fe98b05-6803-4803-83cd-a59e794b956e	TCGA.AO.A0J6.01A-11D-A036-01	TCGA.AO.A0J6.01
TCGA.AO.A124.01	Stage IIA	38	3	Stage IIA	3119	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	3119	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA.AO.A124.01	3506	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AO-A124	3506	0	days	3506	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA.AO.A124.F19395	TCGA-AO-A124	TCGA.AO.A124.01A		Negative					Negative	Modified Radical Mastectomy		YES	NA	NA	-14174	3213	NA	0	3506	NA	NA					<10%		Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%		0	NA		NA	NA	Other, specify		No	NA	C50.9	8523/3	C50.9		YES		Core needle biopsy	730	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	3	NA							NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A124.9009B4A7-3570-4AD6-878E-90CE8DA7980A.pdf	A124	TUMOR FREE								<10%		NO	Primary Tumor	1		5th	YES	NO	YES	AO	Breast	A	LIVING	2002	5cd42d4a-5971-4a01-8c10-99321105a864	cea1bfb5-fe63-4515-8f2b-66696afa23b2	5cd42d4a-5971-4a01-8c10-99321105a864	cea1bfb5-fe63-4515-8f2b-66696afa23b2	TCGA.AO.A124.01A-21-A13E-20	TCGA.AO.A124.01A-11D-A10M-09		TCGA.AO.A124.01	TCGA.AO.A124.01A-11D-A10N-05		184cfad8-a50d-4212-b808-dd5a0275cc32	TCGA.AO.A124.01	TCGA.AO.A124.01A-11D-A10M-09		TCGA.AO.A124.01		TCGA.AO.A124.01A-11D-A10M-09	TCGA.AO.A124.01	5cd42d4a-5971-4a01-8c10-99321105a864	TCGA.AO.A124.01	TCGA.AO.A124.01A-11D-A10L-01		TCGA.AO.A124.01A-11R-A10J-07	5cd42d4a-5971-4a01-8c10-99321105a864	TCGA.AO.A124.01A-11D-A10L-01	TCGA.AO.A124.01
TCGA.AO.A128.01	Stage IIA	61	3	Stage IIA	2877	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	2877	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA.AO.A128.01	3248	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 6		TCGA-AO-A128	3248	0	days	3248	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Lower Outer Quadrant|Right	Sentinel node biopsy alone		TCGA.AO.A128.F19405	TCGA-AO-A128	TCGA.AO.A128.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-22340	2960	NA	0	3248	NA	NA					<10%	49	Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	30	52	1	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	590	NO	Negative	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	6	NA							NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A128.03526CFD-0C3E-4ACB-AB26-3E0B0ED0ADA2.pdf	A128	TUMOR FREE								<10%		YES	Primary Tumor	1			YES	NO	YES	AO	Breast	A	LIVING	2002	4a93eaee-d821-4640-a441-255008aaf3b4	e704bf4e-f9a2-4ae5-a6ae-2cf62564c0ec	4a93eaee-d821-4640-a441-255008aaf3b4	e704bf4e-f9a2-4ae5-a6ae-2cf62564c0ec	TCGA.AO.A128.01A-21-A13E-20			TCGA.AO.A128.01	TCGA.AO.A128.01A-11D-A10N-05		b629bd13-8d7f-4bff-aa80-08dec4b64d8e	TCGA.AO.A128.01	TCGA.AO.A128.01A-11D-A10M-09		TCGA.AO.A128.01			TCGA.AO.A128.01	4a93eaee-d821-4640-a441-255008aaf3b4	TCGA.AO.A128.01	TCGA.AO.A128.01A-11D-A10L-01		TCGA.AO.A128.01A-11R-A10J-07	4a93eaee-d821-4640-a441-255008aaf3b4	TCGA.AO.A128.01A-11D-A10L-01	TCGA.AO.A128.01
TCGA.AO.A129.01	Stage IIB	29	1	No_Conversion	2923	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	2923	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA.AO.A129.01	3286	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 3	mutation cluster 5	TCGA-AO-A129	3286	0	days	3286	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					29	Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA.AO.A129.F19415	TCGA-AO-A129	TCGA.AO.A129.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-10898	2915	NA	0	3286	NA	NA					<10%	49	Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	31	52	1	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative	Negative		21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	3	NA							NO	2	NA	true	No	M0	N1a	T2	Stage IIB	TCGA-AO-A129.DD973A0E-3CC3-4ED7-BE2C-7E5E3C55032B.pdf	A129	TUMOR FREE								<10%		YES	Primary Tumor	1		5th	YES	NO	YES	AO	Breast	A	LIVING	2002	15b9736e-eafc-465e-9ddd-b1b498e8b701	4cd8277c-8a70-44e6-b491-cd35c63408db	15b9736e-eafc-465e-9ddd-b1b498e8b701	4cd8277c-8a70-44e6-b491-cd35c63408db	TCGA.AO.A129.01A-11-A13E-20	TCGA.AO.A129.01A-21D-A10M-09		TCGA.AO.A129.01	TCGA.AO.A129.01A-21D-A10N-05		480c68cf-c569-476a-86eb-cd14d5ba6b54	TCGA.AO.A129.01	TCGA.AO.A129.01A-21D-A10M-09		TCGA.AO.A129.01		TCGA.AO.A129.01A-21D-A10M-09	TCGA.AO.A129.01	15b9736e-eafc-465e-9ddd-b1b498e8b701	TCGA.AO.A129.01	TCGA.AO.A129.01A-21D-A10L-01		TCGA.AO.A129.01A-21R-A10J-07	15b9736e-eafc-465e-9ddd-b1b498e8b701	TCGA.AO.A129.01A-21D-A10L-01	TCGA.AO.A129.01
TCGA.AQ.A04J.01	Stage IIA	45	1	Stage IIA	499	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	499	0	Basal	Basal-like	Negative		-13	-12	followup	T_Other	T2	LIVING	0	TCGA.AQ.A04J.01	819	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AQ-A04J	819	0	days	819	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.AQ.A04J.F21740	TCGA-AQ-A04J	TCGA.AQ.A04J.01A		Negative		0			Negative	Simple Mastectomy		NO	NA	NA	-16615	118	NA	0	819	NA	NA					<10%		Scheduled Follow-up Submission	2012-2-20	FEMALE			<10%		0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Core needle biopsy	160	NO	Negative			20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	4	NA							NO	0	0	false	No	M0	N0 (i+)	T2	Stage IIA	TCGA-AQ-A04J.71CEC5F6-16E5-46E1-A91B-B5E0F699B231.pdf	A04J	TUMOR FREE								<10%		NO	Primary Tumor	1			YES	NO	YES	AQ	Breast	A	LIVING	2009	97168a1f-abf8-414b-af10-b63f5daa7023	57b92480-0f4d-436d-b6f0-1d01a2d6ce21	97168a1f-abf8-414b-af10-b63f5daa7023	57b92480-0f4d-436d-b6f0-1d01a2d6ce21		TCGA.AQ.A04J.01A-02W-A050-09		TCGA.AQ.A04J.01				TCGA.AQ.A04J.01	TCGA.AQ.A04J.01A-02W-A050-09	TCGA.AQ.A04J.01A-02D-A032-05	TCGA.AQ.A04J.01		TCGA.AQ.A04J.01A-02W-A050-09	TCGA.AQ.A04J.01	97168a1f-abf8-414b-af10-b63f5daa7023	TCGA.AQ.A04J.01	TCGA.AQ.A04J.01A-02D-A036-01		TCGA.AQ.A04J.01A-02R-A034-07	97168a1f-abf8-414b-af10-b63f5daa7023	TCGA.AQ.A04J.01A-02D-A036-01	TCGA.AQ.A04J.01
TCGA.AR.A0TS.01	Stage II	46	4	No_Conversion	1138	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1138	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.AR.A0TS.01	2558	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 5	mutation cluster 5	TCGA-AR-A0TS	2558	0	days	2558	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A0TS.F71730	TCGA-AR-A0TS	TCGA.AR.A0TS.01A		Negative		0			Negative	Lumpectomy		YES	NA	NA	-17141	1549	NA	0	2558	NA	NA							Scheduled Follow-up Submission	2015-3-30	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative		NO	16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	5	NA							NO	2	NA	true	No	M0	N1	T2	Stage IIB	TCGA-AR-A0TS.39A0AD32-D372-422F-94F2-173F963C7AAB.pdf	A0TS	TUMOR FREE						YES				YES	Primary Tumor	1		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	3e57b40c-7079-4f05-bf37-f560304966c1	51577886-4016-4714-8b35-c7a61a85baa2	3e57b40c-7079-4f05-bf37-f560304966c1	51577886-4016-4714-8b35-c7a61a85baa2	TCGA.AR.A0TS.01A-21-A13C-20	TCGA.AR.A0TS.01A-11D-A10Y-09		TCGA.AR.A0TS.01			3dd4ebe5-1445-46c9-8815-f9a3dc659585	TCGA.AR.A0TS.01	TCGA.AR.A0TS.01A-11D-A10Y-09	TCGA.AR.A0TS.01A-11D-A112-05	TCGA.AR.A0TS.01	TCGA.AR.A0TS.01	TCGA.AR.A0TS.01A-11D-A10Y-09		3e57b40c-7079-4f05-bf37-f560304966c1		TCGA.AR.A0TS.01A-11D-A111-01	TCGA.AR.A0TS.01	TCGA.AR.A0TS.01A-11R-A115-07	3e57b40c-7079-4f05-bf37-f560304966c1	TCGA.AR.A0TS.01A-11D-A111-01	TCGA.AR.A0TS.01
TCGA.AR.A0TU.01	Stage II	35	4	No_Conversion	360	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	360	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.AR.A0TU.01	709	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-AR-A0TU	709	0	days	709	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A0TU.F71735	TCGA-AR-A0TU	TCGA.AR.A0TU.01A		Negative		0			Negative	Simple Mastectomy		YES	NA	NA	-13039	1633	NA	0	709	NA	NA							Scheduled Follow-up Submission	2015-3-30	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	830	NO	Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	NA	NA							NO	0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-AR-A0TU.81A39E94-059E-4307-A75A-E8C051E9D0C3.pdf	A0TU	TUMOR FREE						YES				NO	Primary Tumor	1		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	2877059f-b560-413b-b8be-40d9fde8fbcf		2877059f-b560-413b-b8be-40d9fde8fbcf		TCGA.AR.A0TU.01A-21-A13C-20	TCGA.AR.A0TU.01A-31D-A10G-09		TCGA.AR.A0TU.01	TCGA.AR.A0TU.01A-31D-A10A-05		3c72159d-4ac6-4f06-89f5-4e7bc6a4e134		TCGA.AR.A0TU.01A-31D-A10G-09				TCGA.AR.A0TU.01A-31D-A10G-09		2877059f-b560-413b-b8be-40d9fde8fbcf				TCGA.AR.A0TU.01A-31R-A109-07	2877059f-b560-413b-b8be-40d9fde8fbcf		TCGA.AR.A0TU.01
TCGA.AR.A0U0.01	Stage II	73	1	No_Conversion	8	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	8	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.AR.A0U0.01	1988	0	days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA basal-like c8			mutation cluster 3	TCGA-AR-A0U0	1988	0	days	1988	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A0U0.F65068	TCGA-AR-A0U0	TCGA.AR.A0U0.01A		Negative		0			Negative	Simple Mastectomy		YES	NA	NA	-26993	2289	NA	0	1988	NA	NA							Scheduled Follow-up Submission	2014-9-18	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO			NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											1	NA	NA							NO	0	2	true	No	M0	N1	T2	Stage IIB	TCGA-AR-A0U0.322BB8BB-100F-4838-9771-EAEE5A3B817A.pdf	A0U0	TUMOR FREE										YES	Primary Tumor	1				NO	YES	AR	Breast	A	LIVING	2004	dea20128-b180-4da1-9da5-0f00bea3b1ab	0c2f9cdb-8c8f-4741-b98f-0d41ac50be83	dea20128-b180-4da1-9da5-0f00bea3b1ab	0c2f9cdb-8c8f-4741-b98f-0d41ac50be83	TCGA.AR.A0U0.01A-21-A13D-20	TCGA.AR.A0U0.01A-11D-A10G-09		TCGA.AR.A0U0.01	TCGA.AR.A0U0.01A-11D-A10A-05		4c67c3c8-cc93-4bb4-a8c6-76232335c00f	TCGA.AR.A0U0.01	TCGA.AR.A0U0.01A-11D-A10G-09		TCGA.AR.A0U0.01		TCGA.AR.A0U0.01A-11D-A10G-09		dea20128-b180-4da1-9da5-0f00bea3b1ab		TCGA.AR.A0U0.01A-11D-A107-01		TCGA.AR.A0U0.01A-11R-A109-07	dea20128-b180-4da1-9da5-0f00bea3b1ab	TCGA.AR.A0U0.01A-11D-A107-01	TCGA.AR.A0U0.01
TCGA.AR.A0U4.01	Stage II	54	1	No_Conversion	1627	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1627	0	Basal	Basal-like	Negative	ReacII	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.AR.A0U4.01	3261	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 11	TCGA-AR-A0U4	3261	0	days	3261	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A0U4.F71739	TCGA-AR-A0U4	TCGA.AR.A0U4.01A		Negative		0			Negative	Simple Mastectomy		NO	NA	NA	-19729	1517	NA	0	3261	NA	NA							Scheduled Follow-up Submission	2015-3-30	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	530	NO	Negative		NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	5	NA							NO	0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-AR-A0U4.6424BA69-DA2B-4CCD-ADDF-DB1BEDA11EBF.pdf	A0U4	TUMOR FREE						YES				NO	Primary Tumor	1		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	ee7156b6-f469-402c-8f63-f4c2f6913db1	753d28b1-7ff1-4211-beaf-6966e9ce0d18	ee7156b6-f469-402c-8f63-f4c2f6913db1	753d28b1-7ff1-4211-beaf-6966e9ce0d18	TCGA.AR.A0U4.01A-21-A13D-20	TCGA.AR.A0U4.01A-11D-A117-09		TCGA.AR.A0U4.01	TCGA.AR.A0U4.01A-11D-A10A-05		e4120a7f-41ff-4928-a173-0cb5f7fb8674	TCGA.AR.A0U4.01			TCGA.AR.A0U4.01		TCGA.AR.A0U4.01A-11D-A117-09	TCGA.AR.A0U4.01	ee7156b6-f469-402c-8f63-f4c2f6913db1	TCGA.AR.A0U4.01	TCGA.AR.A0U4.01A-11D-A107-01		TCGA.AR.A0U4.01A-11R-A109-07	ee7156b6-f469-402c-8f63-f4c2f6913db1	TCGA.AR.A0U4.01A-11D-A107-01	TCGA.AR.A0U4.01
TCGA.AR.A1AI.01	Stage II	47	1	Stage IIA	1881	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1881	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.AR.A1AI.01	3296	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A1AI	3296	0	days	3296	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A1AI.F69268	TCGA-AR-A1AI	TCGA.AR.A1AI.01A		Negative					Negative	Simple Mastectomy		YES	NA	NA	-17229	1939	NA	0	3296	NA	NA	588						Scheduled Follow-up Submission	2014-12-31	FEMALE					2+	NA		NA	NA	Medullary Carcinoma		No	NA	C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	1050	NO	Equivocal	Negative	NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA			Other, specify	New Primary Tumor	Contralateral Breast		NO	0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-AR-A1AI.F5CAE962-5347-46FA-86EE-169121BED547.pdf	A1AI	TUMOR FREE						YES	YES			NO	Primary Tumor	1		6th	YES	NO	YES	AR	Breast	A	LIVING	2005	52ff562f-6a13-435a-acab-16a064633b1d	68564280-daf0-4bbb-9aa0-79493b39231b	52ff562f-6a13-435a-acab-16a064633b1d	68564280-daf0-4bbb-9aa0-79493b39231b	TCGA.AR.A1AI.01A-21-A13E-20	TCGA.AR.A1AI.01A-11D-A12Q-09		TCGA.AR.A1AI.01	TCGA.AR.A1AI.01A-11D-A12R-05		d872badb-8c24-48fe-b482-6b3c262a4259	TCGA.AR.A1AI.01	TCGA.AR.A1AI.01A-11D-A12Q-09		TCGA.AR.A1AI.01	TCGA.AR.A1AI.01	TCGA.AR.A1AI.01A-11D-A12Q-09		52ff562f-6a13-435a-acab-16a064633b1d		TCGA.AR.A1AI.01A-11D-A12N-01	TCGA.AR.A1AI.01	TCGA.AR.A1AI.01A-11R-A12P-07	52ff562f-6a13-435a-acab-16a064633b1d	TCGA.AR.A1AI.01A-11D-A12N-01	TCGA.AR.A1AI.01
TCGA.AR.A1AQ.01	Stage II	49	1	Stage IIA	1309	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1309	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.AR.A1AQ.01	3021	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A1AQ	3021	0	days	3021	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A1AQ.F69276	TCGA-AR-A1AQ	TCGA.AR.A1AQ.01A		Negative					Negative	Other		YES	NA	NA	-18109	1424	NA	0	3021	NA	NA							Scheduled Follow-up Submission	2014-12-31	FEMALE					2+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	180	NO	Equivocal	Negative	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA							NO	0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-AR-A1AQ.FC236604-AAE5-4394-9D39-270FFEFB635A.pdf	A1AQ	TUMOR FREE						YES	YES			YES	Primary Tumor	1	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	747f56be-2fdd-4eb8-99a7-34afd923d8e1	ffbdf887-0c9a-40c0-971a-61eb2bb70e2a	747f56be-2fdd-4eb8-99a7-34afd923d8e1	ffbdf887-0c9a-40c0-971a-61eb2bb70e2a	TCGA.AR.A1AQ.01A-21-A13E-20	TCGA.AR.A1AQ.01A-11D-A12Q-09		TCGA.AR.A1AQ.01	TCGA.AR.A1AQ.01A-11D-A12R-05		23358473-9909-47ff-b683-d046e292d504	TCGA.AR.A1AQ.01	TCGA.AR.A1AQ.01A-11D-A12Q-09		TCGA.AR.A1AQ.01	TCGA.AR.A1AQ.01	TCGA.AR.A1AQ.01A-11D-A12Q-09		747f56be-2fdd-4eb8-99a7-34afd923d8e1		TCGA.AR.A1AQ.01A-11D-A12N-01	TCGA.AR.A1AQ.01	TCGA.AR.A1AQ.01A-11R-A12P-07	747f56be-2fdd-4eb8-99a7-34afd923d8e1	TCGA.AR.A1AQ.01A-11D-A12N-01	TCGA.AR.A1AQ.01
TCGA.AR.A256.01	Stage II	45	1	Stage IIA	2854	2854	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	2854	1	Basal		Negative		NA	NA	enrollment	T_Other	T2	DECEASED	1	TCGA.AR.A256.01	2854	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12		mutation cluster 5	TCGA-AR-A256	1640	1	days	2854	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A256.F31923	TCGA-AR-A256	TCGA.AR.A256.01A		Negative					Negative	Other		YES	NA	NA	-16642	3740	2854	0	NA	NA	NA	1640						Scheduled Follow-up Submission	2012-5-11	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	210	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	NA	NA				Locoregional Disease			YES	0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-AR-A256.0FDC2801-71F8-4D45-BFF1-89445E621A41.pdf	A256								YES			NO	Primary Tumor	1	Mastectomy	5th	YES	NO	YES	AR	Breast	A	DECEASED	2001	60534f8f-970a-4308-9844-a3a41dd6c187	4b23b5e1-813b-4975-8594-627aadcd3f92	60534f8f-970a-4308-9844-a3a41dd6c187	4b23b5e1-813b-4975-8594-627aadcd3f92	TCGA.AR.A256.01A-21-A17I-20	TCGA.AR.A256.01A-11D-A167-09		TCGA.AR.A256.01	TCGA.AR.A256.01A-11D-A16A-05		c98c88ee-f8ed-444b-a51c-67e6d942a8b5	TCGA.AR.A256.01	TCGA.AR.A256.01A-11D-A167-09			TCGA.AR.A256.01	TCGA.AR.A256.01A-11D-A167-09		60534f8f-970a-4308-9844-a3a41dd6c187		TCGA.AR.A256.01A-11D-A166-01	TCGA.AR.A256.01		60534f8f-970a-4308-9844-a3a41dd6c187	TCGA.AR.A256.01A-11D-A166-01	
TCGA.B6.A0I2.01	Stage IA	45	3	Stage I	4360	NA		FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	4360	0	Basal	Basal-like		ReacII	-13	-12	followup	T1	T1	LIVING	0	TCGA.B6.A0I2.01	4361	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-B6-A0I2	4361	0	days	4361	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA.B6.A0I2.F12630	TCGA-B6-A0I2	TCGA.B6.A0I2.01A										NO	NA	NA	-16702	5305	NA	0	4361	NA	NA							Scheduled Follow-up Submission	2011-6-2	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Excisional Biopsy	200	NO				8		Indeterminate (neither Pre or Postmenopausal)									NA											5	3	NA							NO	0	NA	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0I2.CA834E5F-30DC-46CF-AF33-AD11226FC09E.pdf	A0I2	TUMOR FREE										YES	Primary Tumor	1		4th	YES	NO	YES	B6	Breast	A	LIVING	1995	7175b3eb-5198-4d7f-b205-91ae8df344b4	aa5e3733-d47a-4371-99ab-34d98aec9bf6	7175b3eb-5198-4d7f-b205-91ae8df344b4	aa5e3733-d47a-4371-99ab-34d98aec9bf6	TCGA.B6.A0I2.01A-21-A13C-20	TCGA.B6.A0I2.01A-11W-A050-09		TCGA.B6.A0I2.01			3c520911-0d5d-4a69-bef5-f2666b99544c	TCGA.B6.A0I2.01	TCGA.B6.A0I2.01A-11W-A050-09	TCGA.B6.A0I2.01A-11D-A032-05	TCGA.B6.A0I2.01		TCGA.B6.A0I2.01A-11W-A050-09	TCGA.B6.A0I2.01	7175b3eb-5198-4d7f-b205-91ae8df344b4	TCGA.B6.A0I2.01	TCGA.B6.A0I2.01A-11D-A036-01		TCGA.B6.A0I2.01A-11R-A034-07	7175b3eb-5198-4d7f-b205-91ae8df344b4	TCGA.B6.A0I2.01A-11D-A036-01	TCGA.B6.A0I2.01
TCGA.B6.A0RT.01	Stage IIIA	39	1	No_Conversion	2721	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	2721	0	Basal	Basal-like	Negative	ReacII	-13	-12	followup	T_Other	T3	LIVING	0	TCGA.B6.A0RT.01	2721	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-B6-A0RT	2721	0	days	2721	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA.B6.A0RT.F13789	TCGA-B6-A0RT	TCGA.B6.A0RT.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-14374	5047	NA	0	2721	NA	NA				Image Analysis			Scheduled Follow-up Submission	2011-7-12	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO				23	Close	Indeterminate (neither Pre or Postmenopausal)									NA											5	3	NA							NO	1	NA	true	No	M0	N1	T3	Stage IIIA	TCGA-B6-A0RT.64D53A4B-4735-4AD2-A413-520797F5F9CB.pdf	A0RT	TUMOR FREE	Image Analysis									YES	Primary Tumor	1		4th	YES	NO	YES	B6	Breast	A	LIVING	1996	2b721e04-5452-4b34-b3df-c6cdd04e87b1	ee1a99fc-1434-4d2f-a989-02edc2d64dba	2b721e04-5452-4b34-b3df-c6cdd04e87b1	ee1a99fc-1434-4d2f-a989-02edc2d64dba	TCGA.B6.A0RT.01A-11-A13C-20	TCGA.B6.A0RT.01A-21D-A099-09		TCGA.B6.A0RT.01	TCGA.B6.A0RT.01A-21D-A10P-05		f4b94eba-e9e8-4f06-812e-7f68eefa407b	TCGA.B6.A0RT.01	TCGA.B6.A0RT.01A-21D-A099-09		TCGA.B6.A0RT.01		TCGA.B6.A0RT.01A-21D-A099-09	TCGA.B6.A0RT.01	2b721e04-5452-4b34-b3df-c6cdd04e87b1	TCGA.B6.A0RT.01	TCGA.B6.A0RT.01A-21D-A087-01		TCGA.B6.A0RT.01A-21R-A084-07	2b721e04-5452-4b34-b3df-c6cdd04e87b1	TCGA.B6.A0RT.01A-21D-A087-01	TCGA.B6.A0RT.01
TCGA.B6.A402.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.B6.A402.01	2134	0	days										TCGA-B6-A402	2330	1	days	2134	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			47	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA.B6.A402.F60751	TCGA-B6-A402	TCGA.B6.A402.01A		Negative	4 Point Scale	1+	4 Point Scale		Negative	Lumpectomy		YES	NA	NA	-17314	1563	NA	0	2134	NA	NA	2330				<10%			2014-7-8	FEMALE			<10%		1+	NA		NA	4.4	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	10	NO	Negative		NO	3	Negative			Positive	2+		Positive	<10%		<10%	4.1	3 Point Scale	2+	2+	Negative		70-79%		Negative			NA	NA	3.1		3 Point Scale	Other, specify	Locoregional Recurrence	Lymph Node	NO	YES	0	0	true	No	M0	N0 (i-)	T1c	Stage I	TCGA-B6-A402.9BC704DE-0914-49F1-80F9-36CFE52B8484.pdf	A402	WITH TUMOR						YES	YES	<10%		YES	Primary Tumor	1		6th		NO	YES	B6	Breast	A	LIVING	2008	976a1b88-ed7a-493a-8ac9-3d504edfbc76	1adbdc80-ec5b-4c24-8198-6e6166be39c1	976a1b88-ed7a-493a-8ac9-3d504edfbc76	1adbdc80-ec5b-4c24-8198-6e6166be39c1				TCGA.B6.A402.01	TCGA.B6.A402.01A-11D-A23D-05			TCGA.B6.A402.01	TCGA.B6.A402.01A-11D-A23C-09			TCGA.B6.A402.01			976a1b88-ed7a-493a-8ac9-3d504edfbc76		TCGA.B6.A402.01A-11D-A238-01	TCGA.B6.A402.01		976a1b88-ed7a-493a-8ac9-3d504edfbc76	TCGA.B6.A402.01A-11D-A238-01	
TCGA.BH.A0B9.01	Stage IA	44	1	Stage I	1572	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1572	0		Basal-like	Negative	Basal	-13	-12	followup	T1	T1	LIVING	0	TCGA.BH.A0B9.01	1572	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6		miRNA cluster 14	cluster 5	mutation cluster 5	TCGA-BH-A0B9	1572	0	days	1572	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel node biopsy alone		TCGA.BH.A0B9.F15438	TCGA-BH-A0B9	TCGA.BH.A0B9.01A		Negative		0			Negative	Other		NO	NA	NA	-16310	1391	NA	0	1572	NA	NA							Scheduled Follow-up Submission	2010-11-4	FEMALE			<10%		0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Core needle biopsy	190	NO	Negative			1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	5	NA							NO	0	NA	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0B9.EB00527B-1E37-420E-85E4-10063DB4BC1C.pdf	A0B9	TUMOR FREE										YES	Primary Tumor	1	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2006	d5c39754-79c3-432c-b496-34a394662e17	7fd0974b-7ac4-4bdd-904d-234af0722313	d5c39754-79c3-432c-b496-34a394662e17	7fd0974b-7ac4-4bdd-904d-234af0722313	TCGA.BH.A0B9.01A-21-A13C-20	TCGA.BH.A0B9.01A-11W-A071-09		TCGA.BH.A0B9.01	TCGA.BH.A0B9.01A-11D-A10P-05		99bf951a-a4c0-424e-bdf5-4308ec20f38d	TCGA.BH.A0B9.01	TCGA.BH.A0B9.01A-11W-A071-09		TCGA.BH.A0B9.01		TCGA.BH.A0B9.01A-11W-A071-09	TCGA.BH.A0B9.01	d5c39754-79c3-432c-b496-34a394662e17	TCGA.BH.A0B9.01	TCGA.BH.A0B9.01A-11D-A059-01		TCGA.BH.A0B9.01A-11R-A056-07	d5c39754-79c3-432c-b496-34a394662e17	TCGA.BH.A0B9.01A-11D-A059-01	TCGA.BH.A0B9.01
TCGA.BH.A0BG.01	Stage I	73	1	Stage I	756	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	756	0	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA.BH.A0BG.01	1871	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA c1uster 9	cluster 4	mutation cluster 5	TCGA-BH-A0BG	1871	0	days	1871	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left Lower Outer Quadrant			TCGA.BH.A0BG.F58615	TCGA-BH-A0BG	TCGA.BH.A0BG.01A		Negative					Negative	Other			NA	NA	-26988	798	NA	0	1871	NA	NA			NO					2014-4-16	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	4	NA							NO	0	NA	true	No	M0	N0	T1	Stage I	TCGA-BH-A0BG.CB0C2E8E-2D5D-492C-9C7E-0ECD0458425A.pdf	A0BG	TUMOR FREE						NO	YES			YES	Primary Tumor	1	Segmental mastectomy with sentinel axillary lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2008	70b29dd6-1688-4510-94dd-5fcb26a1a908	e0ad6225-f660-4276-9609-f8fc0889a61c	70b29dd6-1688-4510-94dd-5fcb26a1a908	e0ad6225-f660-4276-9609-f8fc0889a61c		TCGA.BH.A0BG.01A-11D-A10Y-09		TCGA.BH.A0BG.01				TCGA.BH.A0BG.01	TCGA.BH.A0BG.01A-11D-A10Y-09	TCGA.BH.A0BG.01A-11D-A112-05	TCGA.BH.A0BG.01	TCGA.BH.A0BG.01	TCGA.BH.A0BG.01A-11D-A10Y-09		70b29dd6-1688-4510-94dd-5fcb26a1a908		TCGA.BH.A0BG.01A-11D-A111-01	TCGA.BH.A0BG.01	TCGA.BH.A0BG.01A-11R-A115-07	70b29dd6-1688-4510-94dd-5fcb26a1a908	TCGA.BH.A0BG.01A-11D-A111-01	TCGA.BH.A0BG.01
TCGA.BH.A18T.01	Stage IIA	70	1	Stage IIA	224	224	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	224	1	Basal	Luminal A	Negative	ReacII	0	-3	enrollment	T_Other	T2	DECEASED	1	TCGA.BH.A18T.01	224	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-BH-A18T	NA	NA	days	224	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-BH-A18T	TCGA.BH.A18T.01A		Negative					Negative	Other			NA	NA	-25674	2737	224	0	NA	NA	NA								2011-7-2	FEMALE					2+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	210	NO	Positive	Negative		NA	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	2	NA								NA	NA	true	No	M0	N0	T2	Stage IIA	TCGA-BH-A18T.B8FF655E-47AB-4BB0-B119-1402A335126A.pdf	A18T	WITH TUMOR											Primary Tumor	1	segmental mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003	733890d7-6557-454e-8697-fe9c619874e3	2e404295-1b50-43a0-b4cc-5d7712e4d3f5	733890d7-6557-454e-8697-fe9c619874e3	2e404295-1b50-43a0-b4cc-5d7712e4d3f5	TCGA.BH.A18T.01A-21-A13E-20	TCGA.BH.A18T.01A-11D-A12B-09		TCGA.BH.A18T.01			169f872a-65f6-40ae-8cd9-948822cc3a20	TCGA.BH.A18T.01	TCGA.BH.A18T.01A-11D-A12B-09	TCGA.BH.A18T.01A-11D-A12E-05	TCGA.BH.A18T.01	TCGA.BH.A18T.01	TCGA.BH.A18T.01A-11D-A12B-09		733890d7-6557-454e-8697-fe9c619874e3		TCGA.BH.A18T.01A-11D-A12A-01	TCGA.BH.A18T.01	TCGA.BH.A18T.01A-11R-A12D-07	733890d7-6557-454e-8697-fe9c619874e3	TCGA.BH.A18T.01A-11D-A12A-01	TCGA.BH.A18T.01
TCGA.C8.A12K.01	Stage IIB	80	1	No_Conversion	0	NA		FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	0	0	Basal	Basal-like		Basal	-13	-12	enrollment	T_Other	T2	LIVING	NA	TCGA.C8.A12K.01	NA	NA	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 3	mutation cluster 8	TCGA-C8-A12K	NA	NA	days	NA	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Right Upper Inner Quadrant	Other (specify)	Pateys surgery		TCGA-C8-A12K	TCGA.C8.A12K.01A								Other		NO	NA	NA	-29463	57	NA	0	0	NA	NA								2011-4-12	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	970	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA								1	NA	true	No	M0	N1	T2	Stage IIB	TCGA-C8-A12K.149E102C-FE01-4FC0-8410-CD9743CAFA15.pdf	A12K	TUMOR FREE											Primary Tumor	1	Pateys surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	cab482fe-e5e3-438a-8ece-322111d17c4b	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	cab482fe-e5e3-438a-8ece-322111d17c4b	TCGA.C8.A12K.01A-11-A13D-20	TCGA.C8.A12K.01A-21D-A10Y-09		TCGA.C8.A12K.01			5daae9b4-734a-479f-a414-50e0629a8598	TCGA.C8.A12K.01	TCGA.C8.A12K.01A-21D-A10Y-09	TCGA.C8.A12K.01A-21D-A112-05	TCGA.C8.A12K.01	TCGA.C8.A12K.01	TCGA.C8.A12K.01A-21D-A10Y-09		0ef00203-8a0a-4d04-aa1e-c1164958d8ec		TCGA.C8.A12K.01A-21D-A111-01	TCGA.C8.A12K.01	TCGA.C8.A12K.01A-21R-A115-07	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	TCGA.C8.A12K.01A-21D-A111-01	TCGA.C8.A12K.01
TCGA.C8.A12V.01	Stage IIA	55	1	Stage IIA	0	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	0	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.C8.A12V.01	385	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-C8-A12V	385	0	days	385	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right	Axillary lymph node dissection alone		TCGA.C8.A12V.F19095	TCGA-C8-A12V	TCGA.C8.A12V.01A		Negative					Negative	Other			NA	NA	-20346	57	NA	0	385	NA	NA			NO				Scheduled Follow-up Submission	2011-12-2	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	540	NO	Negative			5		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA							NO	0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-C8-A12V.8ED8A37B-C885-4333-AC5D-EA73A5A81173.pdf	A12V	TUMOR FREE							YES			NO	Primary Tumor	1	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	b12c9095-55c7-4add-9e22-3d65eeef2040	84a2d172-c9f4-4ce9-8ee8-6ec6b5d4a747	b12c9095-55c7-4add-9e22-3d65eeef2040	84a2d172-c9f4-4ce9-8ee8-6ec6b5d4a747	TCGA.C8.A12V.01A-21-A13D-20	TCGA.C8.A12V.01A-11D-A10Y-09		TCGA.C8.A12V.01			46c61ec3-e651-474c-8ce2-0cbced7cbca5	TCGA.C8.A12V.01	TCGA.C8.A12V.01A-11D-A10Y-09	TCGA.C8.A12V.01A-11D-A112-05	TCGA.C8.A12V.01	TCGA.C8.A12V.01	TCGA.C8.A12V.01A-11D-A10Y-09		b12c9095-55c7-4add-9e22-3d65eeef2040		TCGA.C8.A12V.01A-11D-A111-01	TCGA.C8.A12V.01	TCGA.C8.A12V.01A-11R-A115-07	b12c9095-55c7-4add-9e22-3d65eeef2040	TCGA.C8.A12V.01A-11D-A111-01	TCGA.C8.A12V.01
TCGA.C8.A134.01	Stage IIA	52	1	No_Conversion	0	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	0	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.C8.A134.01	383	0	days	BRCA-LUAD+	C8-BLCA	cluster 4	Cluster 6	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 5	cluster 6	mutation cluster 5	TCGA-C8-A134	383	0	days	383	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left	Axillary lymph node dissection alone		TCGA.C8.A134.F70822	TCGA-C8-A134			Negative					Negative	Other			NA	NA	-19010	NA	NA	0	383	NA	NA							Scheduled Follow-up Submission	2015-3-9	FEMALE					2+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	NA		Equivocal		NO	7	Negative	Peri (6-12 months since last menstrual period)									NA											4	6	NA							NO	NA	NA		No	M0	N0	T2	Stage IIA		A134	TUMOR FREE						YES				NO	Primary Tumor	1	Modified Radical Masectomy	6th	YES	YES	NO	C8	Breast		LIVING	2010	d96863aa-33a8-43bf-a9b5-589de1e9cf44	aad64468-8c93-47ce-bc77-829f4fb8b2d6	d96863aa-33a8-43bf-a9b5-589de1e9cf44	aad64468-8c93-47ce-bc77-829f4fb8b2d6	TCGA.C8.A134.01A-21-A13D-20	TCGA.C8.A134.01A-11D-A10Y-09		TCGA.C8.A134.01			ec21c134-e0b1-44e4-be21-ff70c20ee979	TCGA.C8.A134.01	TCGA.C8.A134.01A-11D-A10Y-09	TCGA.C8.A134.01A-11D-A112-05	TCGA.C8.A134.01	TCGA.C8.A134.01	TCGA.C8.A134.01A-11D-A10Y-09		d96863aa-33a8-43bf-a9b5-589de1e9cf44		TCGA.C8.A134.01A-11D-A111-01	TCGA.C8.A134.01	TCGA.C8.A134.01A-11R-A115-07	d96863aa-33a8-43bf-a9b5-589de1e9cf44	TCGA.C8.A134.01A-11D-A111-01	TCGA.C8.A134.01
TCGA.C8.A27B.01	Stage IIB	48	1	Stage IIB	30	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	30	0	Basal		Negative		NA	NA	enrollment	T_Other	T3	LIVING	0	TCGA.C8.A27B.01	439	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 13	TCGA-C8-A27B	439	0	days	439	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left			TCGA.C8.A27B.F70781	TCGA-C8-A27B	TCGA.C8.A27B.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-17763	93	NA	0	439	NA	NA								2015-3-9	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	240	NO	Negative		NO	NA	Negative	Peri (6-12 months since last menstrual period)									NA											5	5	NA							NO	NA	NA	true	No	M0	N0	T3	Stage IIB	TCGA-C8-A27B.CD43BA31-A5C6-4C0C-AA07-3171332776CC.pdf	A27B	TUMOR FREE						YES	NO			NO	Primary Tumor	1		6th		YES	NO	C8	Breast	A	LIVING	2011	fb03a31f-6611-4343-816d-37a332147eac	2d4cf2b5-75ed-40f3-b2e7-a32bde10b1f2	fb03a31f-6611-4343-816d-37a332147eac	2d4cf2b5-75ed-40f3-b2e7-a32bde10b1f2	TCGA.C8.A27B.01A-21-A17K-20	TCGA.C8.A27B.01A-11D-A167-09		TCGA.C8.A27B.01	TCGA.C8.A27B.01A-11D-A16A-05		14732205-f21b-44fc-9e31-7d8f9dde67df	TCGA.C8.A27B.01	TCGA.C8.A27B.01A-11D-A167-09			TCGA.C8.A27B.01	TCGA.C8.A27B.01A-11D-A167-09		fb03a31f-6611-4343-816d-37a332147eac		TCGA.C8.A27B.01A-11D-A166-01	TCGA.C8.A27B.01		fb03a31f-6611-4343-816d-37a332147eac	TCGA.C8.A27B.01A-11D-A166-01	
TCGA.D8.A147.01	Stage X	45	1	Stage IIA	2	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	2	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.D8.A147.01	584	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 13	TCGA-D8-A147	584	0	days	584	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA.D8.A147.F20737	TCGA-D8-A147	TCGA.D8.A147.01A		Negative					Negative	Lumpectomy			NA	NA	-16736	163	NA	0	584	NA	NA							Scheduled Follow-up Submission	2012-1-14	FEMALE		Hercep Test  TM Dako				NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			1	Negative	Indeterminate (neither Pre or Postmenopausal)									NA											5	5	NA							NO	0	NA	false	No	M0	N0	T2		TCGA-D8-A147.380639A2-E89C-4495-8168-82120617129F.pdf	A147	TUMOR FREE							YES			YES	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	4d28bcbc-dbdd-46f8-9329-49f359480a97	92830f47-3f32-4b74-bef4-4536963be38f	4d28bcbc-dbdd-46f8-9329-49f359480a97	92830f47-3f32-4b74-bef4-4536963be38f	TCGA.D8.A147.01A-21-A13D-20	TCGA.D8.A147.01A-11D-A10Y-09		TCGA.D8.A147.01			a8d9009e-ecf1-420f-a3b7-faab805210de	TCGA.D8.A147.01	TCGA.D8.A147.01A-11D-A10Y-09	TCGA.D8.A147.01A-11D-A112-05	TCGA.D8.A147.01	TCGA.D8.A147.01	TCGA.D8.A147.01A-11D-A10Y-09		4d28bcbc-dbdd-46f8-9329-49f359480a97		TCGA.D8.A147.01A-11D-A111-01	TCGA.D8.A147.01	TCGA.D8.A147.01A-11R-A115-07	4d28bcbc-dbdd-46f8-9329-49f359480a97	TCGA.D8.A147.01A-11D-A111-01	TCGA.D8.A147.01
TCGA.D8.A1XK.01	Stage IB	55	1	Stage IIB	326	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	326	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.D8.A1XK.01	441	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 14	cluster 5		TCGA-D8-A1XK	441	0	days	441	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA.D8.A1XK.F30074	TCGA-D8-A1XK	TCGA.D8.A1XK.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-20092	275	NA	0	441	NA	NA			NO				Scheduled Follow-up Submission	2012-2-4	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA							NO	3	NA	false	No	MX	N1a	T2	Stage IIB	TCGA-D8-A1XK.B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C.pdf	A1XK	TUMOR FREE							YES			YES	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	e4edbc10-8939-4bbf-befa-ee44229e4394	97f9770c-3539-4578-84f4-bb63a7463900	e4edbc10-8939-4bbf-befa-ee44229e4394	97f9770c-3539-4578-84f4-bb63a7463900	TCGA.D8.A1XK.01A-11-A17K-20			TCGA.D8.A1XK.01	TCGA.D8.A1XK.01A-21D-A14N-05		567f0c52-eb40-43cc-a34c-a7e1714b420a	TCGA.D8.A1XK.01	TCGA.D8.A1XK.01A-21D-A14K-09			TCGA.D8.A1XK.01			e4edbc10-8939-4bbf-befa-ee44229e4394		TCGA.D8.A1XK.01A-21D-A14J-01	TCGA.D8.A1XK.01		e4edbc10-8939-4bbf-befa-ee44229e4394	TCGA.D8.A1XK.01A-21D-A14J-01	
TCGA.D8.A1XQ.01	Stage IIA	69	1	Stage IIA	177	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	177	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.D8.A1XQ.01	499	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3		TCGA-D8-A1XQ	499	0	days	499	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.D8.A1XQ.F29449	TCGA-D8-A1XQ	TCGA.D8.A1XQ.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-25345	158	NA	0	499	NA	NA			NO	% IHC			Scheduled Follow-up Submission	2012-3-26	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA							NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1XQ.33B6269D-1D59-4184-A786-2BEB73F6D3A8.pdf	A1XQ	TUMOR FREE					0%		YES	<10%		NO	Primary Tumor	1		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	0c7fc003-950b-4138-8390-036c072b640e	fd2ba09e-a9f8-4cda-810c-ac29afd0e6b2	0c7fc003-950b-4138-8390-036c072b640e	fd2ba09e-a9f8-4cda-810c-ac29afd0e6b2	TCGA.D8.A1XQ.01A-21-A17K-20			TCGA.D8.A1XQ.01	TCGA.D8.A1XQ.01A-11D-A14N-05		43fa736b-5235-4357-8ae7-2b0029efecfc	TCGA.D8.A1XQ.01	TCGA.D8.A1XQ.01A-11D-A14K-09			TCGA.D8.A1XQ.01			0c7fc003-950b-4138-8390-036c072b640e		TCGA.D8.A1XQ.01A-11D-A14J-01	TCGA.D8.A1XQ.01		0c7fc003-950b-4138-8390-036c072b640e	TCGA.D8.A1XQ.01A-11D-A14J-01	
TCGA.E2.A14N.01	Stage IIB	37	4	Stage IIB	1350	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	1350	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.E2.A14N.01	1434	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 5	cluster 6	mutation cluster 5	TCGA-E2-A14N	1434	0	days	1434	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.E2.A14N.F19154	TCGA-E2-A14N	TCGA.E2.A14N.01A		Negative					Negative	Simple Mastectomy		NO	NA	NA	-13743	1240	NA	0	1434	NA	NA			NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-11-17	FEMALE			<10%			NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	440	NO	Negative			38	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	6	NA							NO	1	NA	false	No	M0	N1	T2	Stage IIB	TCGA-E2-A14N.C972EC08-E1AE-4FCB-B8A1-15000306CDE7.pdf	A14N	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	6e45dd01-225d-4871-9a3a-f591808ad234	ec2186e9-17fc-49c1-a3f2-81f51faf1fc7	6e45dd01-225d-4871-9a3a-f591808ad234	ec2186e9-17fc-49c1-a3f2-81f51faf1fc7	TCGA.E2.A14N.01A-21-A17I-20	TCGA.E2.A14N.01A-31D-A135-09		TCGA.E2.A14N.01	TCGA.E2.A14N.01A-31D-A138-05		df24b18e-26f0-494d-a7bc-4672b1a0314b	TCGA.E2.A14N.01	TCGA.E2.A14N.01A-31D-A135-09		TCGA.E2.A14N.01	TCGA.E2.A14N.01	TCGA.E2.A14N.01A-31D-A135-09		6e45dd01-225d-4871-9a3a-f591808ad234		TCGA.E2.A14N.01A-31D-A134-01	TCGA.E2.A14N.01	TCGA.E2.A14N.01A-31R-A137-07	6e45dd01-225d-4871-9a3a-f591808ad234	TCGA.E2.A14N.01A-31D-A134-01	TCGA.E2.A14N.01
TCGA.E2.A14R.01	Stage IIA	62	1	Stage IIA	845	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	845	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.E2.A14R.01	1174	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A14R	971	1	days	1174	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES	YES		62	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA.E2.A14R.F18838	TCGA-E2-A14R	TCGA.E2.A14R.01A		Negative					Negative	Lumpectomy		NO	NA	971	-22686	910	NA	0	1174	NA	NA	971		NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-10-24	FEMALE			<10%		1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA			Other, specify	New Primary Tumor	Endometrial		YES	0	NA	false	No	M0	N0	T2	Stage IIA	TCGA-E2-A14R.0B6DCA80-3108-4D25-B095-3EC704598B23.pdf	A14R	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	76a625e9-22b3-42b8-8813-27c133d0b248	fbf955e5-ed36-4f3a-b8e0-fb63dbb7543d	76a625e9-22b3-42b8-8813-27c133d0b248	fbf955e5-ed36-4f3a-b8e0-fb63dbb7543d		TCGA.E2.A14R.01A-11D-A10Y-09		TCGA.E2.A14R.01				TCGA.E2.A14R.01	TCGA.E2.A14R.01A-11D-A10Y-09	TCGA.E2.A14R.01A-11D-A112-05	TCGA.E2.A14R.01	TCGA.E2.A14R.01	TCGA.E2.A14R.01A-11D-A10Y-09		76a625e9-22b3-42b8-8813-27c133d0b248		TCGA.E2.A14R.01A-11D-A111-01	TCGA.E2.A14R.01	TCGA.E2.A14R.01A-11R-A115-07	76a625e9-22b3-42b8-8813-27c133d0b248	TCGA.E2.A14R.01A-11D-A111-01	TCGA.E2.A14R.01
TCGA.E2.A1B6.01	Stage IIA	44	1	Stage IIA	338	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	338	0		Luminal A	Negative	Basal	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA.E2.A1B6.01	867	0	days	Quiet	C13-AML	cluster 5	Low purity c2	BRCA basal-like c6		miRNA cluster 15	cluster 6	mutation cluster 5	TCGA-E2-A1B6	867	0	days	867	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left	Sentinel node biopsy alone		TCGA.E2.A1B6.F19389	TCGA-E2-A1B6	TCGA.E2.A1B6.01A		Negative					Negative	Simple Mastectomy		NO	NA	NA	-16370	729	NA	0	867	NA	NA			NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-12-8	FEMALE			10-19%		2+	NA		1.03	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	290	NO	Equivocal	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	6	NA							NO	0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-E2-A1B6.539FF792-534D-401D-87A6-B3B7C2BC2EFC.pdf	A1B6	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			NO	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	eb398b00-8669-4c22-8285-03cdf76436f3	29e8a47e-a20b-40c2-98dc-885a21dbf7a3	eb398b00-8669-4c22-8285-03cdf76436f3	29e8a47e-a20b-40c2-98dc-885a21dbf7a3	TCGA.E2.A1B6.01A-21-A13E-20	TCGA.E2.A1B6.01A-31D-A12Q-09		TCGA.E2.A1B6.01	TCGA.E2.A1B6.01A-31D-A12R-05		dc503863-7967-469b-b966-69dcea2dfb86	TCGA.E2.A1B6.01	TCGA.E2.A1B6.01A-31D-A12Q-09		TCGA.E2.A1B6.01	TCGA.E2.A1B6.01	TCGA.E2.A1B6.01A-31D-A12Q-09		eb398b00-8669-4c22-8285-03cdf76436f3		TCGA.E2.A1B6.01A-31D-A12N-01	TCGA.E2.A1B6.01	TCGA.E2.A1B6.01A-31R-A12P-07	eb398b00-8669-4c22-8285-03cdf76436f3	TCGA.E2.A1B6.01A-31D-A12N-01	TCGA.E2.A1B6.01
TCGA.E2.A1LI.01	Stage IIB	57	3	Stage IIB	2750	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	2750	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.E2.A1LI.01	3121	0	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 7		mutation c1uster 9	TCGA-E2-A1LI	3121	0	days	3121	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.E2.A1LI.F20623	TCGA-E2-A1LI	TCGA.E2.A1LI.01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO	NA	NA	-21064	2815	NA	0	3121	NA	NA			NO				Scheduled Follow-up Submission	2012-1-12	FEMALE						NA		1.21	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	80	NO	Equivocal	Negative		2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	NA	NA							NO	0	NA	false	No	M0	N1	T2	Stage IIB	TCGA-E2-A1LI.B3A319BE-2230-43E2-91E5-A3B3C76B85BA.pdf	A1LI	TUMOR FREE		ACIS					YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2003	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	178e0166-9a9b-4495-896e-4a08f661c49a	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	178e0166-9a9b-4495-896e-4a08f661c49a		TCGA.E2.A1LI.01A-12D-A159-09		TCGA.E2.A1LI.01	TCGA.E2.A1LI.01A-12D-A161-05			TCGA.E2.A1LI.01	TCGA.E2.A1LI.01A-12D-A159-09			TCGA.E2.A1LI.01	TCGA.E2.A1LI.01A-12D-A159-09		fa643dcc-4f4c-44d0-9f4d-199de04f8d2b		TCGA.E2.A1LI.01A-12D-A160-01	TCGA.E2.A1LI.01		fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	TCGA.E2.A1LI.01A-12D-A160-01	
TCGA.E2.A1LK.01	Stage IIIC	84	4	Stage IIIA	NA	266	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	266	1	Basal		Negative		NA	NA	enrollment	T_Other	T3	DECEASED	1	TCGA.E2.A1LK.01	266	1	days	Squamous	C4-BRCA/Basal	cluster 3	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-E2-A1LK	155	1	days	266	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	YES		84	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA.E2.A1LK.F20620	TCGA-E2-A1LK	TCGA.E2.A1LK.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	200	-30757	1051	266	0	NA	NA	NA	155		NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2012-1-12	FEMALE			80-89%		2+	NA		1.41	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	70	NO	Equivocal	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Allred Score = 0	Equivocal	2+	Allred score 0+0 = 0	Negative			30-39%	0.95				Negative			Allred score 0+0 = 0	Negative			3	5	NA			Other, specify	Locoregional Disease	Left axilla		YES	11	NA	false	No	M0	N3a	T4b	Stage IIIC	TCGA-E2-A1LK.6CC4E6EF-6664-448E-933E-FFA9117C7ABF.pdf	A1LK	WITH TUMOR	Allred score 0+0 = 0		Allred score = 0	Allred score = 0	Allred score = 0		YES			NO	Primary Tumor	1		6th	NO	NO	YES	E2	Breast	A	DECEASED	2008	d6301614-9ba7-4632-bdca-ac1b11e8e811	0efeb3b3-219b-452f-bc62-148b1b2d909b	d6301614-9ba7-4632-bdca-ac1b11e8e811	0efeb3b3-219b-452f-bc62-148b1b2d909b	TCGA.E2.A1LK.01A-11-A17K-20	TCGA.E2.A1LK.01A-21D-A14G-09		TCGA.E2.A1LK.01	TCGA.E2.A1LK.01A-21D-A14H-05		f5fd203d-214a-42f1-aaf9-c9ee9b12c4fc	TCGA.E2.A1LK.01	TCGA.E2.A1LK.01A-21D-A14G-09			TCGA.E2.A1LK.01	TCGA.E2.A1LK.01A-21D-A14G-09		d6301614-9ba7-4632-bdca-ac1b11e8e811		TCGA.E2.A1LK.01A-21D-A14F-01	TCGA.E2.A1LK.01		d6301614-9ba7-4632-bdca-ac1b11e8e811	TCGA.E2.A1LK.01A-21D-A14F-01	
TCGA.E2.A573.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.E2.A573.01	1062	0	days										TCGA-E2-A573	1062	0	days	1062	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.E2.A573.F61338	TCGA-E2-A573	TCGA.E2.A573.01A		Negative					Negative	Other		NO	NA	NA	-17689	595	NA	0	1062	NA	NA				Allred 0 = 0+0		1.8		2014-6-27	FEMALE			10-19%		2+	200	2.3	1.3	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Equivocal	Negative	NO	4	Negative	Peri (6-12 months since last menstrual period)									NA											NA	NA	NA							NO	0	NA	true	No	M0	N0	T1c	Stage IA	TCGA-E2-A573.14EB270E-0AAB-4C12-8D71-ED79076C2E93.pdf	A573	TUMOR FREE	Allred 0 = 0+0			Allred Score	Allred Score	YES	YES			YES	Primary Tumor	1	Partial Mastectomy	7th		NO	YES	E2	Breast	A	LIVING	2011	be17bc7b-550a-461b-9f7b-2a5845cc12b2	150d0521-0135-44b1-b5c5-635050b30973	be17bc7b-550a-461b-9f7b-2a5845cc12b2	150d0521-0135-44b1-b5c5-635050b30973				TCGA.E2.A573.01	TCGA.E2.A573.01A-11D-A29O-05			TCGA.E2.A573.01	TCGA.E2.A573.01A-11D-A29N-09			TCGA.E2.A573.01			be17bc7b-550a-461b-9f7b-2a5845cc12b2		TCGA.E2.A573.01A-11D-A29M-01	TCGA.E2.A573.01		be17bc7b-550a-461b-9f7b-2a5845cc12b2	TCGA.E2.A573.01A-11D-A29M-01	
TCGA.E9.A22G.01	Stage IIIA	47	1	Stage IIA	0	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	0	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.E9.A22G.01	1239	0	days	Squamous	C4-BRCA/Basal	cluster 3	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 1		mutation cluster 5	TCGA-E9-A22G	1239	0	days	1239	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.E9.A22G.F62594	TCGA-E9-A22G	TCGA.E9.A22G.01A		Negative					Negative			YES	NA	NA	-17300	45	NA	0	1239	NA	NA			NO				Scheduled Follow-up Submission	2014-7-21	FEMALE			<10%			NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	650	NO	Positive		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											3	NA	NA							NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A22G.E34F4BF0-A0C3-4C72-8E3A-F319D4CDDD5D.pdf	A22G	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	88d93dca-ffae-4d57-9a60-346aec436543	3c37bf85-6a5c-4fe9-9c42-5ebd7b27d23f	88d93dca-ffae-4d57-9a60-346aec436543	3c37bf85-6a5c-4fe9-9c42-5ebd7b27d23f	TCGA.E9.A22G.01A-21-A17K-20	TCGA.E9.A22G.01A-11D-A159-09		TCGA.E9.A22G.01	TCGA.E9.A22G.01A-11D-A161-05		62d5983b-ccc1-4700-9cb9-e97ff4bb1277	TCGA.E9.A22G.01	TCGA.E9.A22G.01A-11D-A159-09			TCGA.E9.A22G.01	TCGA.E9.A22G.01A-11D-A159-09		88d93dca-ffae-4d57-9a60-346aec436543		TCGA.E9.A22G.01A-11D-A160-01	TCGA.E9.A22G.01		88d93dca-ffae-4d57-9a60-346aec436543	TCGA.E9.A22G.01A-11D-A160-01	
TCGA.EW.A1PH.01	Stage IIA	52	1	Stage IIA	139	NA	Negative	FEMALE		NA	NA	NA	Negative	M0	Positive	N1	139	0	Basal		Negative		NA	NA	enrollment	T1	T1	LIVING	0	TCGA.EW.A1PH.01	607	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-EW-A1PH	607	0	days	607	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.EW.A1PH.F41145	TCGA-EW-A1PH	TCGA.EW.A1PH.01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES	NA	NA	-19073	77	NA	0	607	NA	NA			NO		<10%		Scheduled Follow-up Submission	2013-3-12	FEMALE			<10%			NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA							NO	1	0	true	No	M0	N1a	T1c	Stage IIA	TCGA-EW-A1PH.2E77693B-FAAD-4CCC-BD4F-3D2470C25143.pdf	A1PH	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	1		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	39413018-090f-46ca-b6df-244124f098c3	9bbe17d3-db31-4ab5-8fea-9c222bc1bbba	39413018-090f-46ca-b6df-244124f098c3	9bbe17d3-db31-4ab5-8fea-9c222bc1bbba		TCGA.EW.A1PH.01A-11D-A14K-09		TCGA.EW.A1PH.01	TCGA.EW.A1PH.01A-11D-A14N-05			TCGA.EW.A1PH.01	TCGA.EW.A1PH.01A-11D-A14K-09			TCGA.EW.A1PH.01	TCGA.EW.A1PH.01A-11D-A14K-09		39413018-090f-46ca-b6df-244124f098c3		TCGA.EW.A1PH.01A-11D-A14J-01	TCGA.EW.A1PH.01		39413018-090f-46ca-b6df-244124f098c3	TCGA.EW.A1PH.01A-11D-A14J-01	
TCGA.GM.A2DF.01		53	NA		1299	NA	Negative	FEMALE		NA	NA	NA					1299	0	Basal		Negative		NA	NA	enrollment			LIVING	0	TCGA.GM.A2DF.01	2155	0	days	High	C4-BRCA/Basal		BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 5			TCGA-GM-A2DF	2155	0	days	2155	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA.GM.A2DF.F47074	TCGA-GM-A2DF	TCGA.GM.A2DF.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-19614	1372	NA	0	2155	NA	NA			NO		<10%	1.40		2013-8-22	FEMALE					1+	60	1.57	1.12	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative	Negative	NO	32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	1	0	false	No	M0	N1a	T1c	Stage IIA	TCGA-GM-A2DF.CA6B733A-6030-422C-9DE9-B9718CBB2FDC.pdf	A2DF	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	1		6th		NO	YES	GM	Breast	A	LIVING	2007	83f8c292-5ae0-4c58-9f08-e58ce391f4f4	1fdda772-80cf-45f4-ae85-79ebf4000fb7	83f8c292-5ae0-4c58-9f08-e58ce391f4f4	1fdda772-80cf-45f4-ae85-79ebf4000fb7	TCGA.GM.A2DF.01A-21-A24A-20			TCGA.GM.A2DF.01	TCGA.GM.A2DF.01A-11D-A17Z-05		1af97bf7-a99d-48f9-9ed1-69612327c1f9	TCGA.GM.A2DF.01	TCGA.GM.A2DF.01A-11D-A17W-09			TCGA.GM.A2DF.01			83f8c292-5ae0-4c58-9f08-e58ce391f4f4		TCGA.GM.A2DF.01A-11D-A17U-01	TCGA.GM.A2DF.01		83f8c292-5ae0-4c58-9f08-e58ce391f4f4	TCGA.GM.A2DF.01A-11D-A17U-01	
TCGA.GM.A3XL.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.GM.A3XL.01	2108	0	days					BRCA basal-like c6		miRNA cluster 4			TCGA-GM-A3XL	2108	0	days	2108	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right|Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.GM.A3XL.F41970	TCGA-GM-A3XL	TCGA.GM.A3XL.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-18171	1779	NA	0	2108	NA	NA					<10%			2013-4-8	FEMALE						NA		0.99	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO		Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A3XL.E8583D11-D6F7-41AC-8CD5-53437CBD8820.pdf	A3XL	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	1		6th		NO	YES	GM	Breast	A	LIVING	2007	29c98197-249e-45c9-96dc-34dfb4ac1430	bb56f0b4-2c20-4ca7-bc85-8f7cc13d5458	29c98197-249e-45c9-96dc-34dfb4ac1430	bb56f0b4-2c20-4ca7-bc85-8f7cc13d5458	TCGA.GM.A3XL.01A-21-A24A-20			TCGA.GM.A3XL.01	TCGA.GM.A3XL.01A-11D-A230-05		01083b39-09ef-40dd-86c0-5cb8a2a5a646	TCGA.GM.A3XL.01	TCGA.GM.A3XL.01A-11D-A22X-09			TCGA.GM.A3XL.01			29c98197-249e-45c9-96dc-34dfb4ac1430		TCGA.GM.A3XL.01A-11D-A22W-01	TCGA.GM.A3XL.01		29c98197-249e-45c9-96dc-34dfb4ac1430	TCGA.GM.A3XL.01A-11D-A22W-01	
TCGA.HN.A2NL.01		NA	NA		NA	NA				NA	NA	NA					NA	NA	Basal				NA	NA					0	TCGA.HN.A2NL.01	79	0	days	Squamous	C4-BRCA/Basal		BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 1			TCGA-HN-A2NL	79	0	days	79	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.HN.A2NL.F60149	TCGA-HN-A2NL	TCGA.HN.A2NL.01A		Negative					Negative	Simple Mastectomy		YES	NA	NA	-20483	NA	NA	0	79	NA	NA								2014-5-30	FEMALE						NA		NA	NA	Infiltrating Lobular Carcinoma		No	NA	C50.9	8520/3	C50.9		YES		Tumor resection	170	NO	Negative		YES	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-HN-A2NL.CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1.pdf	A2NL	TUMOR FREE						YES	YES				Primary Tumor	1		6th		NO	YES	HN	Breast	A	LIVING	NA	6593576c-a4a8-4284-8591-321f980f2e58	a5327c43-f90e-42b7-b76e-13602f606844	6593576c-a4a8-4284-8591-321f980f2e58	a5327c43-f90e-42b7-b76e-13602f606844	TCGA.HN.A2NL.01A-21-A24A-20			TCGA.HN.A2NL.01	TCGA.HN.A2NL.01A-11D-A18O-05		826ef0de-68ba-4771-a305-97f27770407a	TCGA.HN.A2NL.01	TCGA.HN.A2NL.01A-11D-A18P-09			TCGA.HN.A2NL.01			6593576c-a4a8-4284-8591-321f980f2e58		TCGA.HN.A2NL.01A-11D-A18N-01	TCGA.HN.A2NL.01		6593576c-a4a8-4284-8591-321f980f2e58	TCGA.HN.A2NL.01A-11D-A18N-01	
TCGA.OL.A5D7.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.OL.A5D7.01	1780	0	days										TCGA-OL-A5D7	1780	0	days	1780	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.OL.A5D7.F55439	TCGA-OL-A5D7	TCGA.OL.A5D7.01A		Negative					Negative	Lumpectomy			NA	NA	-25643	1415	NA	0	1780	NA	NA								2014-1-10	FEMALE						NA		1.36	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO		Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	NA	0	true	No	MX	N0	T2	Stage IIA	TCGA-OL-A5D7.A8980EE8-52DE-4DA5-84DD-F8E86EBF6A9B.pdf	A5D7	TUMOR FREE						YES	YES			YES	Primary Tumor	1		6th		NO	YES	OL	Breast	A	LIVING	2009	a9f404db-e7fa-49bf-acca-fccd676f2e7c	589febe7-e680-4541-b582-d8eeade0625d	a9f404db-e7fa-49bf-acca-fccd676f2e7c	589febe7-e680-4541-b582-d8eeade0625d				TCGA.OL.A5D7.01	TCGA.OL.A5D7.01A-11D-A27Y-05		2cdb08fa-d13c-496e-8f53-9852a8a165ef	TCGA.OL.A5D7.01	TCGA.OL.A5D7.01A-11D-A27P-09			TCGA.OL.A5D7.01			a9f404db-e7fa-49bf-acca-fccd676f2e7c		TCGA.OL.A5D7.01A-11D-A27O-01	TCGA.OL.A5D7.01		a9f404db-e7fa-49bf-acca-fccd676f2e7c	TCGA.OL.A5D7.01A-11D-A27O-01	
TCGA.OL.A5RW.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.OL.A5RW.01	1106	0	days										TCGA-OL-A5RW	1106	0	days	1106	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.OL.A5RW.F56568	TCGA-OL-A5RW			Negative					Negative	Lumpectomy			NA	NA	-14638	NA	NA	0	1106	NA	NA								2014-2-14	FEMALE						NA		1.91	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Excisional Biopsy	NA			Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											NA	NA	NA							NO	1	NA		No	MX	N1	T1c	Stage IIA		A5RW	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th		NO	YES	OL	Breast		LIVING	2010	c5a7673a-c45e-4789-a2c8-32889f39c102	b3f1bdd3-a76f-4ab7-9c8c-c02c36f1ecee	c5a7673a-c45e-4789-a2c8-32889f39c102	b3f1bdd3-a76f-4ab7-9c8c-c02c36f1ecee				TCGA.OL.A5RW.01	TCGA.OL.A5RW.01A-11D-A28C-05		e1d1d1cd-4b4d-4cfe-86b8-7dfe9ca08c75	TCGA.OL.A5RW.01	TCGA.OL.A5RW.01A-11D-A28B-09			TCGA.OL.A5RW.01			c5a7673a-c45e-4789-a2c8-32889f39c102		TCGA.OL.A5RW.01A-11D-A28A-01	TCGA.OL.A5RW.01		c5a7673a-c45e-4789-a2c8-32889f39c102	TCGA.OL.A5RW.01A-11D-A28A-01	
TCGA.OL.A66I.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.OL.A66I.01	714	0	days										TCGA-OL-A66I	714	0	days	714	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					36	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.OL.A66I.F58496	TCGA-OL-A66I	TCGA.OL.A66I.01A		Negative					Negative	Lumpectomy			NA	NA	-13458	1715	NA	0	714	NA	NA								2014-4-11	FEMALE						NA		1.04	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO		Negative	YES	13	Negative										NA											NA	NA	NA							NO	0	NA	true	No	MX	N1mi	T1c	Stage IIA	TCGA-OL-A66I.800346FC-BC14-4A33-B10C-84224D908481.pdf	A66I	TUMOR FREE						YES	YES			YES	Primary Tumor	1		6th		NO	YES	OL	Breast	A	LIVING	2008	d92ddf45-68b6-42da-9497-8faabcc50be0	a9914a13-282b-42c9-ae86-ad7241f462a9	d92ddf45-68b6-42da-9497-8faabcc50be0	a9914a13-282b-42c9-ae86-ad7241f462a9				TCGA.OL.A66I.01	TCGA.OL.A66I.01A-21D-A29O-05		3e69923d-a657-4a7f-b605-bd2b9222c94f	TCGA.OL.A66I.01	TCGA.OL.A66I.01A-21D-A29N-09			TCGA.OL.A66I.01			d92ddf45-68b6-42da-9497-8faabcc50be0		TCGA.OL.A66I.01A-21D-A29M-01	TCGA.OL.A66I.01		d92ddf45-68b6-42da-9497-8faabcc50be0	TCGA.OL.A66I.01A-21D-A29M-01	
TCGA.OL.A6VO.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.OL.A6VO.01	858	0	days										TCGA-OL-A6VO	858	0	days	858	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Right|Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA.OL.A6VO.F59365	TCGA-OL-A6VO	TCGA.OL.A6VO.01A		Negative					Negative	Lumpectomy			NA	NA	-15780	507	NA	0	858	NA	NA								2014-5-10	FEMALE						NA		1.23	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative	Negative	NO	7	Negative										NA											NA	NA	NA							NO	0	NA	true	No	MX	N0	T1c	Stage IA	TCGA-OL-A6VO.961547D2-F235-47E9-9A6D-D286758E332E.pdf	A6VO	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th		NO	YES	OL	Breast	A	LIVING	2012	5cb12edf-25a1-40f6-831a-5fb1f56676e1	98c2fa71-63aa-4bfe-b49e-41aa4abdb391	5cb12edf-25a1-40f6-831a-5fb1f56676e1	98c2fa71-63aa-4bfe-b49e-41aa4abdb391				TCGA.OL.A6VO.01	TCGA.OL.A6VO.01A-12D-A33F-05		79E2C9D4-0FF5-43E0-B7CE-EF665A49853D	TCGA.OL.A6VO.01				TCGA.OL.A6VO.01			5cb12edf-25a1-40f6-831a-5fb1f56676e1		TCGA.OL.A6VO.01A-12D-A33D-01	TCGA.OL.A6VO.01		5cb12edf-25a1-40f6-831a-5fb1f56676e1	TCGA.OL.A6VO.01A-12D-A33D-01	
TCGA.S3.AA10.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.S3.AA10.01	586	0	days										TCGA-S3-AA10	586	0	days	586	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right|Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.S3.AA10.F70441	TCGA-S3-AA10	TCGA.S3.AA10.01A		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		NO	NA	NA	-24075	168	NA	0	586	NA	NA				CAP scoring guideline 2010				2015-2-26	FEMALE		CAP scoring guideline 2010			1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	410	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-S3-AA10.6A981CB0-F551-48B1-AB91-5D5585A7F282.pdf	AA10	TUMOR FREE	CAP scoring guideline 2010					YES	YES			NO	Primary Tumor	1		7th		YES	NO	S3	Breast	A	LIVING	2013	4c80c4a1-7e99-4f9e-b32c-898ae20206c5	7779cc82-d022-43c2-83be-e23303797ce0	4c80c4a1-7e99-4f9e-b32c-898ae20206c5	7779cc82-d022-43c2-83be-e23303797ce0				TCGA.S3.AA10.01	TCGA.S3.AA10.01A-21D-A41Q-05		F3DF6E4D-CA53-4DEA-B48D-652306B60C77	TCGA.S3.AA10.01				TCGA.S3.AA10.01			4c80c4a1-7e99-4f9e-b32c-898ae20206c5		TCGA.S3.AA10.01A-21D-A41E-01	TCGA.S3.AA10.01		4c80c4a1-7e99-4f9e-b32c-898ae20206c5	TCGA.S3.AA10.01A-21D-A41E-01	
TCGA.A2.A0SX.01	Stage IA	48	1	Stage I	1288	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1288	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T1	T1	LIVING	0	TCGA.A2.A0SX.01	1534	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0SX	1534	0	days	1534	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		48	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA.A2.A0SX.F14037	TCGA-A2-A0SX	TCGA.A2.A0SX.01A	Negative	Negative				Lumpectomy	Negative	Lumpectomy		YES	1239	NA	-17774	1177	NA	0	1534	NA	NA	1239						Scheduled Follow-up Submission	2011-7-14	FEMALE					0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	910	NO	Negative			1	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	4	NA							NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0SX.63F76DB5-8433-4EFE-9054-6C04F065DF2D.pdf	A0SX	WITH TUMOR										YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2007	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	aa2d584e-9a6b-418e-a401-c8a17d669cb8	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	aa2d584e-9a6b-418e-a401-c8a17d669cb8	TCGA.A2.A0SX.01A-21-A13A-20	TCGA.A2.A0SX.01A-12D-A099-09		TCGA.A2.A0SX.01	TCGA.A2.A0SX.01A-12D-A10P-05		13ef422e-b0f0-4c0a-bbe4-3d38bb2a2532	TCGA.A2.A0SX.01	TCGA.A2.A0SX.01A-12D-A099-09		TCGA.A2.A0SX.01		TCGA.A2.A0SX.01A-12D-A099-09	TCGA.A2.A0SX.01	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	TCGA.A2.A0SX.01	TCGA.A2.A0SX.01A-12D-A087-01		TCGA.A2.A0SX.01A-12R-A084-07	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	TCGA.A2.A0SX.01A-12D-A087-01	TCGA.A2.A0SX.01
TCGA.A7.A26F.01	Stage IA	55	3	Stage I	257	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	257	0	Basal		Negative		NA	NA	enrollment	T1	T1	LIVING	0	TCGA.A7.A26F.01	738	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 3	TCGA-A7-A26F	738	0	days	738	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left	Sentinel node biopsy alone		TCGA.A7.A26F.F38499	TCGA-A7-A26F	TCGA.A7.A26F.01B	Negative	Negative					Negative	Lumpectomy		NO	NA	NA	-20210	389	NA	0	738	NA	NA			NO			1.8	Scheduled Follow-up Submission	2012-12-14	FEMALE				PathVysion HER-2 D probe kit.	2+	330	1.9	1.1	NA	Other, specify		No	NA	C50.9	8575/3	C50.9		YES		Fine needle aspiration biopsy	NA	YES	Equivocal	Negative	NO	1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	5	NA							NO	0	NA	false	Yes	M0	N0	T1	Stage IA	TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C.pdf	A26F	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th	YES	YES	NO	A7	Breast	B	LIVING	2010	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	2d32a4ba-d5da-4f17-915c-ac1c1bceac01,5676cfeb-171d-493a-bd7f-902315494da7	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	2d32a4ba-d5da-4f17-915c-ac1c1bceac01,5676cfeb-171d-493a-bd7f-902315494da7	TCGA.A7.A26F.01A-11-A17I-20	TCGA.A7.A26F.01A-21D-A167-09	1b907925-b33c-4e4a-96e0-65f15b4712b9,2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	TCGA.A7.A26F.01	TCGA.A7.A26F.01A-21D-A16A-05,TCGA.A7.A26F.01B-04D-A22R-05	1b907925-b33c-4e4a-96e0-65f15b4712b9,2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	6bda0261-6c33-4c86-8cf9-c9dce2bcadec	TCGA.A7.A26F.01	TCGA.A7.A26F.01A-21D-A167-09,TCGA.A7.A26F.01B-04D-A22N-09			TCGA.A7.A26F.01	TCGA.A7.A26F.01A-21D-A167-09		2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b		TCGA.A7.A26F.01A-21D-A166-01	TCGA.A7.A26F.01		2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	TCGA.A7.A26F.01A-21D-A166-01	
TCGA.A7.A26G.01	Stage IIA	50	3	Stage IIA	209	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	209	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.A7.A26G.01	722	0	days	COAD-READ	C4-BRCA/Basal	cluster 5	Low purity c2	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A7-A26G	722	0	days	722	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA.A7.A26G.F39047	TCGA-A7-A26G	TCGA.A7.A26G.01A		Negative					Negative	Other		NO	NA	NA	-18362	161	NA	0	722	NA	NA			NO				Scheduled Follow-up Submission	2013-1-9	FEMALE						NA		NA	NA	Other, specify		No	NA	C50.9	8575/3	C50.9		YES		Core needle biopsy	410	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	4	NA							NO	0	NA	false	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A7-A26G.6BE810A6-3D30-4F75-89B7-00C866553165.pdf	A26G	TUMOR FREE						YES	YES			NO	Primary Tumor	1	Total Mastectomy	7th	YES	YES	NO	A7	Breast	A	LIVING	2010	8cf1853a-55b2-4fb9-9a65-a46243304d54	766041d3-8592-405b-8fec-225c17bcfa96	8cf1853a-55b2-4fb9-9a65-a46243304d54	766041d3-8592-405b-8fec-225c17bcfa96	TCGA.A7.A26G.01A-11-A17I-20	TCGA.A7.A26G.01A-21D-A167-09		TCGA.A7.A26G.01	TCGA.A7.A26G.01A-21D-A16A-05		1c0d3d0a-579d-4cfc-bea5-cd7ecb74dd88	TCGA.A7.A26G.01	TCGA.A7.A26G.01A-21D-A167-09			TCGA.A7.A26G.01	TCGA.A7.A26G.01A-21D-A167-09		8cf1853a-55b2-4fb9-9a65-a46243304d54		TCGA.A7.A26G.01A-21D-A166-01	TCGA.A7.A26G.01		8cf1853a-55b2-4fb9-9a65-a46243304d54	TCGA.A7.A26G.01A-21D-A166-01	
TCGA.A7.A26I.01	Stage IIA	65	1	Stage IIA	122	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	122	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.A7.A26I.01	661	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4		mutation cluster 5	TCGA-A7-A26I	661	0	days	661	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left	Axillary lymph node dissection alone		TCGA.A7.A26I.F39791	TCGA-A7-A26I	TCGA.A7.A26I.01A	Negative	Negative				Other	Negative	Lumpectomy	Re-Excision of Superior Margin	NO	NA	NA	-23948	40	NA	0	661	NA	NA			NO			2.0	Scheduled Follow-up Submission	2013-2-1	FEMALE				Path Vysion HER-2 D probe kit	2+	229	2.2	1.1	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	120	NO	Equivocal	Negative	NO	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	NA	NA							NO	0	NA	false	Yes	M0	N0	T2	Stage IIA	TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9.pdf	A26I	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th	YES	YES	NO	A7	Breast	A	LIVING	2011	5610fa97-eac4-4306-aead-983ee6570baf	eaf26eaa-106e-46e3-9963-c6185c6ec4d7	5610fa97-eac4-4306-aead-983ee6570baf	eaf26eaa-106e-46e3-9963-c6185c6ec4d7	TCGA.A7.A26I.01A-21-A17I-20	TCGA.A7.A26I.01A-11D-A167-09	e5949631-ebaf-4ec2-aac8-b0a6fd51d946,5610fa97-eac4-4306-aead-983ee6570baf	TCGA.A7.A26I.01	TCGA.A7.A26I.01A-11D-A16A-05	e5949631-ebaf-4ec2-aac8-b0a6fd51d946,5610fa97-eac4-4306-aead-983ee6570baf	c74b933c-9dd5-42a6-a906-4951a21e8bc2	TCGA.A7.A26I.01	TCGA.A7.A26I.01A-11D-A167-09,TCGA.A7.A26I.01B-06D-A22N-09			TCGA.A7.A26I.01	TCGA.A7.A26I.01A-11D-A167-09		5610fa97-eac4-4306-aead-983ee6570baf		TCGA.A7.A26I.01A-11D-A166-01	TCGA.A7.A26I.01		5610fa97-eac4-4306-aead-983ee6570baf	TCGA.A7.A26I.01A-11D-A166-01	
TCGA.A7.A4SD.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.A7.A4SD.01	441	0	days										TCGA-A7-A4SD	441	0	days	441	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right	Sentinel node biopsy alone		TCGA.A7.A4SD.F52732	TCGA-A7-A4SD	TCGA.A7.A4SD.01A		Negative					Negative	Simple Mastectomy		YES	NA	NA	-19131	63	NA	0	441	NA	NA						5		2013-12-5	FEMALE				PathVysion HER-2 D Probe Kit	2+	20	6.4	1.3	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	230	NO	Equivocal	Negative	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-A7-A4SD.563D1ED2-1A8B-4D90-BD42-AC3790D04913.pdf	A4SD	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th		YES	NO	A7	Breast	A	LIVING	2012	cb0d669b-658a-4a41-9904-f838ddb12db2	cf272587-883b-4844-a81e-46fca956cc66	cb0d669b-658a-4a41-9904-f838ddb12db2	cf272587-883b-4844-a81e-46fca956cc66				TCGA.A7.A4SD.01	TCGA.A7.A4SD.01A-11D-A268-05		148f42bd-6aee-4dc7-bf8b-d5e8580c1b4d	TCGA.A7.A4SD.01	TCGA.A7.A4SD.01A-11D-A25Q-09			TCGA.A7.A4SD.01			cb0d669b-658a-4a41-9904-f838ddb12db2		TCGA.A7.A4SD.01A-11D-A25N-01	TCGA.A7.A4SD.01		cb0d669b-658a-4a41-9904-f838ddb12db2	TCGA.A7.A4SD.01A-11D-A25N-01	
TCGA.A7.A4SE.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.A7.A4SE.01	644	0	days										TCGA-A7-A4SE	644	0	days	644	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left	Sentinel node biopsy alone		TCGA.A7.A4SE.F50162	TCGA-A7-A4SE	TCGA.A7.A4SE.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-20080	306	NA	0	644	NA	NA								2013-10-16	FEMALE			<10%		1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Negative		YES	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305.pdf	A4SE	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th		YES	NO	A7	Breast	A	LIVING	2011	6bb217e7-3fd4-477f-87bf-b55e50a33e45	7b527732-597f-49af-bf0c-69b485bbe511	6bb217e7-3fd4-477f-87bf-b55e50a33e45	7b527732-597f-49af-bf0c-69b485bbe511				TCGA.A7.A4SE.01	TCGA.A7.A4SE.01A-11D-A268-05		7309fdea-a4df-4081-adac-88e2966c8642	TCGA.A7.A4SE.01	TCGA.A7.A4SE.01A-11D-A25Q-09			TCGA.A7.A4SE.01			6bb217e7-3fd4-477f-87bf-b55e50a33e45		TCGA.A7.A4SE.01A-11D-A25N-01	TCGA.A7.A4SE.01		6bb217e7-3fd4-477f-87bf-b55e50a33e45	TCGA.A7.A4SE.01A-11D-A25N-01	
TCGA.A7.A6VW.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.A7.A6VW.01	285	0	days										TCGA-A7-A6VW	285	0	days	285	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left	Sentinel node biopsy alone		TCGA.A7.A6VW.F57227	TCGA-A7-A6VW	TCGA.A7.A6VW.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-17539	71	NA	0	285	NA	NA								2014-3-6	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO	Negative		NO	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	NA	false	No	M0	N0	T2	Stage IIA	TCGA-A7-A6VW.BE19CEFA-7A66-480C-BEC0-AF52F4C8A04C.pdf	A6VW	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th		YES	NO	A7	Breast	A	LIVING	2013	f572c953-e1aa-4dd2-a8f8-e292ab7bd139	8a5f6839-507d-4288-91e9-22badf54b089	f572c953-e1aa-4dd2-a8f8-e292ab7bd139	8a5f6839-507d-4288-91e9-22badf54b089				TCGA.A7.A6VW.01	TCGA.A7.A6VW.01A-21D-A33F-05			TCGA.A7.A6VW.01				TCGA.A7.A6VW.01			f572c953-e1aa-4dd2-a8f8-e292ab7bd139		TCGA.A7.A6VW.01A-21D-A33D-01	TCGA.A7.A6VW.01		f572c953-e1aa-4dd2-a8f8-e292ab7bd139	TCGA.A7.A6VW.01A-21D-A33D-01	
TCGA.A7.A6VY.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.A7.A6VY.01	266	0	days										TCGA-A7-A6VY	266	0	days	266	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.A7.A6VY.F57257	TCGA-A7-A6VY	TCGA.A7.A6VY.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-17640	29	NA	0	266	NA	NA								2014-3-6	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	2	NA	false	No	M0	N1	T2	Stage IIB	TCGA-A7-A6VY.BB85F844-C710-41D5-8620-E246DC9D2C6A.pdf	A6VY	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th		YES	NO	A7	Breast	A	LIVING	2013	2fb506f2-4b76-4c20-ae45-8939f2e14753	317d4bae-a933-41ef-ab8a-d4fbb6de5285	2fb506f2-4b76-4c20-ae45-8939f2e14753	317d4bae-a933-41ef-ab8a-d4fbb6de5285				TCGA.A7.A6VY.01	TCGA.A7.A6VY.01A-12D-A33F-05			TCGA.A7.A6VY.01				TCGA.A7.A6VY.01			2fb506f2-4b76-4c20-ae45-8939f2e14753		TCGA.A7.A6VY.01A-12D-A33D-01	TCGA.A7.A6VY.01		2fb506f2-4b76-4c20-ae45-8939f2e14753	TCGA.A7.A6VY.01A-12D-A33D-01	
TCGA.AC.A2QJ.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					1	TCGA.AC.A2QJ.01	446	1	days	BRCA-LUAD+			BRCA non-CIMP c9	KIRC-like c1		miRNA cluster 5			TCGA-AC-A2QJ	237	1	days	446	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES			48	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Other (specify)	Sentinel lymph node and axillary lymph node biopsy	TCGA.AC.A2QJ.F44021	TCGA-AC-A2QJ	TCGA.AC.A2QJ.01A		Negative					Negative	Other		NO	NA	NA	-17569	160	446	0	69	NA	NA	237		NO					2013-6-28	FEMALE						NA		NA	NA	Metaplastic Carcinoma		No	NA	C50.9	8575/3	C50.9		YES		Core needle biopsy	150	NO	Negative		NO	2	Negative	Peri (6-12 months since last menstrual period)									NA											NA	NA	NA			Bone	Distant Metastasis		NO	YES	0	NA	false	No	M0	N0	T4b	Stage IIIB	TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7.pdf	A2QJ	WITH TUMOR						YES	YES			YES	Primary Tumor	1	Mastectomy	7th		YES	NO	AC	Breast	A	DECEASED	2011	49a0f1eb-6ece-48fc-970f-3922263fd20b	52daa11e-014a-4418-8d86-f8c405bd9cc5	49a0f1eb-6ece-48fc-970f-3922263fd20b	52daa11e-014a-4418-8d86-f8c405bd9cc5	TCGA.AC.A2QJ.01A-21-A24A-20			TCGA.AC.A2QJ.01	TCGA.AC.A2QJ.01A-12D-A19Z-05		5755434d-e797-4963-b728-caefc7bd49d5	TCGA.AC.A2QJ.01	TCGA.AC.A2QJ.01A-12D-A19Y-09			TCGA.AC.A2QJ.01			49a0f1eb-6ece-48fc-970f-3922263fd20b		TCGA.AC.A2QJ.01A-12D-A19X-01	TCGA.AC.A2QJ.01		49a0f1eb-6ece-48fc-970f-3922263fd20b	TCGA.AC.A2QJ.01A-12D-A19X-01	
TCGA.AN.A0AL.01	Stage IIIB	41	1	No_Conversion	197	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	197	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T4	LIVING	0	TCGA.AN.A0AL.01	227	0	days	Squamous	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AN-A0AL	227	0	days	227	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA.AN.A0AL.F68944	TCGA-AN-A0AL	TCGA.AN.A0AL.01A		Negative		0			Negative	Modified Radical Mastectomy		NO	NA	NA	-15286	49	NA	0	227	NA	NA				dextran coated charcoal	<10%			2014-12-23	FEMALE		dextran coated charcoal	<10%		0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Tumor resection	300	NO	Negative		NO	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	3	NA							NO	0	0	false	No	M0	N0	T4	Stage IIIB	TCGA-AN-A0AL.20F4DBD9-02FA-4FFD-AEF5-234910D31263.pdf	A0AL	TUMOR FREE	dextran coated charcoal					NO		<10%		NO	Primary Tumor	1		7th		NO	YES	AN	Breast	A	LIVING	2010	467314d6-f946-447f-920a-d33b60f66eb2	7076a7b9-6f06-4660-9fd9-3cbcc66bafda	467314d6-f946-447f-920a-d33b60f66eb2	7076a7b9-6f06-4660-9fd9-3cbcc66bafda	TCGA.AN.A0AL.01A-21-A13B-20	TCGA.AN.A0AL.01A-11W-A019-09		TCGA.AN.A0AL.01			b689bc66-7909-4edc-a0e1-701ffcd1a602	TCGA.AN.A0AL.01	TCGA.AN.A0AL.01A-11W-A019-09	TCGA.AN.A0AL.01A-11D-A00Y-05	TCGA.AN.A0AL.01		TCGA.AN.A0AL.01A-11W-A019-09	TCGA.AN.A0AL.01	467314d6-f946-447f-920a-d33b60f66eb2	TCGA.AN.A0AL.01	TCGA.AN.A0AL.01A-11D-A011-01		TCGA.AN.A0AL.01A-11R-A00Z-07	467314d6-f946-447f-920a-d33b60f66eb2	TCGA.AN.A0AL.01A-11D-A011-01	TCGA.AN.A0AL.01
TCGA.AN.A0XU.01	Stage IIA	54	1	Stage IIA	10	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	10	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.AN.A0XU.01	10	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AN-A0XU	NA	NA	days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Outer Quadrant			TCGA.AN.A0XU.F68961	TCGA-AN-A0XU	TCGA.AN.A0XU.01A		Negative					Negative				NA	NA	-20052	106	NA	0	10	NA	NA			NO					2014-12-23	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative		YES	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	4	NA								0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-AN-A0XU.8216B837-DCF3-4E7F-A72A-212655F394F0.pdf	A0XU	TUMOR FREE				0	0	NO	YES			NO	Primary Tumor	1		7th		NO	YES	AN	Breast	A	LIVING	2010	74cba80b-7677-41d6-ab22-10f1a962ba2f	150ed41d-ca97-413a-ae3e-4cc3ba52d6f1	74cba80b-7677-41d6-ab22-10f1a962ba2f	150ed41d-ca97-413a-ae3e-4cc3ba52d6f1	TCGA.AN.A0XU.01A-21-A13D-20	TCGA.AN.A0XU.01A-11D-A10G-09		TCGA.AN.A0XU.01	TCGA.AN.A0XU.01A-11D-A10A-05		fa8604b6-7128-4db4-bfaf-6f1000fb4017	TCGA.AN.A0XU.01	TCGA.AN.A0XU.01A-11D-A10G-09		TCGA.AN.A0XU.01		TCGA.AN.A0XU.01A-11D-A10G-09	TCGA.AN.A0XU.01	74cba80b-7677-41d6-ab22-10f1a962ba2f	TCGA.AN.A0XU.01	TCGA.AN.A0XU.01A-11D-A107-01		TCGA.AN.A0XU.01A-11R-A109-07	74cba80b-7677-41d6-ab22-10f1a962ba2f	TCGA.AN.A0XU.01A-11D-A107-01	TCGA.AN.A0XU.01
TCGA.AO.A03U.01	Stage IA	31	1	Stage I	1727	1796	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1796	1	Normal	Normal-like	Negative	Basal	-5	0	followup	T1	T1	DECEASED	1	TCGA.AO.A03U.01	1793	1	days	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AO-A03U	1614	1	days	1793	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			NO		31	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA.AO.A03U.F20907	TCGA-AO-A03U	TCGA.AO.A03U.01B		Negative					Negative	Simple Mastectomy		YES	NA	NA	-11354	3254	1793	0	NA	NA	NA	1614				<10%		Scheduled Follow-up Submission	2012-1-24	FEMALE		3+ Positive	<10%		0	NA		NA	NA	Other, specify		No	NA	C50.9	8502/3	C50.9		YES		Core needle biopsy	170	NO	Negative	Negative		8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative			Negative				NA								Negative			5	4	NA			Lung	New Primary Tumor			YES	0	0	true	No	M0	N0 (i-)	T1c	Stage I	TCGA-AO-A03U.A8AF94A0-F3C2-4AB0-AB0C-22BDA51AF546.pdf	A03U	TUMOR FREE								<10%		NO	Primary Tumor	1		6th	YES	NO	YES	AO	Breast	B	DECEASED	2001	bbca4523-28a7-416c-98a8-02c3350705fc	1f2b4987-b022-40f8-a9cf-4dbfd5d377f9	bbca4523-28a7-416c-98a8-02c3350705fc	1f2b4987-b022-40f8-a9cf-4dbfd5d377f9	TCGA.AO.A03U.01B-11-A13E-20	TCGA.AO.A03U.01B-21D-A10M-09		TCGA.AO.A03U.01	TCGA.AO.A03U.01B-21D-A10N-05		93635795-8741-4a0d-b538-48fb08377942	TCGA.AO.A03U.01	TCGA.AO.A03U.01B-21D-A10M-09		TCGA.AO.A03U.01		TCGA.AO.A03U.01B-21D-A10M-09	TCGA.AO.A03U.01	bbca4523-28a7-416c-98a8-02c3350705fc	TCGA.AO.A03U.01	TCGA.AO.A03U.01B-21D-A10L-01		TCGA.AO.A03U.01B-21R-A10J-07	bbca4523-28a7-416c-98a8-02c3350705fc	TCGA.AO.A03U.01B-21D-A10L-01	TCGA.AO.A03U.01
TCGA.AR.A1AJ.01	Stage I	83	3	Stage I	1604	NA	Positive	FEMALE	Negative	1	2	2	Negative	M0	Negative	N0	1604	0	Basal	Basal-like	Negative	ReacI	-13	-12	enrollment	T1	T1	LIVING	0	TCGA.AR.A1AJ.01	3072	0	days	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AR-A1AJ	3072	0	days	3072	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					83	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A1AJ.F69269	TCGA-AR-A1AJ	TCGA.AR.A1AJ.01A		Positive					Negative	Other		YES	NA	NA	-30489	1828	NA	0	3072	NA	NA					10-19%		Scheduled Follow-up Submission	2014-12-31	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	4	NA							NO	0	NA	true	No	M0	N0	T1	Stage I	TCGA-AR-A1AJ.0DEAC35F-8B73-4A9F-B7FA-2F501B736B0E.pdf	A1AJ	TUMOR FREE						NO	YES			YES	Primary Tumor	1	Wide local excision	6th	NO	NO	YES	AR	Breast	A	LIVING	2005	98703904-572d-4220-b959-a1293a2e1c33	146bbf8b-4047-4e89-9463-abba54e8d992	98703904-572d-4220-b959-a1293a2e1c33	146bbf8b-4047-4e89-9463-abba54e8d992	TCGA.AR.A1AJ.01A-31-A13E-20	TCGA.AR.A1AJ.01A-21D-A12Q-09		TCGA.AR.A1AJ.01	TCGA.AR.A1AJ.01A-21D-A12R-05		26cb824a-251d-4b4c-a00c-19de6d7e2562	TCGA.AR.A1AJ.01	TCGA.AR.A1AJ.01A-21D-A12Q-09		TCGA.AR.A1AJ.01	TCGA.AR.A1AJ.01	TCGA.AR.A1AJ.01A-21D-A12Q-09		98703904-572d-4220-b959-a1293a2e1c33		TCGA.AR.A1AJ.01A-21D-A12N-01	TCGA.AR.A1AJ.01	TCGA.AR.A1AJ.01A-21R-A12P-07	98703904-572d-4220-b959-a1293a2e1c33	TCGA.AR.A1AJ.01A-21D-A12N-01	TCGA.AR.A1AJ.01
TCGA.AR.A1AO.01	Stage II	47	1	Stage IIA	1324	NA	Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1324	0	Normal	Normal-like	Negative	Basal	-5	-8	enrollment	T1	T1	LIVING	0	TCGA.AR.A1AO.01	2618	0	days	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A1AO	2618	0	days	2618	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A1AO.F69274	TCGA-AR-A1AO	TCGA.AR.A1AO.01A		Positive					Negative	Other		YES	NA	NA	-17332	1471	NA	0	2618	NA	NA							Scheduled Follow-up Submission	2014-12-31	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	39	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	4	NA							NO	2	NA	true	No	M0	N1	T1	Stage IIA	TCGA-AR-A1AO.37EF1828-0A53-4358-97C7-A7849EC653AF.pdf	A1AO	TUMOR FREE						YES	YES			YES	Primary Tumor	1	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	56183330-0700-46d7-b45f-6d915ae587fa	e18c22cb-6ef7-44c4-8bca-a3d70a3be9ed	56183330-0700-46d7-b45f-6d915ae587fa	e18c22cb-6ef7-44c4-8bca-a3d70a3be9ed	TCGA.AR.A1AO.01A-21-A13E-20	TCGA.AR.A1AO.01A-11D-A12Q-09		TCGA.AR.A1AO.01	TCGA.AR.A1AO.01A-11D-A12R-05		310b6320-7ad9-4977-9c23-e80e0500e94c	TCGA.AR.A1AO.01	TCGA.AR.A1AO.01A-11D-A12Q-09		TCGA.AR.A1AO.01	TCGA.AR.A1AO.01	TCGA.AR.A1AO.01A-11D-A12Q-09		56183330-0700-46d7-b45f-6d915ae587fa		TCGA.AR.A1AO.01A-11D-A12N-01	TCGA.AR.A1AO.01	TCGA.AR.A1AO.01A-11R-A12P-07	56183330-0700-46d7-b45f-6d915ae587fa	TCGA.AR.A1AO.01A-11D-A12N-01	TCGA.AR.A1AO.01
TCGA.AR.A1AR.01	Stage III	50	1	Stage IIIA	NA	523	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N2	523	1	Basal	Basal-like	Negative		-13	0	enrollment	T1	T1	DECEASED	1	TCGA.AR.A1AR.01	524	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AR-A1AR	387	1	days	524	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA.AR.A1AR.F21825	TCGA-AR-A1AR	TCGA.AR.A1AR.01A		Negative					Negative	Lumpectomy			NA	NA	-18482	1416	524	0	NA	NA	NA	387						Additional New Tumor Event	2012-2-27	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA			Other, specify	New Primary Tumor	Breast		YES	5	NA	true	Yes	M0	N2	T1	Stage IIIA	TCGA-AR-A1AR.747FB91B-F523-4FA0-91DD-6014EF55643D.pdf	A1AR	WITH TUMOR										YES	Primary Tumor	1		6th	YES	NO	YES	AR	Breast	A	DECEASED	2007	6d066a72-f59f-45a8-ab90-216000b36da4	c7976361-e689-44f1-9e5a-2a07064f2f95	6d066a72-f59f-45a8-ab90-216000b36da4	c7976361-e689-44f1-9e5a-2a07064f2f95		TCGA.AR.A1AR.01A-31D-A135-09		TCGA.AR.A1AR.01	TCGA.AR.A1AR.01A-31D-A138-05			TCGA.AR.A1AR.01	TCGA.AR.A1AR.01A-31D-A135-09		TCGA.AR.A1AR.01	TCGA.AR.A1AR.01	TCGA.AR.A1AR.01A-31D-A135-09		6d066a72-f59f-45a8-ab90-216000b36da4		TCGA.AR.A1AR.01A-31D-A134-01	TCGA.AR.A1AR.01	TCGA.AR.A1AR.01A-31R-A137-07	6d066a72-f59f-45a8-ab90-216000b36da4	TCGA.AR.A1AR.01A-31D-A134-01	TCGA.AR.A1AR.01
TCGA.AR.A5QQ.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					1	TCGA.AR.A5QQ.01	322	1	days										TCGA-AR-A5QQ	301	1	days	322	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Right	Axillary lymph node dissection alone		TCGA.AR.A5QQ.F42734	TCGA-AR-A5QQ	TCGA.AR.A5QQ.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-24841	576	322	0	NA	NA	NA	301							2013-6-10	FEMALE					1+	NA		NA	NA	Other, specify		No	NA	C50.9	8575/3	C50.9		YES		Core needle biopsy	800	NO	Negative		NO	24		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA			Lung	Distant Metastasis	Liver, bone, chest wall, adrenal glands		YES	1	NA	true	No	M0	N1	T3	Stage IIIA	TCGA-AR-A5QQ.511282C5-02AC-4105-8B52-5BBEC8B45D22.pdf	A5QQ	WITH TUMOR						YES	YES			YES	Primary Tumor	1		7th		NO	YES	AR	Breast	A	DECEASED	2011	16f90247-c9a5-40d5-a3a1-08bba2d1d266	d871dcd8-1cb2-4c05-8ecf-4e30837267ff	16f90247-c9a5-40d5-a3a1-08bba2d1d266	d871dcd8-1cb2-4c05-8ecf-4e30837267ff				TCGA.AR.A5QQ.01	TCGA.AR.A5QQ.01A-11D-A28C-05		23195a90-ef03-4655-9b11-4668986a94c3	TCGA.AR.A5QQ.01	TCGA.AR.A5QQ.01A-11D-A28B-09			TCGA.AR.A5QQ.01			16f90247-c9a5-40d5-a3a1-08bba2d1d266		TCGA.AR.A5QQ.01A-11D-A28A-01	TCGA.AR.A5QQ.01		16f90247-c9a5-40d5-a3a1-08bba2d1d266	TCGA.AR.A5QQ.01A-11D-A28A-01	
TCGA.BH.A0BL.01	Stage I	35	3	Stage I	1339	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	1339	0	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA.BH.A0BL.01	2278	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0BL	2278	0	days	2278	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right Upper Outer Quadrant			TCGA.BH.A0BL.F59189	TCGA-BH-A0BL	TCGA.BH.A0BL.01A		Negative					Negative	Other			NA	NA	-12841	1135	NA	0	2278	NA	NA			NO					2014-5-2	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	4	NA							NO	0	NA	true	No	M0	N0	T1c	Stage I	TCGA-BH-A0BL.DD647293-3CEA-4845-A0B3-D7000CBAB4C0.pdf	A0BL	TUMOR FREE						YES	YES			NO	Primary Tumor	1	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	39ca8590-3733-4b61-9a46-4ec5e6e0501e	970819ce-f25d-4f05-98d7-7b3a22b92558	39ca8590-3733-4b61-9a46-4ec5e6e0501e	970819ce-f25d-4f05-98d7-7b3a22b92558		TCGA.BH.A0BL.01A-11D-A10Y-09		TCGA.BH.A0BL.01				TCGA.BH.A0BL.01	TCGA.BH.A0BL.01A-11D-A10Y-09	TCGA.BH.A0BL.01A-11D-A112-05	TCGA.BH.A0BL.01	TCGA.BH.A0BL.01	TCGA.BH.A0BL.01A-11D-A10Y-09		39ca8590-3733-4b61-9a46-4ec5e6e0501e		TCGA.BH.A0BL.01A-11D-A111-01	TCGA.BH.A0BL.01	TCGA.BH.A0BL.01A-11R-A115-07	39ca8590-3733-4b61-9a46-4ec5e6e0501e	TCGA.BH.A0BL.01A-11D-A111-01	TCGA.BH.A0BL.01
TCGA.C8.A131.01	Stage III	82	1	Stage IIIA	0	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N2	0	0	Basal	Basal-like	Negative	ReacII	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA.C8.A131.01	411	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	OV-like c4	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 2	TCGA-C8-A131	411	0	days	411	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					82	Left	Axillary lymph node dissection alone		TCGA.C8.A131.F70827	TCGA-C8-A131	TCGA.C8.A131.01A		Negative					Negative	Other			NA	NA	-29966	163	NA	0	411	NA	NA			NO				Scheduled Follow-up Submission	2015-3-9	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	460	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											1	5	NA							NO	4	NA	true	No	M0	N2	T2	Stage IIIA	TCGA-C8-A131.65C73797-1A8F-474D-94F6-45A2878B2C45.pdf	A131	TUMOR FREE						YES	YES			NO	Primary Tumor	1	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	5162ef6d-6978-4ff7-b385-a59325cefe17	8451e6fa-790e-4ea7-9068-520299fad8a1	5162ef6d-6978-4ff7-b385-a59325cefe17	8451e6fa-790e-4ea7-9068-520299fad8a1	TCGA.C8.A131.01A-21-A13D-20	TCGA.C8.A131.01A-11D-A10Y-09		TCGA.C8.A131.01			4a1fa1ef-67ab-4ea7-a650-5276030b04ee	TCGA.C8.A131.01	TCGA.C8.A131.01A-11D-A10Y-09	TCGA.C8.A131.01A-11D-A112-05	TCGA.C8.A131.01	TCGA.C8.A131.01	TCGA.C8.A131.01A-11D-A10Y-09		5162ef6d-6978-4ff7-b385-a59325cefe17		TCGA.C8.A131.01A-11D-A111-01	TCGA.C8.A131.01	TCGA.C8.A131.01A-11R-A115-07	5162ef6d-6978-4ff7-b385-a59325cefe17	TCGA.C8.A131.01A-11D-A111-01	TCGA.C8.A131.01
TCGA.D8.A13Z.01	Stage X	51	1	Stage IIIA	210	NA	Negative	FEMALE	Negative	2	2	1	Negative	M0	Positive	N2	210	0	Her2	HER2-enriched	Negative	Basal	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA.D8.A13Z.01	635	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-D8-A13Z	635	0	days	635	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA.D8.A13Z.F20731	TCGA-D8-A13Z	TCGA.D8.A13Z.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-18942	214	NA	0	635	NA	NA							Scheduled Follow-up Submission	2012-1-14	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	470	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											1	4	NA							NO	9	NA	false	No	M0	N2a	T2		TCGA-D8-A13Z.8EFA6C19-2FA1-4F23-AF7B-15681E8E930A.pdf	A13Z	TUMOR FREE		Hercep Test  TM Dako					YES			YES	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	a0230b81-eee6-4c5f-b6de-cb9215dbda5b	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	a0230b81-eee6-4c5f-b6de-cb9215dbda5b	TCGA.D8.A13Z.01A-21-A13D-20	TCGA.D8.A13Z.01A-11D-A10Y-09		TCGA.D8.A13Z.01			ecffe473-31aa-41e3-a964-ca96147a8023	TCGA.D8.A13Z.01	TCGA.D8.A13Z.01A-11D-A10Y-09	TCGA.D8.A13Z.01A-11D-A112-05	TCGA.D8.A13Z.01	TCGA.D8.A13Z.01	TCGA.D8.A13Z.01A-11D-A10Y-09		624ac458-8ff1-441c-a8c5-aaf4a08a4b84		TCGA.D8.A13Z.01A-11D-A111-01	TCGA.D8.A13Z.01	TCGA.D8.A13Z.01A-11R-A115-07	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	TCGA.D8.A13Z.01A-11D-A111-01	TCGA.D8.A13Z.01
TCGA.D8.A1JL.01	Stage IIA	72	3	Stage IIA	265	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	265	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.D8.A1JL.01	611	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-D8-A1JL	611	0	days	611	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA.D8.A1JL.F20747	TCGA-D8-A1JL	TCGA.D8.A1JL.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-26484	264	NA	0	611	NA	NA				manual counting			Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	430	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	2	NA							NO	0	NA	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1JL.156DF753-DB3A-4934-9618-1E18CE46C845.pdf	A1JL	TUMOR FREE	manual counting			0%	0%		YES			NO	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	b4673313-fa18-43e8-a01b-5cdb3cf5425e	8f111081-c896-403e-b965-65d3e3a9ba62	b4673313-fa18-43e8-a01b-5cdb3cf5425e	8f111081-c896-403e-b965-65d3e3a9ba62	TCGA.D8.A1JL.01A-21-A17J-20	TCGA.D8.A1JL.01A-11D-A13L-09		TCGA.D8.A1JL.01	TCGA.D8.A1JL.01A-11D-A13K-05		c5c33030-617d-46a1-89a5-fa6ddd7d06fc	TCGA.D8.A1JL.01	TCGA.D8.A1JL.01A-11D-A13L-09			TCGA.D8.A1JL.01	TCGA.D8.A1JL.01A-11D-A13L-09		b4673313-fa18-43e8-a01b-5cdb3cf5425e		TCGA.D8.A1JL.01A-11D-A13J-01	TCGA.D8.A1JL.01		b4673313-fa18-43e8-a01b-5cdb3cf5425e	TCGA.D8.A1JL.01A-11D-A13J-01	
TCGA.D8.A27M.01	Stage IIA	59	1	Stage I	144	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	144	0	Basal		Negative		NA	NA	enrollment	T1	T1	LIVING	0	TCGA.D8.A27M.01	410	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 5		mutation cluster 5	TCGA-D8-A27M	410	0	days	410	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.D8.A27M.F29592	TCGA-D8-A27M	TCGA.D8.A27M.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-21910	83	NA	0	410	NA	NA			NO				Scheduled Follow-up Submission	2012-3-26	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	140	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	NA	NA							NO	NA	NA	false	No	M0	N0	T1c	Stage IA	TCGA-D8-A27M.85045216-10EC-473C-96A9-268E71D2B566.pdf	A27M	TUMOR FREE							YES			NO	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	20486352-7d5f-4065-ab10-7a3f792ec1e1	e44bc46c-7def-4fec-8865-38842dd349d1	20486352-7d5f-4065-ab10-7a3f792ec1e1	e44bc46c-7def-4fec-8865-38842dd349d1	TCGA.D8.A27M.01A-21-A17L-20	TCGA.D8.A27M.01A-11D-A16D-09		TCGA.D8.A27M.01	TCGA.D8.A27M.01A-11D-A16G-05		1d3de8e5-df7a-4e6c-a929-e03f23ddf78b	TCGA.D8.A27M.01	TCGA.D8.A27M.01A-11D-A16D-09			TCGA.D8.A27M.01	TCGA.D8.A27M.01A-11D-A16D-09		20486352-7d5f-4065-ab10-7a3f792ec1e1		TCGA.D8.A27M.01A-11D-A16C-01	TCGA.D8.A27M.01		20486352-7d5f-4065-ab10-7a3f792ec1e1	TCGA.D8.A27M.01A-11D-A16C-01	
TCGA.E2.A150.01	Stage IIA	48	1	Stage IIA	591	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	591	0	Basal	Basal-like	Negative	X	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.E2.A150.01	1935	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A150	1935	0	days	1935	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.E2.A150.F71066	TCGA-E2-A150	TCGA.E2.A150.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-17580	506	NA	0	1935	NA	NA			NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-3-18	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA							NO	0	NA	false	No	M0	N0	T2	Stage IIA	TCGA-E2-A150.5173DB84-EE23-4973-A244-4BB1D79325C9.pdf	A150	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	46262a6c-8a11-4bb9-8851-8b6e44c95288	752855b4-0b2c-4e89-b11f-f4e52d40c45f	46262a6c-8a11-4bb9-8851-8b6e44c95288	752855b4-0b2c-4e89-b11f-f4e52d40c45f	TCGA.E2.A150.01A-21-A13E-20	TCGA.E2.A150.01A-11D-A12B-09		TCGA.E2.A150.01			c44ec1a9-cea5-46a0-b2c5-1686127fd1eb	TCGA.E2.A150.01	TCGA.E2.A150.01A-11D-A12B-09	TCGA.E2.A150.01A-11D-A12E-05	TCGA.E2.A150.01	TCGA.E2.A150.01	TCGA.E2.A150.01A-11D-A12B-09		46262a6c-8a11-4bb9-8851-8b6e44c95288		TCGA.E2.A150.01A-11D-A12A-01	TCGA.E2.A150.01	TCGA.E2.A150.01A-11R-A12D-07	46262a6c-8a11-4bb9-8851-8b6e44c95288	TCGA.E2.A150.01A-11D-A12A-01	TCGA.E2.A150.01
TCGA.E2.A159.01	Stage IIA	50	1	Stage IIA	515	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	515	0	Basal	Basal-like	Negative	Basal	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA.E2.A159.01	762	0	days	High	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A159	762	0	days	762	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA.E2.A159.F19115	TCGA-E2-A159	TCGA.E2.A159.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-18621	434	NA	0	762	NA	NA			NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-11-8	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	240	NO		Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	3	NA							NO	0	NA	false	No	M0	N0	T2	Stage IIA	TCGA-E2-A159.7CA117DA-5D1C-4F8B-8330-5C58FE05DE36.pdf	A159	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	95c7abfa-a417-4d81-96c2-a952a081d997	c14c922b-4900-455a-8bf9-36021ff843aa	95c7abfa-a417-4d81-96c2-a952a081d997	c14c922b-4900-455a-8bf9-36021ff843aa	TCGA.E2.A159.01A-21-A13E-20	TCGA.E2.A159.01A-11D-A10Y-09		TCGA.E2.A159.01			c9662a04-c4e9-42c3-989f-cade253340dc	TCGA.E2.A159.01	TCGA.E2.A159.01A-11D-A10Y-09	TCGA.E2.A159.01A-11D-A112-05	TCGA.E2.A159.01	TCGA.E2.A159.01	TCGA.E2.A159.01A-11D-A10Y-09		95c7abfa-a417-4d81-96c2-a952a081d997		TCGA.E2.A159.01A-11D-A111-01	TCGA.E2.A159.01	TCGA.E2.A159.01A-11R-A115-07	95c7abfa-a417-4d81-96c2-a952a081d997	TCGA.E2.A159.01A-11D-A111-01	TCGA.E2.A159.01
TCGA.E2.A1AZ.01	Stage IIB	63	4	Stage IIB	1964	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	1964	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA.E2.A1AZ.01	2329	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-E2-A1AZ	2329	0	days	2329	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA.E2.A1AZ.F19462	TCGA-E2-A1AZ	TCGA.E2.A1AZ.01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO	NA	NA	-23230	2527	NA	0	2329	NA	NA			NO				Scheduled Follow-up Submission	2011-12-6	FEMALE						NA		0.42	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	250	NO	Indeterminate	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	NA	NA							NO	1	NA	true	No	M0	N1a	T2	Stage IIB	TCGA-E2-A1AZ.4E233F7D-035A-44A0-A5B6-6248357EB7B2.pdf	A1AZ	TUMOR FREE							YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2004	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	9ca918d1-dde6-4812-b6b8-05a6fb2332c3	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	9ca918d1-dde6-4812-b6b8-05a6fb2332c3	TCGA.E2.A1AZ.01A-21-A13E-20	TCGA.E2.A1AZ.01A-11D-A12Q-09		TCGA.E2.A1AZ.01	TCGA.E2.A1AZ.01A-11D-A12R-05		187a4af6-1941-419e-a58d-d3fb18510b65	TCGA.E2.A1AZ.01	TCGA.E2.A1AZ.01A-11D-A12Q-09		TCGA.E2.A1AZ.01	TCGA.E2.A1AZ.01	TCGA.E2.A1AZ.01A-11D-A12Q-09		fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c		TCGA.E2.A1AZ.01A-11D-A12N-01	TCGA.E2.A1AZ.01	TCGA.E2.A1AZ.01A-11R-A12P-07	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	TCGA.E2.A1AZ.01A-11D-A12N-01	TCGA.E2.A1AZ.01
TCGA.E2.A1LG.01	Stage IIA	50	2	Stage IIA	350	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	350	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.E2.A1LG.01	1523	0	days	Squamous	C4-BRCA/Basal	cluster 5	Low purity c2	KIRC-like c1	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-E2-A1LG	1523	0	days	1523	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.E2.A1LG.F70390	TCGA-E2-A1LG	TCGA.E2.A1LG.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-18492	252	NA	0	1523	NA	NA			NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-3-16	FEMALE			60-69%		2+	NA		1.1	NA	Infiltrating Lobular Carcinoma		No	NA	C50.9	8520/3	C50.9		YES		Tumor resection	310	NO	Equivocal	Negative	NO	19	Negative	Peri (6-12 months since last menstrual period)									NA											5	5	NA							NO	0	NA	false	Yes	M0	N0	T2	Stage IIA	TCGA-E2-A1LG.08A790DE-B01D-4140-BB1C-B4844291D71E.pdf	A1LG	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			NO	Primary Tumor	1		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	b2cc4c34-e90b-4377-b50b-222e507cffcc	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	b2cc4c34-e90b-4377-b50b-222e507cffcc	TCGA.E2.A1LG.01A-41-A17J-20	TCGA.E2.A1LG.01A-21D-A14K-09		TCGA.E2.A1LG.01	TCGA.E2.A1LG.01A-21D-A14N-05		ed36c1d5-f0b6-4ff7-bb8b-34a94cf24075	TCGA.E2.A1LG.01	TCGA.E2.A1LG.01A-21D-A14K-09			TCGA.E2.A1LG.01	TCGA.E2.A1LG.01A-21D-A14K-09		94d92cd8-21cf-495d-b4fe-8f8c6067fe9e		TCGA.E2.A1LG.01A-21D-A14J-01	TCGA.E2.A1LG.01		94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	TCGA.E2.A1LG.01A-21D-A14J-01	
TCGA.E2.A1LL.01	Stage IIIA	73	1	Stage IIIA	1014	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N2	1014	0	Basal		Negative		NA	NA	enrollment	T_Other	T3	LIVING	0	TCGA.E2.A1LL.01	1309	0	days	Squamous	C2-Squamous-like	cluster 1	BRCA CIMP c7	KIRC-like c1	squamous-like c4	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A1LL	1303	1	days	1309	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO		73	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.E2.A1LL.F20616	TCGA-E2-A1LL	TCGA.E2.A1LL.01A		Negative					Negative	Simple Mastectomy		NO	NA	NA	-27028	988	NA	0	1309	NA	NA	1303		NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2012-1-17	FEMALE			<10%		1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	290	NO	Negative			44	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											1	4	NA			Liver	Distant Metastasis			YES	5	NA	false	No	MX	N2a	T3	Stage IIIA	TCGA-E2-A1LL.3327975F-94BE-460E-9900-E063340927BE.pdf	A1LL	WITH TUMOR	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	526c9170-0f25-4374-9287-1fc40acb6555	d64ae769-0555-42d9-ab57-abbb6f292d82	526c9170-0f25-4374-9287-1fc40acb6555	d64ae769-0555-42d9-ab57-abbb6f292d82	TCGA.E2.A1LL.01A-21-A17J-20	TCGA.E2.A1LL.01A-11D-A142-09		TCGA.E2.A1LL.01	TCGA.E2.A1LL.01A-11D-A145-05		fdf3231f-d485-4a5e-b10b-43d9ab536a66	TCGA.E2.A1LL.01	TCGA.E2.A1LL.01A-11D-A142-09			TCGA.E2.A1LL.01	TCGA.E2.A1LL.01A-11D-A142-09		526c9170-0f25-4374-9287-1fc40acb6555		TCGA.E2.A1LL.01A-11D-A141-01	TCGA.E2.A1LL.01		526c9170-0f25-4374-9287-1fc40acb6555	TCGA.E2.A1LL.01A-11D-A141-01	
TCGA.E9.A5FL.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.E9.A5FL.01	24	0	days										TCGA-E9-A5FL	24	0	days	24	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.E9.A5FL.F56061	TCGA-E9-A5FL	TCGA.E9.A5FL.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-24053	73	NA	0	24	NA	NA								2014-1-24	FEMALE						NA		NA	NA	Metaplastic Carcinoma		No	NA	C50.9	8575/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	590	NO	Negative		YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	NA	true	No	M0	N0	T3	Stage IIB	TCGA-E9-A5FL.72186F5B-9F97-428C-8E06-9240E17E88DD.pdf	A5FL	TUMOR FREE						NO	YES			NO	Primary Tumor	1		7th		YES	NO	E9	Breast	A	LIVING	2012	7810122d-fa8b-483d-9398-aa26fc7fedc5	82a8cdff-ba8d-4eb6-ae65-4881a10abc7a	7810122d-fa8b-483d-9398-aa26fc7fedc5	82a8cdff-ba8d-4eb6-ae65-4881a10abc7a				TCGA.E9.A5FL.01	TCGA.E9.A5FL.01A-11D-A27Y-05		dca0a85a-e2c5-4dcf-bc19-4b0374669de4	TCGA.E9.A5FL.01	TCGA.E9.A5FL.01A-11D-A27P-09			TCGA.E9.A5FL.01			7810122d-fa8b-483d-9398-aa26fc7fedc5		TCGA.E9.A5FL.01A-11D-A27O-01	TCGA.E9.A5FL.01		7810122d-fa8b-483d-9398-aa26fc7fedc5	TCGA.E9.A5FL.01A-11D-A27O-01	
TCGA.EW.A1P4.01	Stage IIA	43	1	Stage IIA	501	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	501	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.EW.A1P4.01	907	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-EW-A1P4	907	0	days	907	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.EW.A1P4.F29684	TCGA-EW-A1P4	TCGA.EW.A1P4.01A		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		YES	NA	NA	-15989	525	NA	0	907	NA	NA			NO		<10%		Scheduled Follow-up Submission	2012-3-26	FEMALE			<10%			NA		NA	NA	Medullary Carcinoma		No	NA	C50.9	8510/3	C50.9		YES		Core needle biopsy	290	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	5	NA							NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-EW-A1P4.70C8D54A-9698-4275-BD96-A6EF2E26474B.pdf	A1P4	TUMOR FREE							YES	<10%		YES	Primary Tumor	1		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	91a5b906-6a04-4f0d-8710-172311e84789	260e860c-9034-4c71-bc77-db7f25ae2baf	91a5b906-6a04-4f0d-8710-172311e84789	260e860c-9034-4c71-bc77-db7f25ae2baf	TCGA.EW.A1P4.01A-11-A17J-20	TCGA.EW.A1P4.01A-21D-A142-09		TCGA.EW.A1P4.01	TCGA.EW.A1P4.01A-21D-A145-05		b7cf8b60-fd76-4c2c-aa8e-cc0d0c89009a	TCGA.EW.A1P4.01	TCGA.EW.A1P4.01A-21D-A142-09			TCGA.EW.A1P4.01	TCGA.EW.A1P4.01A-21D-A142-09		91a5b906-6a04-4f0d-8710-172311e84789		TCGA.EW.A1P4.01A-21D-A141-01	TCGA.EW.A1P4.01		91a5b906-6a04-4f0d-8710-172311e84789	TCGA.EW.A1P4.01A-21D-A141-01	
TCGA.EW.A1P7.01	Stage IIA	59	1	Stage IIA	635	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	635	0	Normal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.EW.A1P7.01	915	0	days	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-EW-A1P7	729	1	days	915	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		59	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.EW.A1P7.F29118	TCGA-EW-A1P7			Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES	NA	793	-21750	NA	NA	0	915	NA	NA	729		NO		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			10-19%		2+	NA		1.8	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	NA		Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA			Other, specify	Distant Metastasis	mediastinal lymph nodes		YES	0	0		No	M0	N0 (i-)	T2	Stage IIA		A1P7	WITH TUMOR							YES	<10%		NO	Primary Tumor	1		6th	YES	NO	YES	EW	Breast		LIVING	2009	e11a1fd3-d409-4e09-a8ab-5d0afb455263	f179bb91-8b60-4eaf-aea1-5161b0c96719	e11a1fd3-d409-4e09-a8ab-5d0afb455263	f179bb91-8b60-4eaf-aea1-5161b0c96719		TCGA.EW.A1P7.01A-21D-A142-09		TCGA.EW.A1P7.01	TCGA.EW.A1P7.01A-21D-A145-05			TCGA.EW.A1P7.01	TCGA.EW.A1P7.01A-21D-A142-09			TCGA.EW.A1P7.01	TCGA.EW.A1P7.01A-21D-A142-09		e11a1fd3-d409-4e09-a8ab-5d0afb455263		TCGA.EW.A1P7.01A-21D-A141-01	TCGA.EW.A1P7.01		e11a1fd3-d409-4e09-a8ab-5d0afb455263	TCGA.EW.A1P7.01A-21D-A141-01	
TCGA.EW.A1P8.01	Stage IIIC	58	3	Stage IIIC	239	239	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N3	239	1	Basal		Negative		NA	NA	enrollment	T_Other	T2	DECEASED	1	TCGA.EW.A1P8.01	239	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 12	TCGA-EW-A1P8	207	1	days	239	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			NO		58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.EW.A1P8.F29121	TCGA-EW-A1P8	TCGA.EW.A1P8.01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO	NA	NA	-21501	224	239	0	NA	NA	NA	207		YES		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%			NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	160	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Negative	<10%		<10%	NA						<10%		Negative	Lung|Bone|Liver|Other, specify	skin	5	5	NA			Lung	Distant Metastasis			YES	14	NA	true	No	M0	N3b	T2	Stage IIIC	TCGA-EW-A1P8.6CB5A0ED-5569-4FDC-B651-758BFC6B59D8.pdf	A1P8	WITH TUMOR							YES	<10%		NO	Primary Tumor	1		7th	YES	NO	YES	EW	Breast	A	DECEASED	2010	d763ccd4-4a11-4e84-b0a6-1b42da020ce4	1dce5c12-1c51-4544-b148-7d313826a491	d763ccd4-4a11-4e84-b0a6-1b42da020ce4	1dce5c12-1c51-4544-b148-7d313826a491	TCGA.EW.A1P8.01A-21-A17J-20	TCGA.EW.A1P8.01A-11D-A142-09		TCGA.EW.A1P8.01	TCGA.EW.A1P8.01A-11D-A145-05		9729bae9-2494-4ef3-9382-a564fa2a1363	TCGA.EW.A1P8.01	TCGA.EW.A1P8.01A-11D-A142-09			TCGA.EW.A1P8.01	TCGA.EW.A1P8.01A-11D-A142-09		d763ccd4-4a11-4e84-b0a6-1b42da020ce4		TCGA.EW.A1P8.01A-11D-A141-01	TCGA.EW.A1P8.01		d763ccd4-4a11-4e84-b0a6-1b42da020ce4	TCGA.EW.A1P8.01A-11D-A141-01	
TCGA.EW.A1PB.01	Stage IIIA	70	3	Stage IIIA	608	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	608	0	Basal		Negative		NA	NA	enrollment	T_Other	T3	LIVING	0	TCGA.EW.A1PB.01	608	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-EW-A1PB	608	0	days	608	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.EW.A1PB.F29107	TCGA-EW-A1PB	TCGA.EW.A1PB.01A		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		NO	NA	NA	-25770	569	NA	0	608	NA	NA					<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%			NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	2	NA							NO	2	NA	true	No	MX	N1a	T3	Stage IIIA	TCGA-EW-A1PB.B3B6DE56-F40C-40BF-B6B3-2BC10F695F16.pdf	A1PB	TUMOR FREE							YES	<10%		NO	Primary Tumor	1		6th	NO	NO	YES	EW	Breast	A	LIVING	2009	50674dde-30c1-4530-a164-381d5326e29c	e50f848e-a469-41c1-b44b-4dbc283fd0a6	50674dde-30c1-4530-a164-381d5326e29c	e50f848e-a469-41c1-b44b-4dbc283fd0a6	TCGA.EW.A1PB.01A-21-A17J-20	TCGA.EW.A1PB.01A-11D-A142-09		TCGA.EW.A1PB.01	TCGA.EW.A1PB.01A-11D-A145-05		0bdf178b-3488-411a-bda6-2b7ee3beb0fd	TCGA.EW.A1PB.01	TCGA.EW.A1PB.01A-11D-A142-09			TCGA.EW.A1PB.01	TCGA.EW.A1PB.01A-11D-A142-09		50674dde-30c1-4530-a164-381d5326e29c		TCGA.EW.A1PB.01A-11D-A141-01	TCGA.EW.A1PB.01		50674dde-30c1-4530-a164-381d5326e29c	TCGA.EW.A1PB.01A-11D-A141-01	
TCGA.PL.A8LV.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					NA	TCGA.PL.A8LV.01	NA	NA	days										TCGA-PL-A8LV	NA	NA	days	NA	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right|Right Upper Outer Quadrant	No axillary staging		TCGA.PL.A8LV.F64849	TCGA-PL-A8LV	TCGA.PL.A8LV.01A											NA	NA	-19746	240	NA	0	-7	NA	NA								2014-10-17	FEMALE						NA		NA	NA	Medullary Carcinoma		No	NA	C50.9	8510/3	C50.9		YES		Excisional Biopsy	840	NO			YES	NA											NA											NA	NA	NA								NA	NA	false	No	M0	N0	T4	Stage IIIB	TCGA-PL-A8LV.D35DBECD-5241-4562-85CC-2822BB338279.pdf	A8LV	WITH TUMOR							NO			NO	Primary Tumor	1		7th		YES	NO	PL	Breast	A	LIVING	2013	34f3d207-0bfe-4699-b01b-d145942ba488	22f1be3b-bde1-4466-9f54-316c0924a835	34f3d207-0bfe-4699-b01b-d145942ba488	22f1be3b-bde1-4466-9f54-316c0924a835				TCGA.PL.A8LV.01	TCGA.PL.A8LV.01A-21D-A41Q-05		E260A9A0-230C-482C-A3E6-9A4DB6ECD90F	TCGA.PL.A8LV.01				TCGA.PL.A8LV.01			34f3d207-0bfe-4699-b01b-d145942ba488		TCGA.PL.A8LV.01A-21D-A41E-01	TCGA.PL.A8LV.01		34f3d207-0bfe-4699-b01b-d145942ba488	TCGA.PL.A8LV.01A-21D-A41E-01	
TCGA.PL.A8LZ.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.PL.A8LZ.01	302	0	days										TCGA-PL-A8LZ	302	0	days	302	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					29	Left|Left Upper Outer Quadrant			TCGA.PL.A8LZ.F64850	TCGA-PL-A8LZ	TCGA.PL.A8LZ.01A											NA	NA	-10869	157	NA	0	302	NA	NA								2014-9-15	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Excisional Biopsy	830	NO			NO	NA		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											NA	NA	NA							NO	NA	NA	false	No	M0	N2	T4b	Stage IIIB	TCGA-PL-A8LZ.436F3280-98C7-4FA9-BD6F-1B02CAF1D262.pdf	A8LZ	TUMOR FREE						YES				NO	Primary Tumor	1		7th		YES	NO	PL	Breast	A	LIVING	2013	de01d9b6-e29d-495e-815a-c7d2a7c15af3	0e185d4c-d0cd-4098-a9ce-0a0ead6ab508	de01d9b6-e29d-495e-815a-c7d2a7c15af3	0e185d4c-d0cd-4098-a9ce-0a0ead6ab508				TCGA.PL.A8LZ.01	TCGA.PL.A8LZ.01A-31D-A36K-05			TCGA.PL.A8LZ.01				TCGA.PL.A8LZ.01			de01d9b6-e29d-495e-815a-c7d2a7c15af3		TCGA.PL.A8LZ.01A-31D-A36I-01	TCGA.PL.A8LZ.01		de01d9b6-e29d-495e-815a-c7d2a7c15af3	TCGA.PL.A8LZ.01A-31D-A36I-01	
TCGA.S3.AA15.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.S3.AA15.01	525	0	days										TCGA-S3-AA15	525	0	days	525	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right|Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.S3.AA15.F72098	TCGA-S3-AA15	TCGA.S3.AA15.01A		Negative			3 Point Scale		Negative	Simple Mastectomy		YES	NA	NA	-18659	93	NA	0	525	NA	NA				CAP SCORING GUIDELINE 2010				2015-4-10	FEMALE		CAP SCORING GUIDELINE 2010				NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	990	NO	Negative		NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	2	0	true	No	cM0 (i+)	N1a	T2	Stage IIB	TCGA-S3-AA15.DD2B9E47-8C67-4599-B0B6-0D30DE727B55.pdf	AA15	TUMOR FREE	CAP SCORING GUIDELINE 2010					YES	YES			YES	Primary Tumor	1		7th		YES	NO	S3	Breast	A	LIVING	2013	181e9c9f-7dbd-4f3a-8298-12797c717e1f	51ab9b17-4565-4792-826e-4ea1e86ddaba	181e9c9f-7dbd-4f3a-8298-12797c717e1f	51ab9b17-4565-4792-826e-4ea1e86ddaba				TCGA.S3.AA15.01	TCGA.S3.AA15.01A-11D-A41Q-05		A6D6E30B-1F8A-4B8B-B81C-5E016CBC4561	TCGA.S3.AA15.01				TCGA.S3.AA15.01			181e9c9f-7dbd-4f3a-8298-12797c717e1f		TCGA.S3.AA15.01A-11D-A41E-01	TCGA.S3.AA15.01		181e9c9f-7dbd-4f3a-8298-12797c717e1f	TCGA.S3.AA15.01A-11D-A41E-01	
TCGA.A2.A04P.01	Stage IIIC	36	1	No_Conversion	547	547	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N3	547	1	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	DECEASED	1	TCGA.A2.A04P.01	548	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-A2-A04P	179	1	days	548	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO	NO	36	Left	Axillary lymph node dissection alone		TCGA.A2.A04P.F71021	TCGA-A2-A04P	TCGA.A2.A04P.01A	Positive	Negative				Mastectomy NOS	Negative	Lumpectomy		NO	NA	NA	-13238	2623	548	0	NA	NA	179	179				<10%			2015-3-13	FEMALE						NA		1.3	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Excisional Biopsy	250	NO		Negative	NO	20	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)					Negative				1				Negative				Negative			5	5	NA			Other, specify	Locoregional Recurrence	Axilla	YES	YES	18	0	true	No	M0	N3c	T2	Stage IIIC	TCGA-A2-A04P.0E4B0EA9-14D1-4A82-814D-51CC2B9BA2B5.pdf	A04P	WITH TUMOR						YES		<10%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	DECEASED	2003	357ba9f6-716c-4ef0-8ac8-41977397dbf5	514e30c9-fe93-4d52-a31f-9e771c71d300	357ba9f6-716c-4ef0-8ac8-41977397dbf5	514e30c9-fe93-4d52-a31f-9e771c71d300	TCGA.A2.A04P.01A-41-A13A-20	TCGA.A2.A04P.01A-31D-A128-09		TCGA.A2.A04P.01			15a1aee0-d9cf-4122-9290-0d4bfaee159a	TCGA.A2.A04P.01	TCGA.A2.A04P.01A-31D-A128-09	TCGA.A2.A04P.01A-31D-A032-05	TCGA.A2.A04P.01		TCGA.A2.A04P.01A-31D-A128-09	TCGA.A2.A04P.01	357ba9f6-716c-4ef0-8ac8-41977397dbf5	TCGA.A2.A04P.01	TCGA.A2.A04P.01A-31D-A036-01		TCGA.A2.A04P.01A-31R-A034-07	357ba9f6-716c-4ef0-8ac8-41977397dbf5	TCGA.A2.A04P.01A-31D-A036-01	TCGA.A2.A04P.01
TCGA.A2.A0EQ.01	Stage IIA	64	4	Stage IIA	2426	NA	Negative	FEMALE	Positive	1	1	4	Negative	M0	Negative	N0	2426	0	Her2	HER2-enriched	Negative	Basal	-2	-5	followup	T_Other	T2	LIVING	0	TCGA.A2.A0EQ.01	2426	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 8	TCGA-A2-A0EQ	2426	0	days	2426	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left	Other (specify)	Sentinel lymph node and non-sentinel lymph node biopsy	TCGA.A2.A0EQ.F13720	TCGA-A2-A0EQ	TCGA.A2.A0EQ.01A	Negative	Negative		0		Lumpectomy	Negative	Lumpectomy		YES	NA	NA	-23543	2038	NA	0	2426	NA	NA					<10%		Scheduled Follow-up Submission	2011-6-13	FEMALE					3+	NA		1.1	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Core needle biopsy	600	NO	Positive	Negative		2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	5	NA							NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0EQ.60569C8B-7209-4A3F-A177-F337085E9146.pdf	A0EQ	TUMOR FREE								<10%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	7b6fada0-555f-4234-9436-a498d03e7413	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	7b6fada0-555f-4234-9436-a498d03e7413	TCGA.A2.A0EQ.01A-21-A13C-20	TCGA.A2.A0EQ.01A-11W-A050-09		TCGA.A2.A0EQ.01			cd49aac8-9c6e-41d7-816c-1bdcb4aaca4a	TCGA.A2.A0EQ.01	TCGA.A2.A0EQ.01A-11W-A050-09	TCGA.A2.A0EQ.01A-11D-A032-05	TCGA.A2.A0EQ.01		TCGA.A2.A0EQ.01A-11W-A050-09	TCGA.A2.A0EQ.01	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	TCGA.A2.A0EQ.01	TCGA.A2.A0EQ.01A-11D-A036-01		TCGA.A2.A0EQ.01A-11R-A034-07	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	TCGA.A2.A0EQ.01A-11D-A036-01	TCGA.A2.A0EQ.01
TCGA.A2.A1G6.01	Stage IIIA	50	1	Stage IIIA	132	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N2	132	0	Normal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.A2.A1G6.01	501	0	days	Quiet	C5-KIRC	cluster 5	Low purity c2	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A2-A1G6	501	0	days	501	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right	Axillary lymph node dissection alone		TCGA.A2.A1G6.F20947	TCGA-A2-A1G6	TCGA.A2.A1G6.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-18514	229	NA	0	501	NA	NA			NO				Scheduled Follow-up Submission	2012-1-9	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	770	NO	Negative			9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	6	NA							NO	4	NA	true	No	M0	N2a	T2	Stage IIIA	TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A.pdf	A1G6	TUMOR FREE							YES			YES	Primary Tumor	1		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	8b216b0f-1881-45de-a4ae-78dfd87764fe	e64cdbe2-a5a8-4714-b25f-e27b254e95e8	8b216b0f-1881-45de-a4ae-78dfd87764fe	e64cdbe2-a5a8-4714-b25f-e27b254e95e8	TCGA.A2.A1G6.01A-21-A17I-20	TCGA.A2.A1G6.01A-11D-A13L-09		TCGA.A2.A1G6.01	TCGA.A2.A1G6.01A-11D-A13K-05		02e55cff-87a6-4719-b988-4b8f46f079a5	TCGA.A2.A1G6.01	TCGA.A2.A1G6.01A-11D-A13L-09			TCGA.A2.A1G6.01	TCGA.A2.A1G6.01A-11D-A13L-09		8b216b0f-1881-45de-a4ae-78dfd87764fe		TCGA.A2.A1G6.01A-11D-A13J-01	TCGA.A2.A1G6.01		8b216b0f-1881-45de-a4ae-78dfd87764fe	TCGA.A2.A1G6.01A-11D-A13J-01	
TCGA.A7.A0CE.01	Stage IIA	57	1	Stage IIA	309	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	309	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA.A7.A0CE.01	1074	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A7-A0CE	1074	0	days	1074	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA.A7.A0CE.F39153	TCGA-A7-A0CE	TCGA.A7.A0CE.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-20863	129	NA	0	1074	NA	NA					<10%	2.9		2013-1-14	FEMALE	Vysis AutoVysion System			PathVysion	2+	389	3.2	1.1	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	330	NO	Equivocal	Negative	NO	1	Negative	Indeterminate (neither Pre or Postmenopausal)									NA											5	5	NA							NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0CE.8A853D7F-979F-4112-9659-1FDE84EF5102.pdf	A0CE	TUMOR FREE						YES		<10%		YES	Primary Tumor	1			YES	YES	NO	A7	Breast	A	LIVING	2009	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	f79ed0dc-7704-4967-b62c-0112de377fc3	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	f79ed0dc-7704-4967-b62c-0112de377fc3	TCGA.A7.A0CE.01A-21-A13A-20	TCGA.A7.A0CE.01A-11W-A019-09		TCGA.A7.A0CE.01			7a0dcaa3-a8ab-4437-b642-11872fbf6456	TCGA.A7.A0CE.01	TCGA.A7.A0CE.01A-11W-A019-09	TCGA.A7.A0CE.01A-11D-A00Y-05	TCGA.A7.A0CE.01		TCGA.A7.A0CE.01A-11W-A019-09	TCGA.A7.A0CE.01	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	TCGA.A7.A0CE.01	TCGA.A7.A0CE.01A-11D-A011-01		TCGA.A7.A0CE.01A-11R-A00Z-07	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	TCGA.A7.A0CE.01A-11D-A011-01	TCGA.A7.A0CE.01
TCGA.AO.A0J2.01	Stage IA	41	3	Stage I	585	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	585	0	Her2	HER2-enriched	Negative	Basal	-11	-9	followup	T1	T1	LIVING	0	TCGA.AO.A0J2.01	997	0	days	High	C3-BRCA/Luminal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AO-A0J2	997	0	days	997	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Lower Inner Quadrant|Left	Sentinel node biopsy alone		TCGA.AO.A0J2.F15481	TCGA-AO-A0J2	TCGA.AO.A0J2.01A		Negative					Negative	Simple Mastectomy		YES	NA	NA	-15324	668	NA	0	997	NA	NA					<10%	2.4	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	30-39%	RATIO > 2.2	2+	40	3.5	1.5	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Equivocal	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	4	NA							NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-AO-A0J2.DB0B1C9D-6B94-46EF-A84E-3D912E08B7FD.pdf	A0J2	TUMOR FREE								<10%		NO	Primary Tumor	1			YES	NO	YES	AO	Breast	A	LIVING	2008	81689324-2986-49f6-bef6-f5a525ca36c2	3b7dc667-6a9b-46e3-b0db-f11980cac1fe	81689324-2986-49f6-bef6-f5a525ca36c2	3b7dc667-6a9b-46e3-b0db-f11980cac1fe	TCGA.AO.A0J2.01A-21-A13A-20	TCGA.AO.A0J2.01A-11W-A050-09		TCGA.AO.A0J2.01			c8e29a9a-2a2c-49ad-8101-2f74df959c0c	TCGA.AO.A0J2.01	TCGA.AO.A0J2.01A-11W-A050-09	TCGA.AO.A0J2.01A-11D-A032-05	TCGA.AO.A0J2.01		TCGA.AO.A0J2.01A-11W-A050-09	TCGA.AO.A0J2.01	81689324-2986-49f6-bef6-f5a525ca36c2	TCGA.AO.A0J2.01	TCGA.AO.A0J2.01A-11D-A036-01		TCGA.AO.A0J2.01A-11R-A034-07	81689324-2986-49f6-bef6-f5a525ca36c2	TCGA.AO.A0J2.01A-11D-A036-01	TCGA.AO.A0J2.01
TCGA.AO.A1KR.01		51	1		2140	NA	Negative	FEMALE		NA	NA	NA					2140	0	Basal		Negative		NA	NA	enrollment			LIVING	0	TCGA.AO.A1KR.01	2513	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AO-A1KR	2513	0	days	2513	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA.AO.A1KR.F21768	TCGA-AO-A1KR	TCGA.AO.A1KR.01A		Negative	4 Point Scale		3 Point Scale		Negative	Simple Mastectomy		YES	NA	NA	-18900	1932	NA	0	2513	NA	NA			NO				Scheduled Follow-up Submission	2013-5-21	FEMALE					1+	NA	1	NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	3	NA							NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-AO-A1KR.FF188295-E139-4AEE-8EE8-364536F2BBE8.pdf	A1KR	TUMOR FREE							YES			NO	Primary Tumor	1		6th	YES	NO	YES	AO	Breast	A	LIVING	2005	6d22f538-114f-48b6-94ba-fb60151ed567	0d7cde44-ec86-415a-8667-0ea894d1c344	6d22f538-114f-48b6-94ba-fb60151ed567	0d7cde44-ec86-415a-8667-0ea894d1c344	TCGA.AO.A1KR.01A-21-A17I-20	TCGA.AO.A1KR.01A-12D-A142-09		TCGA.AO.A1KR.01	TCGA.AO.A1KR.01A-12D-A145-05		209b9ca9-04fe-441d-915a-b8f4ef9e4b74	TCGA.AO.A1KR.01	TCGA.AO.A1KR.01A-12D-A142-09			TCGA.AO.A1KR.01	TCGA.AO.A1KR.01A-12D-A142-09		6d22f538-114f-48b6-94ba-fb60151ed567		TCGA.AO.A1KR.01A-12D-A141-01	TCGA.AO.A1KR.01		6d22f538-114f-48b6-94ba-fb60151ed567	TCGA.AO.A1KR.01A-12D-A141-01	
TCGA.AR.A2LH.01		NA	NA		NA	NA				NA	NA	NA					NA	NA	Normal				NA	NA					1	TCGA.AR.A2LH.01	616	1	days	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-AR-A2LH	434	1	days	616	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A2LH.F35165	TCGA-AR-A2LH	TCGA.AR.A2LH.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-20288	1661	616	0	NA	NA	NA	434		YES					2012-12-6	FEMALE					2+	NA		NA	NA	Infiltrating Lobular Carcinoma		No	NA	C50.9	8520/3	C50.9		YES		Core needle biopsy	1100	NO	Equivocal	Negative	NO	39	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA									Bone|Liver		NA	NA	NA			Bone	Distant Metastasis			YES	29	NA	true	No	M0	N3	T3	Stage III	TCGA-AR-A2LH.4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D.pdf	A2LH							YES	YES			YES	Primary Tumor	1		6th		NO	YES	AR	Breast	A	DECEASED	2007	6aa1a643-013f-43d4-a3e6-a4a946ac3678	b99a1cb6-1b23-4d66-8865-ab265a85b41b	6aa1a643-013f-43d4-a3e6-a4a946ac3678	b99a1cb6-1b23-4d66-8865-ab265a85b41b	TCGA.AR.A2LH.01A-41-A24A-20			TCGA.AR.A2LH.01	TCGA.AR.A2LH.01A-31D-A18O-05		eca21066-45f1-49c3-b6ac-d594ed529c0e	TCGA.AR.A2LH.01	TCGA.AR.A2LH.01A-31D-A18P-09			TCGA.AR.A2LH.01			6aa1a643-013f-43d4-a3e6-a4a946ac3678		TCGA.AR.A2LH.01A-31D-A18N-01	TCGA.AR.A2LH.01		6aa1a643-013f-43d4-a3e6-a4a946ac3678	TCGA.AR.A2LH.01A-31D-A18N-01	
TCGA.B6.A0IE.01		38	3	No_Conversion	1998	1998	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	1998	1	LumA	Normal-like	Negative		-2	-3	followup		TX	DECEASED	1	TCGA.B6.A0IE.01	1993	1	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-B6-A0IE	834	1	days	1993	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO		38	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA.B6.A0IE.F12614	TCGA-B6-A0IE	TCGA.B6.A0IE.01A	Negative	Negative					Negative	Other		NO	NA	NA	-13982	5557	1993	0	NA	NA	NA	834			Image Analysis			Scheduled Follow-up Submission	2011-6-1	FEMALE						NA		NA	NA	Mixed Histology (please specify)	Lobular/Ductal	No	NA	C50.9	8520/3	C50.9		YES		Incisional Biopsy	90	NO				24	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											1	4	NA			Bone	Distant Metastasis			YES	6	NA	true	No	M0	N1b	T3	Stage IIIA	TCGA-B6-A0IE.DFCA9C6E-710E-4645-9CFC-A908AAD583F3.pdf	A0IE	WITH TUMOR	Image Analysis									YES	Primary Tumor	1	Wide re-excisional biopsy	4th	YES	NO	YES	B6	Breast	A	DECEASED	1995	f40b4aa3-b474-4c2e-a197-0347e46d3309	0716b4fb-1209-4a73-b14f-245d7277c7f3	f40b4aa3-b474-4c2e-a197-0347e46d3309	0716b4fb-1209-4a73-b14f-245d7277c7f3		TCGA.B6.A0IE.01A-11W-A050-09		TCGA.B6.A0IE.01				TCGA.B6.A0IE.01	TCGA.B6.A0IE.01A-11W-A050-09	TCGA.B6.A0IE.01A-11D-A032-05	TCGA.B6.A0IE.01		TCGA.B6.A0IE.01A-11W-A050-09	TCGA.B6.A0IE.01	f40b4aa3-b474-4c2e-a197-0347e46d3309	TCGA.B6.A0IE.01	TCGA.B6.A0IE.01A-11D-A036-01		TCGA.B6.A0IE.01A-11R-A034-07	f40b4aa3-b474-4c2e-a197-0347e46d3309	TCGA.B6.A0IE.01A-11D-A036-01	TCGA.B6.A0IE.01
TCGA.B6.A0RS.01	Stage IIA	38	1	Stage IIA	3062	3062	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	3062	1	Her2	HER2-enriched	Negative		0	0	followup	T_Other	T2	DECEASED	1	TCGA.B6.A0RS.01	3063	1	days	High	C3-BRCA/Luminal	cluster 5	Cluster 5		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0RS	2041	1	days	3063	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		38	Left Lower Inner Quadrant|Left	Axillary lymph node dissection alone		TCGA.B6.A0RS.F13788	TCGA-B6-A0RS			Negative					Negative	Modified Radical Mastectomy		NO	NA	2041	-14134	NA	3063	0	NA	NA	NA	2041						Scheduled Follow-up Submission	2011-7-12	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	NA					15	Negative	Indeterminate (neither Pre or Postmenopausal)					Negative				NA								Negative			5	4	NA			Other, specify	New Primary Tumor	Breast		YES	0	NA		No	M0	N0 (i-)	T2	Stage IIA		A0RS	WITH TUMOR										NO	Primary Tumor	1		3rd	YES	NO	YES	B6	Breast		DECEASED	1988	be1f09ae-deec-45d7-8504-fea3f6e7feb4	e191f444-0987-42d9-baed-ceb74591810f	be1f09ae-deec-45d7-8504-fea3f6e7feb4	e191f444-0987-42d9-baed-ceb74591810f		TCGA.B6.A0RS.01A-11D-A099-09		TCGA.B6.A0RS.01	TCGA.B6.A0RS.01A-11D-A10P-05			TCGA.B6.A0RS.01			TCGA.B6.A0RS.01		TCGA.B6.A0RS.01A-11D-A099-09	TCGA.B6.A0RS.01	be1f09ae-deec-45d7-8504-fea3f6e7feb4	TCGA.B6.A0RS.01	TCGA.B6.A0RS.01A-11D-A087-01		TCGA.B6.A0RS.01A-11R-A084-07	be1f09ae-deec-45d7-8504-fea3f6e7feb4	TCGA.B6.A0RS.01A-11D-A087-01	TCGA.B6.A0RS.01
TCGA.BH.A0B3.01	Stage IIB	53	1	No_Conversion	1203	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1203	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA.BH.A0B3.01	1203	0	days	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0B3	1203	0	days	1203	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA.BH.A0B3.F15418	TCGA-BH-A0B3	TCGA.BH.A0B3.01A		Negative		0			Negative	Other		NO	NA	NA	-19479	1030	NA	0	1203	NA	NA							Scheduled Follow-up Submission	2010-11-3	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Core needle biopsy	280	NO	Negative			29	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	4	NA							NO	2	NA	true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0B3.A6E2735B-AAD3-48D7-8289-306257CB5B6F.pdf	A0B3	TUMOR FREE										YES	Primary Tumor	1	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007	6d2744ba-4817-482b-ad46-2e4e0897ad88	c3288d38-aff7-4cf9-8b44-e3eb22e261ca	6d2744ba-4817-482b-ad46-2e4e0897ad88	c3288d38-aff7-4cf9-8b44-e3eb22e261ca	TCGA.BH.A0B3.01A-21-A13A-20	TCGA.BH.A0B3.01A-11W-A071-09		TCGA.BH.A0B3.01	TCGA.BH.A0B3.01A-11D-A10P-05		971d0c2f-844b-45a2-a541-05189e0278d4	TCGA.BH.A0B3.01	TCGA.BH.A0B3.01A-11W-A071-09		TCGA.BH.A0B3.01		TCGA.BH.A0B3.01A-11W-A071-09	TCGA.BH.A0B3.01	6d2744ba-4817-482b-ad46-2e4e0897ad88	TCGA.BH.A0B3.01	TCGA.BH.A0B3.01A-11D-A059-01		TCGA.BH.A0B3.01A-11R-A056-07	6d2744ba-4817-482b-ad46-2e4e0897ad88	TCGA.BH.A0B3.01A-11D-A059-01	TCGA.BH.A0B3.01
TCGA.BH.A0E0.01	Stage IIIC	38	1	No_Conversion	133	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N3	133	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T3	LIVING	0	TCGA.BH.A0E0.01	134	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-BH-A0E0	NA	NA	days	134	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA.BH.A0E0.F4603	TCGA-BH-A0E0	TCGA.BH.A0E0.01A		Negative		0			Negative	Modified Radical Mastectomy		NO	NA	NA	-14175	136	NA	0	134	NA	NA				H-SCORE 0				2010-10-16	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Core needle biopsy	620	NO	Negative			21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	5	NA								10	NA	true	No	M0	N3a	T3	Stage IIIC	TCGA-BH-A0E0.975989FE-8785-42C1-8551-53661B7B16A1.pdf	A0E0	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE					YES	Primary Tumor	1			YES	NO	YES	BH	Breast	A	LIVING	2009	fac9101c-a974-4415-9eac-d2d433d02b13	d0d4963f-0739-4d50-a631-119847fc08d7	fac9101c-a974-4415-9eac-d2d433d02b13	d0d4963f-0739-4d50-a631-119847fc08d7	TCGA.BH.A0E0.01A-21-A13B-20	TCGA.BH.A0E0.01A-11W-A071-09		TCGA.BH.A0E0.01	TCGA.BH.A0E0.01A-11D-A10P-05		9ccd25d1-e45d-469d-942d-0b514d4cb5a0	TCGA.BH.A0E0.01	TCGA.BH.A0E0.01A-11W-A071-09		TCGA.BH.A0E0.01		TCGA.BH.A0E0.01A-11W-A071-09	TCGA.BH.A0E0.01	fac9101c-a974-4415-9eac-d2d433d02b13	TCGA.BH.A0E0.01	TCGA.BH.A0E0.01A-11D-A059-01		TCGA.BH.A0E0.01A-11R-A056-07	fac9101c-a974-4415-9eac-d2d433d02b13	TCGA.BH.A0E0.01A-11D-A059-01	TCGA.BH.A0E0.01
TCGA.BH.A18Q.01	Stage IIB	56	1	No_Conversion	1692	1692	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1692	1	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	DECEASED	1	TCGA.BH.A18Q.01	1692	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 5	mutation cluster 13	TCGA-BH-A18Q	NA	NA	days	1692	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left	Axillary lymph node dissection alone			TCGA-BH-A18Q	TCGA.BH.A18Q.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-20675	3417	1692	0	NA	NA	NA								2011-6-24	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.8	8500/3	C50.8		YES		Core needle biopsy	130	NO	Positive	Negative		25	Negative										NA											5	5	NA								2	2	true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A18Q.BB4C7377-F10C-48D2-A8AA-6D5B43FEB108.pdf	A18Q								YES				Primary Tumor	1				NO	YES	BH	Breast	A	DECEASED	2001	2c75afc3-11b5-444d-b6e0-61d76b299f40	94a07da0-f029-444a-86d7-d9bc24e7e76d	2c75afc3-11b5-444d-b6e0-61d76b299f40	94a07da0-f029-444a-86d7-d9bc24e7e76d	TCGA.BH.A18Q.01A-21-A13E-20	TCGA.BH.A18Q.01A-12D-A12B-09		TCGA.BH.A18Q.01			44798c24-89d7-4d25-a4bc-3d2fab66b4e8	TCGA.BH.A18Q.01	TCGA.BH.A18Q.01A-12D-A12B-09	TCGA.BH.A18Q.01A-12D-A12E-05	TCGA.BH.A18Q.01	TCGA.BH.A18Q.01	TCGA.BH.A18Q.01A-12D-A12B-09		2c75afc3-11b5-444d-b6e0-61d76b299f40		TCGA.BH.A18Q.01A-12D-A12A-01	TCGA.BH.A18Q.01	TCGA.BH.A18Q.01A-12R-A12D-07	2c75afc3-11b5-444d-b6e0-61d76b299f40	TCGA.BH.A18Q.01A-12D-A12A-01	TCGA.BH.A18Q.01
TCGA.BH.A18V.01	Stage IIB	48	1	No_Conversion	1555	1555	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1555	1	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	DECEASED	1	TCGA.BH.A18V.01	1556	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 2	TCGA-BH-A18V	NA	NA	days	1556	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right	Axillary lymph node dissection alone			TCGA-BH-A18V	TCGA.BH.A18V.01A		Negative					Negative	Other			NA	NA	-17682	3621	1556	0	NA	NA	NA			YES					2011-7-2	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.4	8500/3	C50.4		YES		Core needle biopsy	300	NO	Negative			25	Negative			Negative			Negative				NA								Negative	Other, specify	axilaary node negative but intrammary node positive	5	5	NA								0	NA	true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A18V.3C1C2CED-A1CF-48FC-BCB2-658D74E1982B.pdf	A18V								YES				Primary Tumor	1	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2001	429b50eb-316f-459c-bc3a-0aca6e6dba46	12aa84c3-f49b-408a-a863-97f2254e442e	429b50eb-316f-459c-bc3a-0aca6e6dba46	12aa84c3-f49b-408a-a863-97f2254e442e		TCGA.BH.A18V.01A-11D-A12B-09		TCGA.BH.A18V.01			7bf9da92-5872-4f29-ba4d-f247ec7984f0	TCGA.BH.A18V.01	TCGA.BH.A18V.01A-11D-A12B-09	TCGA.BH.A18V.01A-11D-A12E-05	TCGA.BH.A18V.01	TCGA.BH.A18V.01	TCGA.BH.A18V.01A-11D-A12B-09		429b50eb-316f-459c-bc3a-0aca6e6dba46		TCGA.BH.A18V.01A-11D-A12A-01	TCGA.BH.A18V.01	TCGA.BH.A18V.01A-11R-A12D-07	429b50eb-316f-459c-bc3a-0aca6e6dba46	TCGA.BH.A18V.01A-11D-A12A-01	TCGA.BH.A18V.01
TCGA.BH.A1EW.01	Stage IIA	38	3	No_Conversion	NA	1694	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	1694	1	LumA	Luminal B	Negative		-3	-3	enrollment	T_Other	T2	DECEASED	1	TCGA.BH.A1EW.01	1694	1	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A1EW	NA	NA	days	1694	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Left Upper Outer Quadrant				TCGA-BH-A1EW	TCGA.BH.A1EW.01A		Negative					Negative	Other			NA	NA	-14090	4230	1694	0	NA	NA	NA								2011-9-7	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Negative			16		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											1	6	NA								1	NA	true	No	M0	N1b	T2	Stage IIA	TCGA-BH-A1EW.56EFCA58-2328-4C5C-9618-981447E76B12.pdf	A1EW	WITH TUMOR							YES				Primary Tumor	1	Left segmental mastectomy with level 1 and level 2 axillary dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999	59783c67-6446-44c1-b9b3-505470f54c82	aff7ebf5-e7ff-4932-972f-758e23aedf4b	59783c67-6446-44c1-b9b3-505470f54c82	aff7ebf5-e7ff-4932-972f-758e23aedf4b	TCGA.BH.A1EW.01A-21-A17I-20	TCGA.BH.A1EW.01A-11D-A135-09		TCGA.BH.A1EW.01	TCGA.BH.A1EW.01A-11D-A138-05		fd676c7e-c137-4699-a8ea-57b72b10ff5b	TCGA.BH.A1EW.01	TCGA.BH.A1EW.01A-11D-A135-09		TCGA.BH.A1EW.01	TCGA.BH.A1EW.01	TCGA.BH.A1EW.01A-11D-A135-09		59783c67-6446-44c1-b9b3-505470f54c82		TCGA.BH.A1EW.01A-11D-A134-01	TCGA.BH.A1EW.01	TCGA.BH.A1EW.01A-11R-A137-07	59783c67-6446-44c1-b9b3-505470f54c82	TCGA.BH.A1EW.01A-11D-A134-01	TCGA.BH.A1EW.01
TCGA.BH.A1F6.01		51	NA		NA	2965	Negative	FEMALE		NA	NA	NA					2965	1	Basal		Negative		NA	NA	enrollment			DECEASED	1	TCGA.BH.A1F6.01	2965	1	days	High	C4-BRCA/Basal		BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12		mutation cluster 5	TCGA-BH-A1F6	NA	NA	days	2965	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left				TCGA-BH-A1F6	TCGA.BH.A1F6.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-18691	5230	2965	0	NA	NA	NA								2011-9-7	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Negative			6											NA											NA	NA	NA								6	NA	true	No	MX	N2a	T4d		TCGA-BH-A1F6.7E9B0BE7-121E-423F-AA37-445BA922FC13.pdf	A1F6								YES				Primary Tumor	1				NO	YES	BH	Breast	A	DECEASED	1996	5f5a884c-ffbd-401a-8689-baded1bdbe50	9221bace-db00-4adc-ac61-aa064672c1ad	5f5a884c-ffbd-401a-8689-baded1bdbe50	9221bace-db00-4adc-ac61-aa064672c1ad	TCGA.BH.A1F6.01A-21-A17I-20	TCGA.BH.A1F6.01A-11D-A13L-09		TCGA.BH.A1F6.01	TCGA.BH.A1F6.01A-11D-A13K-05		9e1df13d-422b-46a6-8dd0-0f3d943c301b	TCGA.BH.A1F6.01	TCGA.BH.A1F6.01A-11D-A13L-09			TCGA.BH.A1F6.01	TCGA.BH.A1F6.01A-11D-A13L-09		5f5a884c-ffbd-401a-8689-baded1bdbe50		TCGA.BH.A1F6.01A-11D-A13J-01	TCGA.BH.A1F6.01		5f5a884c-ffbd-401a-8689-baded1bdbe50	TCGA.BH.A1F6.01A-11D-A13J-01	
TCGA.BH.A1FC.01	Stage IIA	78	4	Stage IIA	NA	3471	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	3471	1	Basal		Negative		NA	NA	enrollment	T1	T1	DECEASED	1	TCGA.BH.A1FC.01	3472	1	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-BH-A1FC	NA	NA	days	3472	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right Upper Outer Quadrant				TCGA-BH-A1FC	TCGA.BH.A1FC.01A		Negative					Negative	Other			NA	NA	-28706	4456	3472	0	NA	NA	NA								2011-9-8	FEMALE						NA		NA	NA	Medullary Carcinoma		No	NA	C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	90	NO	Negative			23		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	3	NA								1	NA	true	No	M0	N1b	T1c	Stage IIA	TCGA-BH-A1FC.7B1B31D2-0CC5-4EE6-8AF3-16DF726BE13F.pdf	A1FC	TUMOR FREE							YES				Primary Tumor	1	localized segmental mastectomy with axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1998	42e2160c-07b5-4be6-a989-1e3474926d2a	2b2b809a-ad8d-42c1-baf9-39886ab3d8b1	42e2160c-07b5-4be6-a989-1e3474926d2a	2b2b809a-ad8d-42c1-baf9-39886ab3d8b1	TCGA.BH.A1FC.01A-21-A17I-20	TCGA.BH.A1FC.01A-11D-A13L-09		TCGA.BH.A1FC.01	TCGA.BH.A1FC.01A-11D-A13K-05		9ce04c0d-97f2-4acd-a985-c9b162221210	TCGA.BH.A1FC.01	TCGA.BH.A1FC.01A-11D-A13L-09			TCGA.BH.A1FC.01	TCGA.BH.A1FC.01A-11D-A13L-09		42e2160c-07b5-4be6-a989-1e3474926d2a		TCGA.BH.A1FC.01A-11D-A13J-01	TCGA.BH.A1FC.01		42e2160c-07b5-4be6-a989-1e3474926d2a	TCGA.BH.A1FC.01A-11D-A13J-01	
TCGA.BH.A42U.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.BH.A42U.01	3364	0	days										TCGA-BH-A42U	3364	0	days	3364	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Right			TCGA.BH.A42U.F61923	TCGA-BH-A42U	TCGA.BH.A42U.01A		Negative					Negative	Simple Mastectomy			NA	NA	-29330	3080	NA	0	3364	NA	NA								2014-7-10	FEMALE						NA		NA	NA	Infiltrating Lobular Carcinoma		No	NA	C50.9	8520/3	C50.9		YES		Core needle biopsy	290	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	NA	NA	true	No	M0	N0	T2	Stage IIA	TCGA-BH-A42U.25F791D8-27D6-4DC6-8D96-5D5CF68A5F13.pdf	A42U	TUMOR FREE						NO	YES			NO	Primary Tumor	1		6th		YES	NO	BH	Breast	A	LIVING	2004	b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	ede65d88-d290-4017-b9d7-9be40d87e6b0	b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	ede65d88-d290-4017-b9d7-9be40d87e6b0				TCGA.BH.A42U.01	TCGA.BH.A42U.01A-12D-A244-05		6bab8423-84c9-41ec-88f7-5efcfcc1ab30	TCGA.BH.A42U.01	TCGA.BH.A42U.01A-12D-A243-09			TCGA.BH.A42U.01			b3ce7ee4-fc5e-445c-b1ca-5f324b33678a		TCGA.BH.A42U.01A-12D-A242-01	TCGA.BH.A42U.01		b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	TCGA.BH.A42U.01A-12D-A242-01	
TCGA.C8.A26X.01	Stage II	58	4	Stage IIA	11	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	11	0	Her2		Negative		NA	NA	enrollment	T1	T1	LIVING	0	TCGA.C8.A26X.01	376	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7		mutation cluster 3	TCGA-C8-A26X	376	0	days	376	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant			TCGA.C8.A26X.F70792	TCGA-C8-A26X	TCGA.C8.A26X.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-21463	136	NA	0	376	NA	NA								2015-3-9	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Negative		NO	NA	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	NA	NA							NO	NA	NA	true	No	M0	N1	T1	Stage IIA	TCGA-C8-A26X.8C845114-BBC6-45F2-9135-7E8298E24422.pdf	A26X	TUMOR FREE						YES	NO			NO	Primary Tumor	1		6th		YES	NO	C8	Breast	A	LIVING	2010	5213da80-35ac-4172-b2e8-de686e73a498	95c7e7dd-400b-4864-8593-40f348078b3a	5213da80-35ac-4172-b2e8-de686e73a498	95c7e7dd-400b-4864-8593-40f348078b3a	TCGA.C8.A26X.01A-41-A17K-20	TCGA.C8.A26X.01A-31D-A16D-09		TCGA.C8.A26X.01	TCGA.C8.A26X.01A-31D-A16G-05		6a344715-e7bd-49b5-9ca7-0e1060a19710	TCGA.C8.A26X.01	TCGA.C8.A26X.01A-31D-A16D-09			TCGA.C8.A26X.01	TCGA.C8.A26X.01A-31D-A16D-09		5213da80-35ac-4172-b2e8-de686e73a498		TCGA.C8.A26X.01A-31D-A16C-01	TCGA.C8.A26X.01		5213da80-35ac-4172-b2e8-de686e73a498	TCGA.C8.A26X.01A-31D-A16C-01	
TCGA.C8.A26Y.01	Stage II	90	2	Stage IIA	13	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	13	0	Her2		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.C8.A26Y.01	394	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-C8-A26Y	394	0	days	394	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Left Upper Outer Quadrant			TCGA.C8.A26Y.F70791	TCGA-C8-A26Y	TCGA.C8.A26Y.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-32872	134	NA	0	394	NA	NA								2015-3-9	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Negative		NO	NA	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	NA	NA							NO	NA	NA	true	No	M0	N0	T2	Stage IIA	TCGA-C8-A26Y.B660432A-A67B-40CC-89F8-80648DB8AE98.pdf	A26Y	TUMOR FREE						NO	NO			NO	Primary Tumor	1		6th		YES	NO	C8	Breast	A	LIVING	2010	afad9647-befe-4493-8386-475d0097c716	cb3f1e06-cab8-4345-bf54-4d99ea20fbb6	afad9647-befe-4493-8386-475d0097c716	cb3f1e06-cab8-4345-bf54-4d99ea20fbb6	TCGA.C8.A26Y.01A-21-A17K-20			TCGA.C8.A26Y.01	TCGA.C8.A26Y.01A-11D-A16G-05		4cf610ef-12f6-4149-ab0b-d0211e9642a6	TCGA.C8.A26Y.01	TCGA.C8.A26Y.01A-11D-A16D-09			TCGA.C8.A26Y.01			afad9647-befe-4493-8386-475d0097c716		TCGA.C8.A26Y.01A-11D-A16C-01	TCGA.C8.A26Y.01		afad9647-befe-4493-8386-475d0097c716	TCGA.C8.A26Y.01A-11D-A16C-01	
TCGA.C8.A3M7.01		NA	NA		NA	NA				NA	NA	NA					NA	NA	LumA				NA	NA					1	TCGA.C8.A3M7.01	1034	1	days	Iq	C3-BRCA/Luminal		BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-C8-A3M7	1034	1	days	1034	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			60	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA.C8.A3M7.F70838	TCGA-C8-A3M7			Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-22096	NA	1034	0	1	NA	NA	1034		NO					2015-3-9	FEMALE						NA		NA	NA	Infiltrating Lobular Carcinoma		No	NA	C50.9	8520/3	C50.9		YES		Tumor resection	NA		Negative		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA				Locoregional Recurrence		NO	YES	0	NA		No	M0	N0	T4b	Stage IIIB		A3M7	WITH TUMOR						YES	YES			YES	Primary Tumor	1		7th		YES	NO	C8	Breast		DECEASED	2010	b55b6630-7cf5-4bca-b76f-e135271018e4	fa8586a0-46be-45b5-9dd0-54f20b4c673c	b55b6630-7cf5-4bca-b76f-e135271018e4	fa8586a0-46be-45b5-9dd0-54f20b4c673c	TCGA.C8.A3M7.01A-21-A24A-20			TCGA.C8.A3M7.01	TCGA.C8.A3M7.01A-12D-A21R-05		c07c21cd-c286-4fd3-b98a-886e161a6ead	TCGA.C8.A3M7.01	TCGA.C8.A3M7.01A-12D-A21Q-09			TCGA.C8.A3M7.01			b55b6630-7cf5-4bca-b76f-e135271018e4		TCGA.C8.A3M7.01A-12D-A21P-01	TCGA.C8.A3M7.01		b55b6630-7cf5-4bca-b76f-e135271018e4	TCGA.C8.A3M7.01A-12D-A21P-01	
TCGA.D8.A143.01	Stage IIA	51	3	Stage IIA	431	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	431	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA.D8.A143.01	431	0	days	High	C3-BRCA/Luminal	cluster 5	BRCA CIMP c7	squamous c3	BRCA nonbasal-like c7			mutation cluster 3	TCGA-D8-A143	431	0	days	431	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA.D8.A143.F13817	TCGA-D8-A143	TCGA.D8.A143.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-18984	211	NA	0	431	NA	NA							Scheduled Follow-up Submission	2011-7-4	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	NA	NA							NO	0	NA	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A143.F8C2F3EF-FA73-4FF8-9A4E-7F557E68D560.pdf	A143	TUMOR FREE							YES			NO	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	e49bd6ce-bbab-4c77-a49d-6a85bf2e1f14	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	e49bd6ce-bbab-4c77-a49d-6a85bf2e1f14	TCGA.D8.A143.01A-21-A13D-20	TCGA.D8.A143.01A-11D-A10Y-09		TCGA.D8.A143.01			e9cd47fb-4a8f-44c9-af6a-f931387d14a7	TCGA.D8.A143.01	TCGA.D8.A143.01A-11D-A10Y-09	TCGA.D8.A143.01A-11D-A112-05	TCGA.D8.A143.01	TCGA.D8.A143.01	TCGA.D8.A143.01A-11D-A10Y-09		4bf5f56d-448a-426a-8edc-f1bdbf6a8d55		TCGA.D8.A143.01A-11D-A111-01	TCGA.D8.A143.01	TCGA.D8.A143.01A-11R-A115-07	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	TCGA.D8.A143.01A-11D-A111-01	TCGA.D8.A143.01
TCGA.D8.A1JF.01	Stage IIIA	79	3	Stage IIIA	96	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N2	96	0	Her2		Negative		NA	NA	enrollment	T1	T1	LIVING	0	TCGA.D8.A1JF.01	366	0	days	COAD-READ	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 8	TCGA-D8-A1JF	366	0	days	366	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.D8.A1JF.F14058	TCGA-D8-A1JF			Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-29199	NA	NA	0	366	NA	NA							Scheduled Follow-up Submission	2011-7-18	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	NA		Negative			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											1	3	NA							NO	8	NA		No	M0	N2a	T1c	Stage IIIA		A1JF	TUMOR FREE							YES			NO	Primary Tumor	1		7th	YES	YES	NO	D8	Breast		LIVING	2010	a74b20ca-06f9-47ec-8888-cb01e0ba3257	b93cb7b4-ce63-4f54-864e-f271f86c0781	a74b20ca-06f9-47ec-8888-cb01e0ba3257	b93cb7b4-ce63-4f54-864e-f271f86c0781	TCGA.D8.A1JF.01A-21-A17J-20	TCGA.D8.A1JF.01A-11D-A13L-09		TCGA.D8.A1JF.01	TCGA.D8.A1JF.01A-11D-A13K-05		c9bf8bae-3cf7-4b3f-8fb4-51e9bd4e83a8	TCGA.D8.A1JF.01	TCGA.D8.A1JF.01A-11D-A13L-09			TCGA.D8.A1JF.01	TCGA.D8.A1JF.01A-11D-A13L-09		a74b20ca-06f9-47ec-8888-cb01e0ba3257		TCGA.D8.A1JF.01A-11D-A13J-01	TCGA.D8.A1JF.01		a74b20ca-06f9-47ec-8888-cb01e0ba3257	TCGA.D8.A1JF.01A-11D-A13J-01	
TCGA.D8.A1JG.01	Stage IIA	62	1	Stage IIA	187	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	187	0	Her2		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.D8.A1JG.01	1612	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-D8-A1JG	1612	0	days	1612	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.D8.A1JG.F72208	TCGA-D8-A1JG	TCGA.D8.A1JG.01B		Negative					Negative	Lumpectomy		NO	NA	NA	-22878	215	NA	0	1612	NA	NA							Scheduled Follow-up Submission	2015-4-29	FEMALE					2+	NA	not amplified	NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	250	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	3	NA							NO	0	NA	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1JG.E1907A10-207B-41F1-8B8B-24D5B551BD05.pdf	A1JG	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	B	LIVING	2010	ee8b563d-11bb-4d84-ac53-e2acc8d0275d	0dd5d01d-8c6d-48ff-9cc0-fdc8d853b87c	ee8b563d-11bb-4d84-ac53-e2acc8d0275d	0dd5d01d-8c6d-48ff-9cc0-fdc8d853b87c	TCGA.D8.A1JG.01B-21-A17J-20	TCGA.D8.A1JG.01B-11D-A13L-09		TCGA.D8.A1JG.01	TCGA.D8.A1JG.01B-11D-A13K-05		dc251841-a624-484b-b4ce-b149651d3b57	TCGA.D8.A1JG.01	TCGA.D8.A1JG.01B-11D-A13L-09			TCGA.D8.A1JG.01	TCGA.D8.A1JG.01B-11D-A13L-09		ee8b563d-11bb-4d84-ac53-e2acc8d0275d		TCGA.D8.A1JG.01B-11D-A13J-01	TCGA.D8.A1JG.01		ee8b563d-11bb-4d84-ac53-e2acc8d0275d	TCGA.D8.A1JG.01B-11D-A13J-01	
TCGA.E2.A1L7.01	Stage IIIA	40	1	Stage IIIA	633	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N2	633	0	LumB		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.E2.A1L7.01	1836	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-E2-A1L7	1619	1	days	1836	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES			40	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.E2.A1L7.F70298	TCGA-E2-A1L7	TCGA.E2.A1L7.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-14854	548	NA	0	1836	NA	1662	1619		NO	Allred score 1+1 = 2			Scheduled Follow-up Submission	2015-3-16	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	150	NO	Negative		NO	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)					Negative				NA								Negative			2	5	NA			Other, specify	New Primary Tumor	left breast	YES	YES	7	NA	false	No	M0	N2	T2	Stage IIIA	TCGA-E2-A1L7.E78526AB-D72D-4407-B7E1-2255BB5B2F68.pdf	A1L7	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 2	YES	YES			YES	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	ec38c31b-def8-41cc-8656-57ce98f3faa7	11491d25-c862-49e4-8e23-ebbed8e1d87b	ec38c31b-def8-41cc-8656-57ce98f3faa7	11491d25-c862-49e4-8e23-ebbed8e1d87b	TCGA.E2.A1L7.01A-21-A17J-20	TCGA.E2.A1L7.01A-11D-A142-09		TCGA.E2.A1L7.01	TCGA.E2.A1L7.01A-11D-A145-05		9a9baaf4-427c-48cd-ae41-25fd84ae612f	TCGA.E2.A1L7.01	TCGA.E2.A1L7.01A-11D-A142-09			TCGA.E2.A1L7.01	TCGA.E2.A1L7.01A-11D-A142-09		ec38c31b-def8-41cc-8656-57ce98f3faa7		TCGA.E2.A1L7.01A-11D-A141-01	TCGA.E2.A1L7.01		ec38c31b-def8-41cc-8656-57ce98f3faa7	TCGA.E2.A1L7.01A-11D-A141-01	
TCGA.E2.A1LH.01	Stage I	59	3	Stage I	2875	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	2875	0	Basal		Negative		NA	NA	enrollment	T1	T1	LIVING	0	TCGA.E2.A1LH.01	3247	0	days	High	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8			mutation cluster 2	TCGA-E2-A1LH	3247	0	days	3247	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right	Sentinel node biopsy alone		TCGA.E2.A1LH.F20649	TCGA-E2-A1LH	TCGA.E2.A1LH.01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO	NA	NA	-21628	2998	NA	0	3247	NA	NA			NO				Scheduled Follow-up Submission	2012-1-12	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	NA	NA							NO	0	NA	false	No	M0	N0	T1c	Stage I	TCGA-E2-A1LH.DAB174BB-862D-49BE-9BA4-9C11C4489305.pdf	A1LH	TUMOR FREE		ACIS					YES			YES	Primary Tumor	1		5th	YES	NO	YES	E2	Breast	A	LIVING	2002	66f3892f-f4ec-412c-9c56-a9e9b56a15ee	8bab6eb6-da3c-49d9-b786-d078f8ebda09	66f3892f-f4ec-412c-9c56-a9e9b56a15ee	8bab6eb6-da3c-49d9-b786-d078f8ebda09		TCGA.E2.A1LH.01A-11D-A14G-09		TCGA.E2.A1LH.01	TCGA.E2.A1LH.01A-11D-A14H-05			TCGA.E2.A1LH.01	TCGA.E2.A1LH.01A-11D-A14G-09			TCGA.E2.A1LH.01	TCGA.E2.A1LH.01A-11D-A14G-09		66f3892f-f4ec-412c-9c56-a9e9b56a15ee		TCGA.E2.A1LH.01A-11D-A14F-01	TCGA.E2.A1LH.01		66f3892f-f4ec-412c-9c56-a9e9b56a15ee	TCGA.E2.A1LH.01A-11D-A14F-01	
TCGA.E9.A1ND.01	Stage IIB	75	1	Stage IIB	0	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	0	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.E9.A1ND.01	1266	0	days	Squamous	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 2	TCGA-E9-A1ND	1266	0	days	1266	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.E9.A1ND.F62586	TCGA-E9-A1ND	TCGA.E9.A1ND.01A		Negative					Negative			YES	NA	NA	-27400	37	NA	0	1266	NA	NA			NO				Scheduled Follow-up Submission	2014-7-21	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	420	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA							NO	1	0	true	No	M0	N1	T2	Stage IIB	TCGA-E9-A1ND.AC26EE69-27D8-4523-917A-68573F5F614E.pdf	A1ND	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	526da11e-9125-4fcd-98d7-02994c9783d1	20428d6b-edda-4596-af5d-2ae057ba9bbd	526da11e-9125-4fcd-98d7-02994c9783d1	20428d6b-edda-4596-af5d-2ae057ba9bbd	TCGA.E9.A1ND.01A-21-A17J-20	TCGA.E9.A1ND.01A-11D-A142-09		TCGA.E9.A1ND.01	TCGA.E9.A1ND.01A-11D-A145-05		c323e6ab-8ba2-4347-a5d0-931a5d9754a1	TCGA.E9.A1ND.01	TCGA.E9.A1ND.01A-11D-A142-09			TCGA.E9.A1ND.01	TCGA.E9.A1ND.01A-11D-A142-09		526da11e-9125-4fcd-98d7-02994c9783d1		TCGA.E9.A1ND.01A-11D-A141-01	TCGA.E9.A1ND.01		526da11e-9125-4fcd-98d7-02994c9783d1	TCGA.E9.A1ND.01A-11D-A141-01	
TCGA.E9.A1RH.01	Stage IIA	63	4	Stage IIA	14	NA		FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	14	0	Her2				NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.E9.A1RH.01	1417	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1RH	1417	0	days	1417	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA.E9.A1RH.F70141	TCGA-E9-A1RH	TCGA.E9.A1RH.01A								Lumpectomy		NO	NA	NA	-23224	32	NA	0	1417	NA	NA			NO				Scheduled Follow-up Submission	2015-1-28	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	410	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	4	NA							NO	0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1RH.FA93BDAA-B56E-4217-9022-4EBE6009FCF7.pdf	A1RH	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	422a4277-12f1-42ae-9f94-88d37517b9b0	f1b4f790-083e-44f0-b924-06dc7c167a20	422a4277-12f1-42ae-9f94-88d37517b9b0	f1b4f790-083e-44f0-b924-06dc7c167a20	TCGA.E9.A1RH.01A-11-A17J-20	TCGA.E9.A1RH.01A-21D-A167-09		TCGA.E9.A1RH.01	TCGA.E9.A1RH.01A-21D-A16A-05		7daa20aa-d253-4dc4-a90b-c68c6535d837	TCGA.E9.A1RH.01	TCGA.E9.A1RH.01A-21D-A167-09			TCGA.E9.A1RH.01	TCGA.E9.A1RH.01A-21D-A167-09		422a4277-12f1-42ae-9f94-88d37517b9b0		TCGA.E9.A1RH.01A-21D-A166-01	TCGA.E9.A1RH.01		422a4277-12f1-42ae-9f94-88d37517b9b0	TCGA.E9.A1RH.01A-21D-A166-01	
TCGA.EW.A1OV.01	Stage IIB	56	1	Stage IIB	522	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	522	0	Her2		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.EW.A1OV.01	789	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-EW-A1OV	789	0	days	789	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA.EW.A1OV.F29119	TCGA-EW-A1OV	TCGA.EW.A1OV.01A	Negative	Negative	3 Point Scale		3 Point Scale	Modified radical mastectomy	Negative	Lumpectomy		YES	NA	NA	-20764	469	NA	0	789	NA	NA			NO		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%			NA		1.8	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative	Negative		6	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	5	NA							NO	0	1	true	No	MX	N1mi	T2	Stage IIB	TCGA-EW-A1OV.88E39E13-8ADC-481A-992E-610B3BEBCBD4.pdf	A1OV	TUMOR FREE							YES	<10%		NO	Primary Tumor	1		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	b21367b5-91a3-4546-ba89-e33c462cb75b	5ffeb466-cd09-441c-a635-9feea1d71ff4	b21367b5-91a3-4546-ba89-e33c462cb75b	5ffeb466-cd09-441c-a635-9feea1d71ff4	TCGA.EW.A1OV.01A-21-A17J-20	TCGA.EW.A1OV.01A-11D-A142-09		TCGA.EW.A1OV.01	TCGA.EW.A1OV.01A-11D-A145-05		c9e8a21c-2cd8-404b-a8dc-7958940df71a	TCGA.EW.A1OV.01	TCGA.EW.A1OV.01A-11D-A142-09			TCGA.EW.A1OV.01	TCGA.EW.A1OV.01A-11D-A142-09		b21367b5-91a3-4546-ba89-e33c462cb75b		TCGA.EW.A1OV.01A-11D-A141-01	TCGA.EW.A1OV.01		b21367b5-91a3-4546-ba89-e33c462cb75b	TCGA.EW.A1OV.01A-11D-A141-01	
TCGA.EW.A1P1.01	Stage IIIC	68	1	Stage IIIC	919	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N3	919	0			Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.EW.A1P1.01	1210	0	days	Kirc+	C5-KIRC	cluster 1	Low purity c2	KIRC-like c1		miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-EW-A1P1	1014	1	days	1210	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	YES		68	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.EW.A1P1.F29115	TCGA-EW-A1P1	TCGA.EW.A1P1.01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO	NA	1200	-24923	850	NA	0	1210	NA	NA	1014		YES		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		2+	NA		1.8	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Equivocal	1+		Negative	<10%		<10%	NA						<10%		Negative	Lung		1	6	NA			Lung	Distant Metastasis			YES	11	NA	true	No	MX	N3b	T2	Stage IIIC	TCGA-EW-A1P1.AE0C51EF-017E-4F53-968C-804110F9A7E6.pdf	A1P1	TUMOR FREE							YES	<10%		YES	Primary Tumor	1		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	8a430d45-6511-4900-954e-fd01106d0f22	cceccfe3-7764-4959-89ee-978af184c489	8a430d45-6511-4900-954e-fd01106d0f22	cceccfe3-7764-4959-89ee-978af184c489	TCGA.EW.A1P1.01A-21-A17J-20	TCGA.EW.A1P1.01A-31D-A14G-09		TCGA.EW.A1P1.01	TCGA.EW.A1P1.01A-31D-A14H-05		3d649ce7-95df-442d-a4bb-88e71c4f5b10	TCGA.EW.A1P1.01	TCGA.EW.A1P1.01A-31D-A14G-09			TCGA.EW.A1P1.01	TCGA.EW.A1P1.01A-31D-A14G-09		8a430d45-6511-4900-954e-fd01106d0f22		TCGA.EW.A1P1.01A-31D-A14F-01	TCGA.EW.A1P1.01		8a430d45-6511-4900-954e-fd01106d0f22	TCGA.EW.A1P1.01A-31D-A14F-01	
TCGA.GM.A2DB.01		62	NA		1615	NA	Negative	FEMALE		NA	NA	NA					1615	0	Her2		Negative		NA	NA	enrollment			LIVING	0	TCGA.GM.A2DB.01	2406	0	days	Squamous	C3-BRCA/Luminal		BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DB	2406	0	days	2406	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.GM.A2DB.F47156	TCGA-GM-A2DB	TCGA.GM.A2DB.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-22883	1644	NA	0	2406	NA	NA			NO		<10%	1.50		2013-8-22	FEMALE					1+	60	1.67	1.11	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative	Negative	NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A2DB.5A315635-886B-459E-AF5D-079F66E859F0.pdf	A2DB	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	1		6th		NO	YES	GM	Breast	A	LIVING	2006	e5aeb7a3-1454-4605-a924-d4b1ed082e87	49a7d88b-449d-4070-82b3-d81ee76c7757	e5aeb7a3-1454-4605-a924-d4b1ed082e87	49a7d88b-449d-4070-82b3-d81ee76c7757	TCGA.GM.A2DB.01A-21-A24A-20			TCGA.GM.A2DB.01	TCGA.GM.A2DB.01A-31D-A18O-05		06141302-8b54-448e-811d-c6b69434ec4a	TCGA.GM.A2DB.01	TCGA.GM.A2DB.01A-31D-A19Y-09			TCGA.GM.A2DB.01			e5aeb7a3-1454-4605-a924-d4b1ed082e87		TCGA.GM.A2DB.01A-31D-A18N-01	TCGA.GM.A2DB.01		e5aeb7a3-1454-4605-a924-d4b1ed082e87	TCGA.GM.A2DB.01A-31D-A18N-01	
TCGA.GM.A2DD.01		53	NA		1309	NA	Negative	FEMALE		NA	NA	NA					1309	0	Normal		Negative		NA	NA	enrollment			LIVING	0	TCGA.GM.A2DD.01	2282	0	days	High	C3-BRCA/Luminal		BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DD	2282	0	days	2282	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right	Sentinel node biopsy alone		TCGA.GM.A2DD.F47070	TCGA-GM-A2DD			Negative					Negative	Simple Mastectomy		YES	NA	NA	-19415	NA	NA	0	2282	NA	NA			NO		<10%	1.45		2013-8-22	FEMALE			<10%		2+	60	1.62	1.11	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	NA		Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0		Yes	M0	N0 (i-)	T1c	Stage I		A2DD	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	1		6th		NO	YES	GM	Breast		LIVING	2007	ddc6e148-34b7-4466-b692-3bb227004e2b	ebef101a-cc11-448a-b8a6-b5e0c6f0f998	ddc6e148-34b7-4466-b692-3bb227004e2b	ebef101a-cc11-448a-b8a6-b5e0c6f0f998	TCGA.GM.A2DD.01A-21-A24A-20			TCGA.GM.A2DD.01	TCGA.GM.A2DD.01A-11D-A17Z-05		cf5d72b5-6d47-450b-90e3-8ffe9e291e75	TCGA.GM.A2DD.01	TCGA.GM.A2DD.01A-11D-A17W-09			TCGA.GM.A2DD.01			ddc6e148-34b7-4466-b692-3bb227004e2b		TCGA.GM.A2DD.01A-11D-A17U-01	TCGA.GM.A2DD.01		ddc6e148-34b7-4466-b692-3bb227004e2b	TCGA.GM.A2DD.01A-11D-A17U-01	
TCGA.GM.A2DH.01		58	NA		1286	NA	Negative	FEMALE		NA	NA	NA					1286	0	Her2		Negative		NA	NA	enrollment			LIVING	0	TCGA.GM.A2DH.01	2193	0	days	High	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 10			TCGA-GM-A2DH	2193	0	days	2193	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.GM.A2DH.F47081	TCGA-GM-A2DH	TCGA.GM.A2DH.01A		Negative					Negative	Simple Mastectomy		YES	NA	NA	-21344	1464	NA	0	2193	NA	NA			NO		<10%	2.80		2013-8-22	FEMALE					1+	60	2.80	1	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	1	false	No	M0	N0 (i+)	T1c	Stage I	TCGA-GM-A2DH.C3243207-2190-4435-9AA9-39E3B913E316.pdf	A2DH	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	1		6th		NO	YES	GM	Breast	A	LIVING	2007	ec2ac902-f5ca-45a5-a72a-1b266360410a	9a25d4b1-36c8-47f9-9b9c-72a11a7388ba	ec2ac902-f5ca-45a5-a72a-1b266360410a	9a25d4b1-36c8-47f9-9b9c-72a11a7388ba	TCGA.GM.A2DH.01A-21-A24A-20			TCGA.GM.A2DH.01	TCGA.GM.A2DH.01A-11D-A17Z-05		d2a00ef2-dd0f-4bd7-91e5-21e80e8b7e9e	TCGA.GM.A2DH.01	TCGA.GM.A2DH.01A-11D-A17W-09			TCGA.GM.A2DH.01			ec2ac902-f5ca-45a5-a72a-1b266360410a		TCGA.GM.A2DH.01A-11D-A17U-01	TCGA.GM.A2DH.01		ec2ac902-f5ca-45a5-a72a-1b266360410a	TCGA.GM.A2DH.01A-11D-A17U-01	
TCGA.GM.A2DI.01		52	NA		1883	NA	Negative	FEMALE		NA	NA	NA					1883	0	LumA		Negative		NA	NA	enrollment			LIVING	0	TCGA.GM.A2DI.01	2590	0	days	Squamous	C3-BRCA/Luminal		Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3			TCGA-GM-A2DI	2590	0	days	2590	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA.GM.A2DI.F47089	TCGA-GM-A2DI	TCGA.GM.A2DI.01A		Negative					Negative	Simple Mastectomy		YES	NA	NA	-19030	2144	NA	0	2590	NA	NA			NO		<10%	3.33		2013-8-22	FEMALE						60	3.53	1.06	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO		Negative	NO	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											NA	NA	NA							NO	0	1	false	No	M0	N0 (i+)	T1c	Stage I	TCGA-GM-A2DI.D437E9FF-5C09-4FD6-BB0B-0881CD4C50D7.pdf	A2DI	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	1		6th		NO	YES	GM	Breast	A	LIVING	2005	c50e1f9f-6059-4609-876d-938efb8a784e	82f1dfdc-1d68-4dd2-b933-80961316de23	c50e1f9f-6059-4609-876d-938efb8a784e	82f1dfdc-1d68-4dd2-b933-80961316de23	TCGA.GM.A2DI.01A-21-A24A-20			TCGA.GM.A2DI.01	TCGA.GM.A2DI.01A-31D-A18O-05		88140136-0e0a-44e3-84ac-ae2e2724a95f	TCGA.GM.A2DI.01	TCGA.GM.A2DI.01A-31D-A18P-09			TCGA.GM.A2DI.01			c50e1f9f-6059-4609-876d-938efb8a784e		TCGA.GM.A2DI.01A-31D-A18N-01	TCGA.GM.A2DI.01		c50e1f9f-6059-4609-876d-938efb8a784e	TCGA.GM.A2DI.01A-31D-A18N-01	
TCGA.LL.A5YO.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.LL.A5YO.01	440	0	days										TCGA-LL-A5YO	440	0	days	440	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.LL.A5YO.F58638	TCGA-LL-A5YO	TCGA.LL.A5YO.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-18354	47	NA	0	440	NA	NA								2014-4-17	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Negative		NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											NA	NA	NA							NO	0	0	false	No	MX	N0	T1b	Stage IA	TCGA-LL-A5YO.C5C5D704-2558-4D4B-937B-33BD91132882.pdf	A5YO	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th		YES	NO	LL	Breast	A	LIVING	2013	4b5b44ea-8589-4aea-a69f-b5d5041b1acd	51c263b0-32eb-49fe-b7ed-7de6b0a94c33	4b5b44ea-8589-4aea-a69f-b5d5041b1acd	51c263b0-32eb-49fe-b7ed-7de6b0a94c33				TCGA.LL.A5YO.01	TCGA.LL.A5YO.01A-21D-A28C-05		62e25802-1209-470d-8fe1-6c17c1c28b71	TCGA.LL.A5YO.01	TCGA.LL.A5YO.01A-21D-A28B-09			TCGA.LL.A5YO.01			4b5b44ea-8589-4aea-a69f-b5d5041b1acd		TCGA.LL.A5YO.01A-21D-A28A-01	TCGA.LL.A5YO.01		4b5b44ea-8589-4aea-a69f-b5d5041b1acd	TCGA.LL.A5YO.01A-21D-A28A-01	
TCGA.LL.A740.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.LL.A740.01	441	0	days										TCGA-LL-A740	441	0	days	441	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.LL.A740.F65059	TCGA-LL-A740	TCGA.LL.A740.01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES	NA	NA	-22416	37	NA	0	441	NA	NA						2.9		2014-9-18	FEMALE					2+	113	3.3	1.2	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	410	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	MX	N0 (i-)	T1c	Stage IA	TCGA-LL-A740.3AD4AA3C-5F68-43D1-B578-07AB574D4DE3.pdf	A740	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th		YES	NO	LL	Breast	A	LIVING	2013	9014d9c4-ab6b-4318-9b07-c00266d9f5a9	02600c52-6742-4d06-b417-16694f0c026b	9014d9c4-ab6b-4318-9b07-c00266d9f5a9	02600c52-6742-4d06-b417-16694f0c026b				TCGA.LL.A740.01	TCGA.LL.A740.01A-21D-A32T-05		A13762BD-83CD-4DBC-94FE-1879E3A4B5A4	TCGA.LL.A740.01				TCGA.LL.A740.01			9014d9c4-ab6b-4318-9b07-c00266d9f5a9		TCGA.LL.A740.01A-21D-A32H-01	TCGA.LL.A740.01		9014d9c4-ab6b-4318-9b07-c00266d9f5a9	TCGA.LL.A740.01A-21D-A32H-01	
TCGA.OL.A5D6.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					1	TCGA.OL.A5D6.01	1104	1	days										TCGA-OL-A5D6	1104	0	days	1104	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA.OL.A5D6.F55437	TCGA-OL-A5D6	TCGA.OL.A5D6.01A		Negative					Negative	Simple Mastectomy			NA	NA	-26052	1378	1104	0	385	NA	NA								2014-1-10	FEMALE						NA		1.13	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200	NO		Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	NA	0	true	No	MX	N0	T2	Stage IIA	TCGA-OL-A5D6.AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740.pdf	A5D6	TUMOR FREE						YES	YES			NO	Primary Tumor	1		6th		NO	YES	OL	Breast	A	DECEASED	2009	5657c6b6-ba04-4dd8-8623-2a3834820f7d	5e5b667c-4179-45ba-882c-21d35684ae1a	5657c6b6-ba04-4dd8-8623-2a3834820f7d	5e5b667c-4179-45ba-882c-21d35684ae1a				TCGA.OL.A5D6.01	TCGA.OL.A5D6.01A-21D-A27Y-05			TCGA.OL.A5D6.01	TCGA.OL.A5D6.01A-21D-A27P-09			TCGA.OL.A5D6.01			5657c6b6-ba04-4dd8-8623-2a3834820f7d		TCGA.OL.A5D6.01A-21D-A27O-01	TCGA.OL.A5D6.01		5657c6b6-ba04-4dd8-8623-2a3834820f7d	TCGA.OL.A5D6.01A-21D-A27O-01	
TCGA.OL.A66P.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.OL.A66P.01	428	0	days										TCGA-OL-A66P	428	0	days	428	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Right	Sentinel node biopsy alone		TCGA.OL.A66P.F58494	TCGA-OL-A66P	TCGA.OL.A66P.01A		Negative					Negative	Simple Mastectomy			NA	NA	-27489	98	NA	0	428	NA	NA								2014-4-11	FEMALE						NA		1.13	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO		Negative	NO	2	Negative										NA											NA	NA	NA							NO	NA	NA	true	No	MX	N0	T2	Stage IIA	TCGA-OL-A66P.979468F0-6B4A-4759-9CA2-7BA1D1441BC2.pdf	A66P	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th		NO	YES	OL	Breast	A	LIVING	2013	bbd01868-6fc1-42e7-b375-f0ac1a54a43c	da0238e7-c2e7-4a86-a3ef-3e49d1dfc228	bbd01868-6fc1-42e7-b375-f0ac1a54a43c	da0238e7-c2e7-4a86-a3ef-3e49d1dfc228				TCGA.OL.A66P.01	TCGA.OL.A66P.01A-11D-A31V-05		737f4dca-ab51-4053-ad90-6654f312ca6d	TCGA.OL.A66P.01				TCGA.OL.A66P.01			bbd01868-6fc1-42e7-b375-f0ac1a54a43c		TCGA.OL.A66P.01A-11D-A31T-01	TCGA.OL.A66P.01		bbd01868-6fc1-42e7-b375-f0ac1a54a43c	TCGA.OL.A66P.01A-11D-A31T-01	
TCGA.OL.A97C.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.OL.A97C.01	271	0	days										TCGA-OL-A97C	271	0	days	271	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Left			TCGA.OL.A97C.F66330	TCGA-OL-A97C	TCGA.OL.A97C.01A		Negative					Negative	Simple Mastectomy			NA	NA	-24735	216	NA	0	271	NA	NA								2014-10-31	FEMALE						NA		NA	NA	Other, specify		No	NA	C50.9	9020/3	C50.9		YES		Fine needle aspiration biopsy	410	NO		Negative	NO	6		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	NA	true	No	M0	N0	T3	Stage IIB	TCGA-OL-A97C.1582865E-9294-4D78-8B16-92FB70381D15.pdf	A97C	TUMOR FREE							YES			NO	Primary Tumor	1		7th		NO	YES	OL	Breast	A	LIVING	2013	590ae2bc-c076-4547-97dc-e2c8a0d396a6	9eb5ef11-18df-40b8-8c58-0236102b90e0	590ae2bc-c076-4547-97dc-e2c8a0d396a6	9eb5ef11-18df-40b8-8c58-0236102b90e0				TCGA.OL.A97C.01	TCGA.OL.A97C.01A-32D-A41Q-05			TCGA.OL.A97C.01				TCGA.OL.A97C.01			590ae2bc-c076-4547-97dc-e2c8a0d396a6		TCGA.OL.A97C.01A-32D-A41E-01	TCGA.OL.A97C.01		590ae2bc-c076-4547-97dc-e2c8a0d396a6	TCGA.OL.A97C.01A-32D-A41E-01	
TCGA.A1.A0SK.01	Stage IIA	54	1	Stage IIA	594	967	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	967	1	Basal	Basal-like	Negative	Basal	-13	-6	followup	T_Other	T2	DECEASED	1	TCGA.A1.A0SK.01	967	1	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	GBM-like c6	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-A1-A0SK	NA	NA	days	967	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.A1.A0SK.F15926	TCGA-A1-A0SK	TCGA.A1.A0SK.01A	Negative	Negative				Other	Negative	Lumpectomy	surgical resection		NA	NA	-20048	1164	967	0	NA	NA	NA							Scheduled Follow-up Submission	2011-9-7	FEMALE					0	NA		NA	NA	Other, specify		No	NA	C50.9	8013/3	C50.9		YES		Excisional Biopsy	160	NO	Negative			4	Positive	Indeterminate (neither Pre or Postmenopausal)									NA											5	5	NA								0	NA	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A1-A0SK.13302EC6-6511-42FE-AA8B-C875B5384FFE.pdf	A0SK	WITH TUMOR											Primary Tumor	1		6th		NO	YES	A1	Breast	A	DECEASED	2007	a63583ca-0ef2-4417-b435-5f3a6951d0c2	c76440c7-2213-4933-b79d-d832910334ea	a63583ca-0ef2-4417-b435-5f3a6951d0c2	c76440c7-2213-4933-b79d-d832910334ea	TCGA.A1.A0SK.01A-21-A13A-20	TCGA.A1.A0SK.01A-12D-A099-09		TCGA.A1.A0SK.01	TCGA.A1.A0SK.01A-12D-A10P-05		8d8099ba-c207-473b-8ffc-e9610494386c	TCGA.A1.A0SK.01	TCGA.A1.A0SK.01A-12D-A099-09		TCGA.A1.A0SK.01		TCGA.A1.A0SK.01A-12D-A099-09	TCGA.A1.A0SK.01	a63583ca-0ef2-4417-b435-5f3a6951d0c2	TCGA.A1.A0SK.01	TCGA.A1.A0SK.01A-12D-A087-01		TCGA.A1.A0SK.01A-12R-A084-07	a63583ca-0ef2-4417-b435-5f3a6951d0c2	TCGA.A1.A0SK.01A-12D-A087-01	TCGA.A1.A0SK.01
TCGA.A1.A0SO.01	Stage IIB	67	1	Stage IIB	852	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	852	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA.A1.A0SO.01	852	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-A1-A0SO	NA	NA	days	852	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SO	TCGA.A1.A0SO.01A		Negative					Negative	Modified Radical Mastectomy			NA	NA	-24826	1057	NA	0	852	NA	NA						3.2		2010-12-6	FEMALE						NA	5	1.6	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA								1	NA	true	No	M0	N1	T2	Stage IIB	TCGA-A1-A0SO.6104F94F-BA8F-4435-A839-E1FEA6EFFDF3.pdf	A0SO	TUMOR FREE											Primary Tumor	1		6th		NO	YES	A1	Breast	A	LIVING	2007	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	e3b21b55-af53-4b23-97ef-5be59a3495d8	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	e3b21b55-af53-4b23-97ef-5be59a3495d8	TCGA.A1.A0SO.01A-11-A13A-20	TCGA.A1.A0SO.01A-22D-A099-09		TCGA.A1.A0SO.01	TCGA.A1.A0SO.01A-22D-A10P-05		3c86150e-49f3-4303-bd6e-3d4bcc4aad50	TCGA.A1.A0SO.01			TCGA.A1.A0SO.01		TCGA.A1.A0SO.01A-22D-A099-09	TCGA.A1.A0SO.01	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	TCGA.A1.A0SO.01	TCGA.A1.A0SO.01A-22D-A087-01		TCGA.A1.A0SO.01A-22R-A084-07	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	TCGA.A1.A0SO.01A-22D-A087-01	TCGA.A1.A0SO.01
TCGA.A2.A04U.01	Stage IIA	47	NA	Stage IIA	670	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	670	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA.A2.A04U.01	2654	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A2-A04U	NA	NA	days	2654	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right	Sentinel node biopsy alone		TCGA.A2.A04U.F59317	TCGA-A2-A04U	TCGA.A2.A04U.01A		Negative					Negative	Simple Mastectomy		YES	NA	NA	-17474	1924	NA	0	2654	NA	NA					<10%			2014-5-8	FEMALE					1+	NA		2.2	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative	Positive	YES	3	Negative	Peri (6-12 months since last menstrual period)									NA											5	5	NA								0	1	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A04U.B14456B1-4992-492D-AFB5-4F975F20A277.pdf	A04U	TUMOR FREE						YES		<10%		NO	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	4d12d021-3673-4e14-9fd9-033f811f87da	544dd94e-abd8-4cca-98cf-d1c2c646f23a	4d12d021-3673-4e14-9fd9-033f811f87da	544dd94e-abd8-4cca-98cf-d1c2c646f23a	TCGA.A2.A04U.01A-21-A13A-20	TCGA.A2.A04U.01A-11D-A10Y-09		TCGA.A2.A04U.01			485e1504-dfe0-43a4-83a1-f4376e8e687b	TCGA.A2.A04U.01	TCGA.A2.A04U.01A-11D-A10Y-09	TCGA.A2.A04U.01A-11D-A112-05	TCGA.A2.A04U.01	TCGA.A2.A04U.01	TCGA.A2.A04U.01A-11D-A10Y-09		4d12d021-3673-4e14-9fd9-033f811f87da		TCGA.A2.A04U.01A-11D-A111-01	TCGA.A2.A04U.01	TCGA.A2.A04U.01A-11R-A115-07	4d12d021-3673-4e14-9fd9-033f811f87da	TCGA.A2.A04U.01A-11D-A111-01	TCGA.A2.A04U.01
TCGA.A2.A0T0.01	Stage IIB	59	1	No_Conversion	533	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	533	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA.A2.A0T0.01	533	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 12	TCGA-A2-A0T0	533	0	days	533	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA.A2.A0T0.F13944	TCGA-A2-A0T0	TCGA.A2.A0T0.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-21575	268	NA	0	533	NA	NA					<10%		Scheduled Follow-up Submission	2011-7-18	FEMALE			<10%		0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA							NO	2	NA	true	No	M0	N1	T2	Stage IIB	TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096.pdf	A0T0	TUMOR FREE								<10%		YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	7e073ecd-452a-4cba-9dfd-8601f3245721	07d13cdb-332c-4bd8-82f6-8655881cea74	7e073ecd-452a-4cba-9dfd-8601f3245721	07d13cdb-332c-4bd8-82f6-8655881cea74	TCGA.A2.A0T0.01A-11-A13D-20	TCGA.A2.A0T0.01A-22D-A099-09		TCGA.A2.A0T0.01	TCGA.A2.A0T0.01A-22D-A10P-05		87565b35-30bd-4e31-bb26-404baf053cdc	TCGA.A2.A0T0.01	TCGA.A2.A0T0.01A-22D-A099-09		TCGA.A2.A0T0.01		TCGA.A2.A0T0.01A-22D-A099-09	TCGA.A2.A0T0.01	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA.A2.A0T0.01	TCGA.A2.A0T0.01A-22D-A087-01		TCGA.A2.A0T0.01A-22R-A084-07	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA.A2.A0T0.01A-22D-A087-01	TCGA.A2.A0T0.01
TCGA.A2.A0T2.01	Stage IV	66	3	No_Conversion	240	240	Negative	FEMALE	Negative	2	2	2	Positive	M1	Positive	N3	240	1	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T3	DECEASED	1	TCGA.A2.A0T2.01	255	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A2-A0T2	NA	NA	days	255	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO		NO	66	Right	Axillary lymph node dissection alone		TCGA.A2.A0T2.F3706	TCGA-A2-A0T2	TCGA.A2.A0T2.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-24235	261	255	0	NA	NA	NA					<10%			2010-11-12	FEMALE					0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	270	NO	Negative			14	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA									Liver	Abdomen	5	3	NA								10	NA	true	No	M1	N3	T3	Stage IV	TCGA-A2-A0T2.0DCD80E1-173E-4A1B-BDD8-74C7D12C1313.pdf	A0T2	WITH TUMOR								<10%		NO	Primary Tumor	1			NO	NO	YES	A2	Breast	A	DECEASED	2009	491c6c41-d1c5-4be7-bb7c-9df7275aa388	eaf1eb18-1568-459d-be40-71e5e92df673	491c6c41-d1c5-4be7-bb7c-9df7275aa388	eaf1eb18-1568-459d-be40-71e5e92df673	TCGA.A2.A0T2.01A-21-A13D-20	TCGA.A2.A0T2.01A-11W-A097-09		TCGA.A2.A0T2.01	TCGA.A2.A0T2.01A-11D-A10P-05		73634c23-d25e-4268-a1bb-f8270a5d1d00	TCGA.A2.A0T2.01	TCGA.A2.A0T2.01A-11W-A097-09		TCGA.A2.A0T2.01		TCGA.A2.A0T2.01A-11W-A097-09	TCGA.A2.A0T2.01	491c6c41-d1c5-4be7-bb7c-9df7275aa388	TCGA.A2.A0T2.01	TCGA.A2.A0T2.01A-11D-A087-01		TCGA.A2.A0T2.01A-11R-A084-07	491c6c41-d1c5-4be7-bb7c-9df7275aa388	TCGA.A2.A0T2.01A-11D-A087-01	TCGA.A2.A0T2.01
TCGA.A2.A0YE.01	Stage IIB	48	3	No_Conversion	553	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Positive	N1	553	0	Basal	Basal-like	Negative	X	-13	-12	followup	T_Other	T2	LIVING	0	TCGA.A2.A0YE.01	554	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8				TCGA-A2-A0YE	554	0	days	554	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.A2.A0YE.F15771	TCGA-A2-A0YE	TCGA.A2.A0YE.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-17727	238	NA	0	554	NA	NA					<10%		Scheduled Follow-up Submission	2011-8-30	FEMALE		No membrane staining or incomplete membrane staining in <10% of tumor cells is negative	<10%		0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	NA	NA							NO	1	NA	true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A0YE.C58701EF-98C4-448E-978C-B39D125CC7E8.pdf	A0YE	TUMOR FREE								<10%		YES	Primary Tumor	1			YES	NO	YES	A2	Breast	A	LIVING	2010	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	c5387233-2168-406d-aa69-9e92df136d0d	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	c5387233-2168-406d-aa69-9e92df136d0d	TCGA.A2.A0YE.01A-21-A13D-20			TCGA.A2.A0YE.01	TCGA.A2.A0YE.01A-11D-A10A-05		510563aa-4a19-4dd1-82c8-ac67f8a77a55	TCGA.A2.A0YE.01	TCGA.A2.A0YE.01A-11D-A10G-09		TCGA.A2.A0YE.01				7f57b9e7-1b1b-4e07-beb4-b877b7651f7b		TCGA.A2.A0YE.01A-11D-A107-01		TCGA.A2.A0YE.01A-11R-A109-07	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	TCGA.A2.A0YE.01A-11D-A107-01	TCGA.A2.A0YE.01
TCGA.A2.A3XU.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					1	TCGA.A2.A3XU.01	912	1	days					BRCA basal-like c6		miRNA cluster 4			TCGA-A2-A3XU	596	1	days	912	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			35	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA.A2.A3XU.F34704	TCGA-A2-A3XU	TCGA.A2.A3XU.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-13046	2089	912	0	NA	NA	NA	596					1.5		2012-8-30	FEMALE						60	1.66	1.1	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Excisional Biopsy	350	NO		Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive				NA								Positive			NA	NA	NA			Other, specify	Locoregional Recurrence	Breast	NO	YES	3	0	true	No	M0	N1mi	T2	Stage IIB	TCGA-A2-A3XU.5018EC57-96C6-4D63-B708-45559B4D8527.pdf	A3XU	WITH TUMOR						YES	YES			YES	Primary Tumor	1		6th		NO	YES	A2	Breast	A	DECEASED	2006	2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	a57d2d29-cd47-4048-9c06-8b8cd2456f9b	2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	a57d2d29-cd47-4048-9c06-8b8cd2456f9b	TCGA.A2.A3XU.01A-21-A24A-20			TCGA.A2.A3XU.01	TCGA.A2.A3XU.01A-12D-A230-05		2233e116-6f58-4bf5-bcb7-528fc4ff8d30	TCGA.A2.A3XU.01	TCGA.A2.A3XU.01A-12D-A22X-09			TCGA.A2.A3XU.01			2ec1df5c-7272-44f4-922c-cdd6ba37f6b6		TCGA.A2.A3XU.01A-12D-A22W-01	TCGA.A2.A3XU.01		2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	TCGA.A2.A3XU.01A-12D-A22W-01	
TCGA.A2.A3XY.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					1	TCGA.A2.A3XY.01	1093	1	days										TCGA-A2-A3XY	1072	1	days	1093	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES			49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.A2.A3XY.F55836	TCGA-A2-A3XY	TCGA.A2.A3XY.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-18059	703	1093	0	786	NA	NA	1072		NO					2014-1-16	FEMALE						NA		1.13	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	950	NO	Negative	Negative	NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA			Brain	Distant Metastasis		NO	YES	3	NA	true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F.pdf	A3XY	WITH TUMOR						YES	YES			YES	Primary Tumor	1		7th		YES	NO	A2	Breast	A	DECEASED	2010	42c88ed3-de96-487d-8b03-e1d4269d0505	43446fc2-82dd-4759-af34-b0db537143f2	42c88ed3-de96-487d-8b03-e1d4269d0505	43446fc2-82dd-4759-af34-b0db537143f2				TCGA.A2.A3XY.01	TCGA.A2.A3XY.01A-11D-A23D-05			TCGA.A2.A3XY.01	TCGA.A2.A3XY.01A-11D-A23C-09			TCGA.A2.A3XY.01			42c88ed3-de96-487d-8b03-e1d4269d0505		TCGA.A2.A3XY.01A-11D-A238-01	TCGA.A2.A3XY.01		42c88ed3-de96-487d-8b03-e1d4269d0505	TCGA.A2.A3XY.01A-11D-A238-01	
TCGA.A7.A0DA.01	Stage IIA	62	1	Stage IIA	373	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	373	0	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T2	LIVING	0	TCGA.A7.A0DA.01	1085	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 4	mutation cluster 13	TCGA-A7-A0DA	1085	0	days	1085	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.A7.A0DA.F38487	TCGA-A7-A0DA	TCGA.A7.A0DA.01A		Negative					Negative	Lumpectomy			NA	NA	-22708	177	NA	0	1085	NA	NA								2012-12-14	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	350	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	4	NA							NO	0	NA	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0DA.69AC5937-3FFD-40FB-9922-79DB3CED7510.pdf	A0DA	TUMOR FREE						YES				YES	Primary Tumor	1			YES	YES	NO	A7	Breast	A	LIVING	2009	9d04c180-7c23-490e-92cf-c018629b8b7f	91c8c373-e923-4e7f-b8b3-2417e92760c7	9d04c180-7c23-490e-92cf-c018629b8b7f	91c8c373-e923-4e7f-b8b3-2417e92760c7	TCGA.A7.A0DA.01A-11-A13C-20	TCGA.A7.A0DA.01A-31D-A10Y-09		TCGA.A7.A0DA.01			190fcd17-0d7a-4d28-9958-492d56360678	TCGA.A7.A0DA.01	TCGA.A7.A0DA.01A-31D-A10Y-09	TCGA.A7.A0DA.01A-31D-A112-05	TCGA.A7.A0DA.01	TCGA.A7.A0DA.01	TCGA.A7.A0DA.01A-31D-A10Y-09		9d04c180-7c23-490e-92cf-c018629b8b7f		TCGA.A7.A0DA.01A-31D-A111-01	TCGA.A7.A0DA.01	TCGA.A7.A0DA.01A-31R-A115-07	9d04c180-7c23-490e-92cf-c018629b8b7f	TCGA.A7.A0DA.01A-31D-A111-01	TCGA.A7.A0DA.01
TCGA.A7.A5ZV.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.A7.A5ZV.01	368	0	days										TCGA-A7-A5ZV	368	0	days	368	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left	Sentinel node biopsy alone		TCGA.A7.A5ZV.F51143	TCGA-A7-A5ZV	TCGA.A7.A5ZV.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-22966	154	NA	0	368	NA	NA						2.5		2013-11-8	FEMALE				PathVysion HER-2 D Probe Kit	2+	40	3.8	1.5	NA	Infiltrating Carcinoma NOS		No	NA	C50.9	8010/3	C50.9		YES		Core needle biopsy	940	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	NA	false	No	M0	N0	T2	Stage IIA	TCGA-A7-A5ZV.FA5CF5A2-F44A-4303-9200-32250FAEF374.pdf	A5ZV	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th		YES	NO	A7	Breast	A	LIVING	2012	e121ae32-63c2-4b13-b135-d1837fc10999	37f156e4-c11a-4934-b0d2-c860222f68d6	e121ae32-63c2-4b13-b135-d1837fc10999	37f156e4-c11a-4934-b0d2-c860222f68d6				TCGA.A7.A5ZV.01	TCGA.A7.A5ZV.01A-11D-A28C-05		cc46932d-0799-42ae-8a92-5bf65e381969	TCGA.A7.A5ZV.01	TCGA.A7.A5ZV.01A-11D-A28B-09			TCGA.A7.A5ZV.01			e121ae32-63c2-4b13-b135-d1837fc10999		TCGA.A7.A5ZV.01A-11D-A28A-01	TCGA.A7.A5ZV.01		e121ae32-63c2-4b13-b135-d1837fc10999	TCGA.A7.A5ZV.01A-11D-A28A-01	
TCGA.A7.A6VV.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.A7.A6VV.01	313	0	days										TCGA-A7-A6VV	313	0	days	313	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA.A7.A6VV.F57249	TCGA-A7-A6VV	TCGA.A7.A6VV.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-18695	85	NA	0	313	NA	NA								2014-3-6	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	1100	NO	Negative		NO	5	Negative	Peri (6-12 months since last menstrual period)									NA											NA	NA	NA							NO	0	NA	false	No	M0	N0	T2	Stage IIA	TCGA-A7-A6VV.C26EAF0E-202B-4F3E-9E59-3395A1BFCAB8.pdf	A6VV	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th		YES	NO	A7	Breast	A	LIVING	2013	c02ec36d-9e79-4e2f-a46c-f898838766df	7406aaff-b28a-4b4c-8fa3-b4e208b8cf85	c02ec36d-9e79-4e2f-a46c-f898838766df	7406aaff-b28a-4b4c-8fa3-b4e208b8cf85				TCGA.A7.A6VV.01	TCGA.A7.A6VV.01A-22D-A33F-05		66E3766B-46AB-4A9B-8B6E-1EECA04D9B62	TCGA.A7.A6VV.01				TCGA.A7.A6VV.01			c02ec36d-9e79-4e2f-a46c-f898838766df		TCGA.A7.A6VV.01A-22D-A33D-01	TCGA.A7.A6VV.01		c02ec36d-9e79-4e2f-a46c-f898838766df	TCGA.A7.A6VV.01A-22D-A33D-01	
TCGA.AC.A2BK.01		NA	NA		NA	NA				NA	NA	NA					NA	NA	Basal				NA	NA					0	TCGA.AC.A2BK.01	2222	0	days	High	C4-BRCA/Basal		BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4			TCGA-AC-A2BK	2222	0	days	2222	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.AC.A2BK.F43987	TCGA-AC-A2BK	TCGA.AC.A2BK.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-28625	1717	NA	0	2222	NA	NA			NO					2013-6-10	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative		NO	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	6	NA	false	No	MX	N2a	T2	Stage IIIA	TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A.pdf	A2BK	TUMOR FREE						YES	YES			YES	Primary Tumor	1		6th		NO	YES	AC	Breast	A	LIVING	2006	08893743-829b-4594-ab67-d5eb5e80a4f3	d35e1d61-8d2b-4a12-a245-99c4d13c7f43	08893743-829b-4594-ab67-d5eb5e80a4f3	d35e1d61-8d2b-4a12-a245-99c4d13c7f43	TCGA.AC.A2BK.01A-21-A24A-20			TCGA.AC.A2BK.01	TCGA.AC.A2BK.01A-11D-A21R-05		1392fc51-37de-493d-a7e9-01269e73c9c5	TCGA.AC.A2BK.01	TCGA.AC.A2BK.01A-11D-A21Q-09			TCGA.AC.A2BK.01			08893743-829b-4594-ab67-d5eb5e80a4f3		TCGA.AC.A2BK.01A-11D-A21P-01	TCGA.AC.A2BK.01		08893743-829b-4594-ab67-d5eb5e80a4f3	TCGA.AC.A2BK.01A-11D-A21P-01	
TCGA.AC.A2QH.01		NA	NA		NA	NA				NA	NA	NA					NA	NA	Basal				NA	NA					0	TCGA.AC.A2QH.01	1005	0	days	Squamous			Cluster 5		GBM-like c6	miRNA cluster 13			TCGA-AC-A2QH	1005	0	days	1005	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.AC.A2QH.F64100	TCGA-AC-A2QH	TCGA.AC.A2QH.01A		Negative					Negative	Modified Radical Mastectomy		YES	NA	NA	-21488	108	NA	0	1005	NA	NA			NO					2014-8-26	FEMALE						NA		NA	NA	Metaplastic Carcinoma		No	NA	C50.9	8575/3	C50.9		YES		Core needle biopsy	150	NO	Negative		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	MX	N0	T3	Stage IIB	TCGA-AC-A2QH.C2A0E948-2B9E-4E49-90C4-57CE4C4A95B3.pdf	A2QH	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th		YES	NO	AC	Breast	A	LIVING	2011	d848ad65-9261-4854-a6bd-e76484c6a337	116845a5-2178-44ff-8cac-58b95dd85081,86c22622-a7fb-4c73-8d6a-40be9a307dbe	d848ad65-9261-4854-a6bd-e76484c6a337	116845a5-2178-44ff-8cac-58b95dd85081,86c22622-a7fb-4c73-8d6a-40be9a307dbe			d848ad65-9261-4854-a6bd-e76484c6a337,eeef0334-de2a-4206-84ad-cd18e349635e	TCGA.AC.A2QH.01	TCGA.AC.A2QH.01A-11D-A18O-05,TCGA.AC.A2QH.01B-04D-A22R-05	d848ad65-9261-4854-a6bd-e76484c6a337,eeef0334-de2a-4206-84ad-cd18e349635e		TCGA.AC.A2QH.01	TCGA.AC.A2QH.01B-04D-A22N-09,TCGA.AC.A2QH.01A-11D-A18P-09			TCGA.AC.A2QH.01			d848ad65-9261-4854-a6bd-e76484c6a337		TCGA.AC.A2QH.01A-11D-A18N-01	TCGA.AC.A2QH.01		d848ad65-9261-4854-a6bd-e76484c6a337	TCGA.AC.A2QH.01A-11D-A18N-01	
TCGA.AN.A0AR.01	Stage IIA	55	1	No_Conversion	9	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	9	0		Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA.AN.A0AR.01	10	0	days	Squamous	C8-BLCA	cluster 5	Cluster 5	BRCA basal-like c6		miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0AR	NA	NA	days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right Upper Inner Quadrant	No axillary staging		TCGA.AN.A0AR.F68946	TCGA-AN-A0AR	TCGA.AN.A0AR.01A		Negative		0			Negative	Modified Radical Mastectomy		NO	NA	NA	-20152	34	NA	0	10	NA	NA								2014-12-23	FEMALE					0	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Tumor resection	150	NO	Negative		YES	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	5	NA								0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0AR.0E27F140-3D60-4027-A370-68127564DE38.pdf	A0AR	TUMOR FREE						NO				NO	Primary Tumor	1				NO	YES	AN	Breast	A	LIVING	2010	12c36b7c-f302-4cea-bb4f-5a01211e00e9	f6743da4-ebb2-4223-ba29-2b1a0859181f	12c36b7c-f302-4cea-bb4f-5a01211e00e9	f6743da4-ebb2-4223-ba29-2b1a0859181f	TCGA.AN.A0AR.01A-21-A13B-20	TCGA.AN.A0AR.01A-11W-A019-09		TCGA.AN.A0AR.01			a18bbbc7-9c94-4fe9-a927-5c07be69428c	TCGA.AN.A0AR.01	TCGA.AN.A0AR.01A-11W-A019-09	TCGA.AN.A0AR.01A-11D-A00Y-05	TCGA.AN.A0AR.01		TCGA.AN.A0AR.01A-11W-A019-09	TCGA.AN.A0AR.01	12c36b7c-f302-4cea-bb4f-5a01211e00e9	TCGA.AN.A0AR.01	TCGA.AN.A0AR.01A-11D-A011-01		TCGA.AN.A0AR.01A-11R-A00Z-07	12c36b7c-f302-4cea-bb4f-5a01211e00e9	TCGA.AN.A0AR.01A-11D-A011-01	TCGA.AN.A0AR.01
TCGA.AN.A0FJ.01	Stage IV	59	1	No_Conversion	241	NA	Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N2	241	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA.AN.A0FJ.01	242	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0FJ	NA	NA	days	242	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.AN.A0FJ.F68950	TCGA-AN-A0FJ	TCGA.AN.A0FJ.01A		Positive		0			Negative	Modified Radical Mastectomy		NO	NA	NA	-21910	70	NA	0	242	NA	NA				dextran coated charcoal	10-19%			2014-12-23	FEMALE		dextran coated charcoal	40-49%		1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	1+	YES		Tumor resection	280	NO	Positive		YES	14	Negative	Peri (6-12 months since last menstrual period)									NA											5	5	NA								8	0	false	No	M1	N2	T2	Stage IV	TCGA-AN-A0FJ.59163BD6-41E8-4489-81F0-036484447886.pdf	A0FJ	TUMOR FREE	dextran coated charcoal					NO		<10%		NO	Primary Tumor	1				NO	YES	AN	Breast	A	LIVING	2010	d6b8993f-e850-47a9-842d-ef6173866780	84412819-5a7d-4d8c-a834-7170777e94e6	d6b8993f-e850-47a9-842d-ef6173866780	84412819-5a7d-4d8c-a834-7170777e94e6	TCGA.AN.A0FJ.01A-21-A13A-20	TCGA.AN.A0FJ.01A-11W-A019-09		TCGA.AN.A0FJ.01			d2876882-dd7e-43af-b066-d578da1f8f3d	TCGA.AN.A0FJ.01	TCGA.AN.A0FJ.01A-11W-A019-09	TCGA.AN.A0FJ.01A-11D-A00Y-05	TCGA.AN.A0FJ.01		TCGA.AN.A0FJ.01A-11W-A019-09	TCGA.AN.A0FJ.01	d6b8993f-e850-47a9-842d-ef6173866780	TCGA.AN.A0FJ.01	TCGA.AN.A0FJ.01A-11D-A011-01		TCGA.AN.A0FJ.01A-11R-A00Z-07	d6b8993f-e850-47a9-842d-ef6173866780	TCGA.AN.A0FJ.01A-11D-A011-01	TCGA.AN.A0FJ.01
TCGA.AN.A0FL.01	Stage IIA	62	1	No_Conversion	230	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	230	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA.AN.A0FL.01	231	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0FL	NA	NA	days	231	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA.AN.A0FL.F68952	TCGA-AN-A0FL	TCGA.AN.A0FL.01A		Negative		1+			Negative	Modified Radical Mastectomy		NO	NA	NA	-22805	69	NA	0	231	NA	NA				dextran coated charcoal	<10%			2014-12-23	FEMALE		dextran coated charcoal	20-29%		1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	1+	YES		Tumor resection	310	NO	Positive		YES	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA								0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0FL.049A2CA6-951A-452F-963A-F54FE87ECA31.pdf	A0FL	TUMOR FREE	dextran coated charcoal					NO		<10%		NO	Primary Tumor	1				NO	YES	AN	Breast	A	LIVING	2010	299add94-3b97-41a6-9fd4-c572f88982d5	a5ec69cb-1eeb-4a12-bdc6-e7f3b6eaa7df	299add94-3b97-41a6-9fd4-c572f88982d5	a5ec69cb-1eeb-4a12-bdc6-e7f3b6eaa7df	TCGA.AN.A0FL.01A-21-A13A-20	TCGA.AN.A0FL.01A-11W-A050-09		TCGA.AN.A0FL.01			ef3ba9e1-e1ca-477a-8700-37e88c048655	TCGA.AN.A0FL.01	TCGA.AN.A0FL.01A-11W-A050-09	TCGA.AN.A0FL.01A-11D-A032-05	TCGA.AN.A0FL.01		TCGA.AN.A0FL.01A-11W-A050-09	TCGA.AN.A0FL.01	299add94-3b97-41a6-9fd4-c572f88982d5	TCGA.AN.A0FL.01	TCGA.AN.A0FL.01A-11D-A036-01		TCGA.AN.A0FL.01A-11R-A034-07	299add94-3b97-41a6-9fd4-c572f88982d5	TCGA.AN.A0FL.01A-11D-A036-01	TCGA.AN.A0FL.01
TCGA.AN.A0FX.01	Stage IIA	52	1	No_Conversion	10	NA	Negative	FEMALE	Negative	1	1	2	Negative	M0	Negative	N0	10	0	Basal	Basal-like	Negative	ReacII	-13	-11	enrollment	T_Other	T2	LIVING	0	TCGA.AN.A0FX.01	10	0	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AN-A0FX	NA	NA	days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Outer Quadrant	No axillary staging		TCGA.AN.A0FX.F68967	TCGA-AN-A0FX	TCGA.AN.A0FX.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-19309	34	NA	0	10	NA	NA								2014-12-24	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Positive		YES	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	4	NA								0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0FX.0CC079D3-EB90-47B5-B554-599A67C9E12A.pdf	A0FX	TUMOR FREE				0	0	NO				NO	Primary Tumor	1				NO	YES	AN	Breast	A	LIVING	2010	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	de299c77-a9d8-4acf-97ae-337427f27132	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	de299c77-a9d8-4acf-97ae-337427f27132	TCGA.AN.A0FX.01A-21-A13C-20	TCGA.AN.A0FX.01A-11W-A050-09		TCGA.AN.A0FX.01			14bd231c-c5f5-4e4a-a2e3-4ee4a17248af	TCGA.AN.A0FX.01	TCGA.AN.A0FX.01A-11W-A050-09	TCGA.AN.A0FX.01A-11D-A032-05	TCGA.AN.A0FX.01		TCGA.AN.A0FX.01A-11W-A050-09	TCGA.AN.A0FX.01	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	TCGA.AN.A0FX.01	TCGA.AN.A0FX.01A-11D-A036-01		TCGA.AN.A0FX.01A-11R-A034-07	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	TCGA.AN.A0FX.01A-11D-A036-01	TCGA.AN.A0FX.01
TCGA.AN.A0G0.01	Stage IIA	56	NA	No_Conversion	16	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	16	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA.AN.A0G0.01	16	0	days		C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AN-A0G0	NA	NA	days	16	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Inner Quadrant	No axillary staging		TCGA.AN.A0G0.F68970	TCGA-AN-A0G0	TCGA.AN.A0G0.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-20504	34	NA	0	16	NA	NA								2014-12-24	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Negative		YES	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA								0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0G0.08519263-5ADD-4BA3-9BC6-C737ACA7DFE4.pdf	A0G0	TUMOR FREE				0	0	YES				YES	Primary Tumor	1				NO	YES	AN	Breast	A	LIVING	2010	c09e8a88-5a82-4fd6-8d03-ef3ecb988003	ab6ead94-e5ae-4bfc-bbe3-8ecac5a98a54	c09e8a88-5a82-4fd6-8d03-ef3ecb988003	ab6ead94-e5ae-4bfc-bbe3-8ecac5a98a54	TCGA.AN.A0G0.01A-21-A13C-20	TCGA.AN.A0G0.01A-11W-A050-09		TCGA.AN.A0G0.01			8675dc8b-b185-4aa8-9c1c-60505e502215		TCGA.AN.A0G0.01A-11W-A050-09	TCGA.AN.A0G0.01A-11D-A032-05			TCGA.AN.A0G0.01A-11W-A050-09	TCGA.AN.A0G0.01	c09e8a88-5a82-4fd6-8d03-ef3ecb988003	TCGA.AN.A0G0.01			TCGA.AN.A0G0.01A-11R-A034-07	c09e8a88-5a82-4fd6-8d03-ef3ecb988003		TCGA.AN.A0G0.01
TCGA.AO.A12F.01	Stage IIA	36	1	Stage IIA	1471	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1471	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA.AO.A12F.01	1842	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AO-A12F	1842	0	days	1842	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					36	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA.AO.A12F.F19434	TCGA-AO-A12F	TCGA.AO.A12F.01A		Negative					Negative	Simple Mastectomy		YES	NA	NA	-13409	1578	NA	0	1842	NA	NA					<10%		Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%		1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	600	NO	Negative			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	5	NA							NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A12F.96B43BA2-7099-436C-8AFD-FD53E55E7F51.pdf	A12F	TUMOR FREE								<10%		YES	Primary Tumor	1		6th	YES	NO	YES	AO	Breast	A	LIVING	2006	05610046-ec77-4592-892a-464a81d55c45	d36528cb-bb4a-4878-abf6-1709a1a0fb7e	05610046-ec77-4592-892a-464a81d55c45	d36528cb-bb4a-4878-abf6-1709a1a0fb7e	TCGA.AO.A12F.01A-21-A13D-20	TCGA.AO.A12F.01A-11D-A10Y-09		TCGA.AO.A12F.01			8f64c41b-17ee-40d2-98d6-4c483e5d5384	TCGA.AO.A12F.01	TCGA.AO.A12F.01A-11D-A10Y-09	TCGA.AO.A12F.01A-11D-A112-05	TCGA.AO.A12F.01	TCGA.AO.A12F.01	TCGA.AO.A12F.01A-11D-A10Y-09		05610046-ec77-4592-892a-464a81d55c45		TCGA.AO.A12F.01A-11D-A111-01	TCGA.AO.A12F.01	TCGA.AO.A12F.01A-11R-A115-07	05610046-ec77-4592-892a-464a81d55c45	TCGA.AO.A12F.01A-11D-A111-01	TCGA.AO.A12F.01
TCGA.AQ.A54N.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.AQ.A54N.01	78	0	days										TCGA-AQ-A54N	78	0	days	78	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Lower Inner Quadrant	Sentinel node biopsy alone		TCGA.AQ.A54N.F55736	TCGA-AQ-A54N	TCGA.AQ.A54N.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-18741	639	NA	0	78	NA	NA								2014-1-14	FEMALE					2+	NA		1.1	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Equivocal	Negative	YES	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	Yes	M0	N0	T2	Stage IIA	TCGA-AQ-A54N.9BF0E34A-F78C-4BFD-AC4C-926FA1D60342.pdf	A54N	TUMOR FREE						NO	YES			NO	Primary Tumor	1		7th		YES	NO	AQ	Breast	A	LIVING	2011	ed3e6c57-a0ec-4441-a1a1-794f3f15e112	1ba42f73-8bc1-44c5-87ca-251e2691764d	ed3e6c57-a0ec-4441-a1a1-794f3f15e112	1ba42f73-8bc1-44c5-87ca-251e2691764d				TCGA.AQ.A54N.01	TCGA.AQ.A54N.01A-11D-A268-05		3b93ce2c-bc79-48ef-910d-9d1e7c070008	TCGA.AQ.A54N.01	TCGA.AQ.A54N.01A-11D-A25Q-09			TCGA.AQ.A54N.01			ed3e6c57-a0ec-4441-a1a1-794f3f15e112		TCGA.AQ.A54N.01A-11D-A25N-01	TCGA.AQ.A54N.01		ed3e6c57-a0ec-4441-a1a1-794f3f15e112	TCGA.AQ.A54N.01A-11D-A25N-01	
TCGA.AR.A0TP.01	Stage II	43	1	No_Conversion	2392	NA	Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	2392	0	Basal	Basal-like	Negative	Basal	-13	-11	enrollment	T_Other	T2	LIVING	0	TCGA.AR.A0TP.01	4275	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A0TP	4275	0	days	4275	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A0TP.F71715	TCGA-AR-A0TP	TCGA.AR.A0TP.01A		Positive					Negative	Other		YES	NA	NA	-15812	2512	NA	0	4275	NA	NA					<10%		Scheduled Follow-up Submission	2015-3-30	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	650	NO	Negative		NO	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	3	NA							NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-AR-A0TP.E1A92F92-1DD2-4E33-9C16-3FD0371D1431.pdf	A0TP	TUMOR FREE						YES				YES	Primary Tumor	1	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2003	f9739b94-ac64-40d5-bfdd-041a412976c4	17e54aa6-f5d6-437a-8345-d40805c86430	f9739b94-ac64-40d5-bfdd-041a412976c4	17e54aa6-f5d6-437a-8345-d40805c86430	TCGA.AR.A0TP.01A-21-A13C-20	TCGA.AR.A0TP.01A-11D-A099-09		TCGA.AR.A0TP.01	TCGA.AR.A0TP.01A-11D-A10P-05		c8173431-25a0-4853-a0ca-7df5c5cf40e8	TCGA.AR.A0TP.01			TCGA.AR.A0TP.01		TCGA.AR.A0TP.01A-11D-A099-09	TCGA.AR.A0TP.01	f9739b94-ac64-40d5-bfdd-041a412976c4	TCGA.AR.A0TP.01	TCGA.AR.A0TP.01A-11D-A087-01		TCGA.AR.A0TP.01A-11R-A084-07	f9739b94-ac64-40d5-bfdd-041a412976c4	TCGA.AR.A0TP.01A-11D-A087-01	TCGA.AR.A0TP.01
TCGA.AR.A1AH.01	Stage II	51	1	Stage IIB	2298	NA	Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	2298	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA.AR.A1AH.01	3807	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A1AH	3807	0	days	3807	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA.AR.A1AH.F69267	TCGA-AR-A1AH	TCGA.AR.A1AH.01A		Positive					Negative	Other			NA	NA	-18991	2368	NA	0	3807	NA	NA	1136				10-19%		Scheduled Follow-up Submission	2014-12-31	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA			Other, specify	New Primary Tumor	Renal		NO	1	NA	true	No	M0	N1	T2	Stage IIB	TCGA-AR-A1AH.75F29A17-B6AF-43B9-BE12-3ABF850F23BA.pdf	A1AH	TUMOR FREE						YES	YES			NO	Primary Tumor	1	Total Mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2004	ff0d7627-cec2-42e7-891b-cba5f42e3272	1d7e40a7-9af9-45db-9586-9f8a3f6a1824	ff0d7627-cec2-42e7-891b-cba5f42e3272	1d7e40a7-9af9-45db-9586-9f8a3f6a1824	TCGA.AR.A1AH.01A-21-A13E-20	TCGA.AR.A1AH.01A-11D-A12B-09		TCGA.AR.A1AH.01			180cde2e-13d3-462d-bba2-ae37bdee0f3f	TCGA.AR.A1AH.01	TCGA.AR.A1AH.01A-11D-A12B-09	TCGA.AR.A1AH.01A-11D-A12E-05	TCGA.AR.A1AH.01	TCGA.AR.A1AH.01	TCGA.AR.A1AH.01A-11D-A12B-09		ff0d7627-cec2-42e7-891b-cba5f42e3272		TCGA.AR.A1AH.01A-11D-A12A-01	TCGA.AR.A1AH.01	TCGA.AR.A1AH.01A-11R-A12D-07	ff0d7627-cec2-42e7-891b-cba5f42e3272	TCGA.AR.A1AH.01A-11D-A12A-01	TCGA.AR.A1AH.01
TCGA.AR.A1AY.01	Stage I	65	1	Stage I	614	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	614	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA.AR.A1AY.01	1026	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A1AY	1026	0	days	1026	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A1AY.F49482	TCGA-AR-A1AY	TCGA.AR.A1AY.01A		Negative					Negative	Other		YES	NA	NA	-23927	1085	NA	0	1026	NA	NA							Scheduled Follow-up Submission	2013-10-2	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA							NO	0	NA	true	No	M0	N0	T1	Stage I	TCGA-AR-A1AY.01D97550-C616-4001-85A5-5502D35FA38E.pdf	A1AY	TUMOR FREE						YES	YES			YES	Primary Tumor	1	Wide Local Excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2008	49c4166c-701a-4f53-8968-99aec3347214	dab4207f-5e33-4cbb-81af-b3f005c74c16	49c4166c-701a-4f53-8968-99aec3347214	dab4207f-5e33-4cbb-81af-b3f005c74c16	TCGA.AR.A1AY.01A-11-A13E-20	TCGA.AR.A1AY.01A-21D-A12Q-09		TCGA.AR.A1AY.01	TCGA.AR.A1AY.01A-21D-A12R-05		1815b916-4da0-4ada-9774-7231a10c6862	TCGA.AR.A1AY.01	TCGA.AR.A1AY.01A-21D-A12Q-09		TCGA.AR.A1AY.01	TCGA.AR.A1AY.01	TCGA.AR.A1AY.01A-21D-A12Q-09		49c4166c-701a-4f53-8968-99aec3347214		TCGA.AR.A1AY.01A-21D-A12N-01	TCGA.AR.A1AY.01	TCGA.AR.A1AY.01A-21R-A12P-07	49c4166c-701a-4f53-8968-99aec3347214	TCGA.AR.A1AY.01A-21D-A12N-01	TCGA.AR.A1AY.01
TCGA.AR.A2LR.01		NA	NA		NA	NA				NA	NA	NA					NA	NA	Basal				NA	NA					0	TCGA.AR.A2LR.01	1742	0	days	High	C4-BRCA/Basal		BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 5			TCGA-AR-A2LR	1742	0	days	1742	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA.AR.A2LR.F71747	TCGA-AR-A2LR	TCGA.AR.A2LR.01A		Negative					Negative	Simple Mastectomy			NA	NA	-18214	447	NA	0	1742	NA	NA			NO					2015-3-30	FEMALE						NA		NA	NA	Metaplastic Carcinoma		No	NA	C50.9	8575/3	C50.9		YES		Core needle biopsy	800	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	NA	true	Yes	M0	N0	T1	Stage I	TCGA-AR-A2LR.C310F4EC-D8B1-45C4-8D55-705A9EE35902.pdf	A2LR	TUMOR FREE						NO	YES			NO	Primary Tumor	1		7th		NO	YES	AR	Breast	A	LIVING	2010	9f693816-6957-413c-a100-54f7bc0eddf9	9ba65dff-5f6c-4d9e-8e58-8350a7c1dcbe	9f693816-6957-413c-a100-54f7bc0eddf9	9ba65dff-5f6c-4d9e-8e58-8350a7c1dcbe	TCGA.AR.A2LR.01A-21-A24A-20			TCGA.AR.A2LR.01	TCGA.AR.A2LR.01A-12D-A18O-05		1504ffd3-5ca4-4858-a554-120455f8d456	TCGA.AR.A2LR.01	TCGA.AR.A2LR.01A-12D-A18P-09						9f693816-6957-413c-a100-54f7bc0eddf9		TCGA.AR.A2LR.01A-12D-A18N-01			9f693816-6957-413c-a100-54f7bc0eddf9	TCGA.AR.A2LR.01A-12D-A18N-01	
TCGA.B6.A0I6.01	Stage IIA	49	NA	No_Conversion	991	997	Negative	FEMALE		NA	NA	NA	Negative	M0	Positive	N1	997	1	Basal	Basal-like	Negative	Basal	-13	0	followup	T1	T1	DECEASED	1	TCGA.B6.A0I6.01	991	1	days		C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0I6	859	1	days	991	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO		49	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA.B6.A0I6.F12605	TCGA-B6-A0I6	TCGA.B6.A0I6.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-18014	7362	991	0	NA	NA	NA	859						Scheduled Follow-up Submission	2011-6-1	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	200	NO				32	Negative	Indeterminate (neither Pre or Postmenopausal)									NA											5	4	NA			Other, specify	Distant Metastasis	Skin and bone		YES	6	NA	true	No	M0	N1	T1c	Stage IIA	TCGA-B6-A0I6.2D3D759B-D06A-4FC6-855A-5E9F83ADBED9.pdf	A0I6	WITH TUMOR										NO	Primary Tumor	1		3rd	YES	NO	YES	B6	Breast	A	DECEASED	1990	09c248f8-cdd7-4c13-9085-26c56544bcf7	ba92130c-fd4f-492f-b4c8-8420a9d017f9	09c248f8-cdd7-4c13-9085-26c56544bcf7	ba92130c-fd4f-492f-b4c8-8420a9d017f9	TCGA.B6.A0I6.01A-21-A13B-20	TCGA.B6.A0I6.01A-11D-A128-09		TCGA.B6.A0I6.01			4b55651d-88f5-411e-9986-702e8173a3d9		TCGA.B6.A0I6.01A-11D-A128-09	TCGA.B6.A0I6.01A-11D-A032-05			TCGA.B6.A0I6.01A-11D-A128-09	TCGA.B6.A0I6.01	09c248f8-cdd7-4c13-9085-26c56544bcf7	TCGA.B6.A0I6.01			TCGA.B6.A0I6.01A-11R-A034-07	09c248f8-cdd7-4c13-9085-26c56544bcf7		TCGA.B6.A0I6.01
TCGA.B6.A0IQ.01	Stage IIIA	40	1	No_Conversion	4284	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	4284	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T3	LIVING	0	TCGA.B6.A0IQ.01	4285	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 5	mutation cluster 5	TCGA-B6-A0IQ	4285	0	days	4285	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA.B6.A0IQ.F12629	TCGA-B6-A0IQ	TCGA.B6.A0IQ.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-14669	5238	NA	0	4285	NA	NA				Image Analysis			Scheduled Follow-up Submission	2011-6-2	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	210	NO				26	Negative	Indeterminate (neither Pre or Postmenopausal)									NA											5	5	NA							NO	1	NA	true	No	M0	N1b	T3	Stage IIIA	TCGA-B6-A0IQ.0ED7357E-662C-4D65-82ED-29739919068F.pdf	A0IQ	TUMOR FREE	Image Analysis									YES	Primary Tumor	1		4th	YES	NO	YES	B6	Breast	A	LIVING	1996	2e9c893c-1d72-49a7-8755-1ede20b26fcf	758e3752-e267-4bb3-be83-a88b6eb7e9fc	2e9c893c-1d72-49a7-8755-1ede20b26fcf	758e3752-e267-4bb3-be83-a88b6eb7e9fc	TCGA.B6.A0IQ.01A-21-A13B-20	TCGA.B6.A0IQ.01A-11W-A050-09		TCGA.B6.A0IQ.01			940d8074-3223-49f6-8d86-d50e9ae69c9b	TCGA.B6.A0IQ.01	TCGA.B6.A0IQ.01A-11W-A050-09	TCGA.B6.A0IQ.01A-11D-A032-05	TCGA.B6.A0IQ.01		TCGA.B6.A0IQ.01A-11W-A050-09	TCGA.B6.A0IQ.01	2e9c893c-1d72-49a7-8755-1ede20b26fcf	TCGA.B6.A0IQ.01	TCGA.B6.A0IQ.01A-11D-A036-01		TCGA.B6.A0IQ.01A-11R-A034-07	2e9c893c-1d72-49a7-8755-1ede20b26fcf	TCGA.B6.A0IQ.01A-11D-A036-01	TCGA.B6.A0IQ.01
TCGA.B6.A0RE.01		61	1	No_Conversion	6434	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	6434	0	Basal	Basal-like	Negative		-13	-12	followup		TX	LIVING	0	TCGA.B6.A0RE.01	7777	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0RE	7777	0	days	7777	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA.B6.A0RE.F71507	TCGA-B6-A0RE	TCGA.B6.A0RE.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-22449	7492	NA	0	7777	NA	NA							Scheduled Follow-up Submission	2015-3-26	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Other method, specify:	90	NO			NO	14	Negative	Indeterminate (neither Pre or Postmenopausal)									NA											5	4	NA							NO	0	NA	true	No	M0	N0 (i-)	TX	Stage X	TCGA-B6-A0RE.5607C6CE-21D5-495E-9174-85F1E2E0CB9D.pdf	A0RE	TUMOR FREE						NO				YES	Primary Tumor	1			NO	NO	YES	B6	Breast	A	LIVING	1989	ad46ed65-3cc2-4956-9d90-3e1edca24417	268d0a2b-cd03-425f-8775-4202f6a2e339	ad46ed65-3cc2-4956-9d90-3e1edca24417	268d0a2b-cd03-425f-8775-4202f6a2e339		TCGA.B6.A0RE.01A-11W-A071-09		TCGA.B6.A0RE.01	TCGA.B6.A0RE.01A-11D-A10P-05			TCGA.B6.A0RE.01	TCGA.B6.A0RE.01A-11W-A071-09		TCGA.B6.A0RE.01		TCGA.B6.A0RE.01A-11W-A071-09	TCGA.B6.A0RE.01	ad46ed65-3cc2-4956-9d90-3e1edca24417	TCGA.B6.A0RE.01	TCGA.B6.A0RE.01A-11D-A059-01		TCGA.B6.A0RE.01A-11R-A056-07	ad46ed65-3cc2-4956-9d90-3e1edca24417	TCGA.B6.A0RE.01A-11D-A059-01	TCGA.B6.A0RE.01
TCGA.B6.A0RU.01	Stage IA	49	1	Stage I	3991	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	3991	0	Basal	Basal-like	Negative	Basal	-13	-11	followup	T1	T1	LIVING	0	TCGA.B6.A0RU.01	8605	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-B6-A0RU	8605	0	days	8605	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			YES		40	Right	Axillary lymph node dissection alone		TCGA.B6.A0RU.F71565	TCGA-B6-A0RU	TCGA.B6.A0RU.01A		Negative					Negative	Other		NO	NA	3076	-14920	7290	NA	0	8605	NA	NA	3076			Image Analysis			Scheduled Follow-up Submission	2015-3-26	FEMALE						NA		NA	NA	Other, specify		No	NA	C50.9	8523/3	C50.9		YES		Tumor resection	170	NO			NO	15	Negative	Indeterminate (neither Pre or Postmenopausal)									NA											5	6	NA			Other, specify	New Primary Tumor	Right Breast		NO	0	NA	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0RU.39C689CA-F7BA-4554-BEC8-11F9C8142D9C.pdf	A0RU	TUMOR FREE	Image Analysis					YES				YES	Primary Tumor	1	Excisional biopsy	3rd	YES	NO	YES	B6	Breast	A	LIVING	1990	7abad802-817a-4d95-b022-f21cc4b1d9bc	39df545d-dade-4342-8ac3-312fd5664692	7abad802-817a-4d95-b022-f21cc4b1d9bc	39df545d-dade-4342-8ac3-312fd5664692	TCGA.B6.A0RU.01A-21-A13C-20	TCGA.B6.A0RU.01A-11D-A099-09		TCGA.B6.A0RU.01	TCGA.B6.A0RU.01A-11D-A10P-05		608bb166-ceaa-49d5-ae7d-d4060e8c6dc2	TCGA.B6.A0RU.01	TCGA.B6.A0RU.01A-11D-A099-09		TCGA.B6.A0RU.01		TCGA.B6.A0RU.01A-11D-A099-09	TCGA.B6.A0RU.01	7abad802-817a-4d95-b022-f21cc4b1d9bc	TCGA.B6.A0RU.01	TCGA.B6.A0RU.01A-11D-A087-01		TCGA.B6.A0RU.01A-11R-A084-07	7abad802-817a-4d95-b022-f21cc4b1d9bc	TCGA.B6.A0RU.01A-11D-A087-01	TCGA.B6.A0RU.01
TCGA.B6.A0WX.01	Stage IIIA	40	1	No_Conversion	653	653	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	653	1	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T3	DECEASED	1	TCGA.B6.A0WX.01	639	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0WX	563	1	days	639	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO		40	Left	Axillary lymph node dissection alone		TCGA.B6.A0WX.F15729	TCGA-B6-A0WX	TCGA.B6.A0WX.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-14784	4476	639	0	NA	NA	NA	563			Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE						NA		NA	NA	Other, specify		No	NA	C50.9	8520/3	C50.9		YES		Excisional Biopsy	300	NO				21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	4	NA			Bone	Distant Metastasis			YES	9	NA	true	No	M0	N1b	T3	Stage IIIA	TCGA-B6-A0WX.EE5BB205-D59B-4FEF-8D8F-D5720EDEB075.pdf	A0WX	WITH TUMOR	Image Analysis									NO	Primary Tumor	1		5th	YES	NO	YES	B6	Breast	A	DECEASED	1998	8dc04505-fae5-4185-b3f8-53882fbbb4fd	b0c0bc65-5f9b-4f23-a1c9-e3f86c0ef65c	8dc04505-fae5-4185-b3f8-53882fbbb4fd	b0c0bc65-5f9b-4f23-a1c9-e3f86c0ef65c	TCGA.B6.A0WX.01A-21-A13D-20	TCGA.B6.A0WX.01A-11D-A10G-09		TCGA.B6.A0WX.01	TCGA.B6.A0WX.01A-11D-A10A-05		f484ca3b-7c40-42fe-b5aa-a73453b45b0b	TCGA.B6.A0WX.01	TCGA.B6.A0WX.01A-11D-A10G-09		TCGA.B6.A0WX.01		TCGA.B6.A0WX.01A-11D-A10G-09	TCGA.B6.A0WX.01	8dc04505-fae5-4185-b3f8-53882fbbb4fd	TCGA.B6.A0WX.01	TCGA.B6.A0WX.01A-11D-A107-01		TCGA.B6.A0WX.01A-11R-A109-07	8dc04505-fae5-4185-b3f8-53882fbbb4fd	TCGA.B6.A0WX.01A-11D-A107-01	TCGA.B6.A0WX.01
TCGA.BH.A0AV.01	Stage I	52	1	Stage I	1180	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1180	0	Basal	Basal-like	Negative	ReacII	-13	0	enrollment	T1	T1	LIVING	0	TCGA.BH.A0AV.01	1820	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0AV	1820	0	days	1820	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Inner Quadrant			TCGA.BH.A0AV.F59174	TCGA-BH-A0AV	TCGA.BH.A0AV.01A		Negative					Negative	Other			NA	NA	-19314	761	NA	0	1820	NA	NA			NO					2014-5-2	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO		Negative	NO	2	Negative										NA											5	4	NA							NO	0	NA	true	No	M0	N0	T1c	Stage I	TCGA-BH-A0AV.6DFA6F0F-09BC-4246-87B9-247207B74A39.pdf	A0AV	TUMOR FREE						YES	YES			YES	Primary Tumor	1	Segmental mastectomy with left axillary lymph node dissection	6th		NO	YES	BH	Breast	A	LIVING	2008	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	fe110a00-ddf8-468a-966e-4823df9cbe40	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	fe110a00-ddf8-468a-966e-4823df9cbe40	TCGA.BH.A0AV.01A-21-A13C-20	TCGA.BH.A0AV.01A-31D-A10Y-09		TCGA.BH.A0AV.01			9a298279-0097-4dfc-bfb0-b119b92d1fd7	TCGA.BH.A0AV.01	TCGA.BH.A0AV.01A-31D-A10Y-09	TCGA.BH.A0AV.01A-31D-A112-05	TCGA.BH.A0AV.01	TCGA.BH.A0AV.01	TCGA.BH.A0AV.01A-31D-A10Y-09		afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93		TCGA.BH.A0AV.01A-31D-A111-01	TCGA.BH.A0AV.01	TCGA.BH.A0AV.01A-31R-A115-07	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	TCGA.BH.A0AV.01A-31D-A111-01	TCGA.BH.A0AV.01
TCGA.BH.A0E6.01	Stage IA	69	1	Stage I	292	NA	Negative	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	292	0	Basal	Basal-like	Negative	ReacI	-13	0	followup	T1	T1	LIVING	0	TCGA.BH.A0E6.01	293	0	days	High	C4-BRCA/Basal	cluster 1	BRCA basal-like c8	OV-like c4	BRCA basal-like c8	miRNA cluster 12	cluster 4	mutation cluster 2	TCGA-BH-A0E6	NA	NA	days	293	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA.BH.A0E6.F4650	TCGA-BH-A0E6	TCGA.BH.A0E6.01A		Negative		0			Negative	Other		NO	NA	NA	-25408	134	NA	0	293	NA	NA				H-SCORE 0		2.38		2010-11-16	FEMALE					2+	40	2.83	1.19	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	0	YES		Core needle biopsy	80	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											1	4	NA								0	NA	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0E6.739E1733-3540-4E82-AC91-F511105DABD5.pdf	A0E6	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE					YES	Primary Tumor	1	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009	6bf094a5-1f62-406c-9b3a-e686bb4a074e	245f6917-4912-4707-9289-d4bc54345b81	6bf094a5-1f62-406c-9b3a-e686bb4a074e	245f6917-4912-4707-9289-d4bc54345b81	TCGA.BH.A0E6.01A-21-A13C-20	TCGA.BH.A0E6.01A-11W-A050-09		TCGA.BH.A0E6.01			1b1bb0d9-e8c0-4efa-bab4-73225525bd9c	TCGA.BH.A0E6.01	TCGA.BH.A0E6.01A-11W-A050-09	TCGA.BH.A0E6.01A-11D-A032-05	TCGA.BH.A0E6.01		TCGA.BH.A0E6.01A-11W-A050-09	TCGA.BH.A0E6.01	6bf094a5-1f62-406c-9b3a-e686bb4a074e	TCGA.BH.A0E6.01	TCGA.BH.A0E6.01A-11D-A036-01		TCGA.BH.A0E6.01A-11R-A034-07	6bf094a5-1f62-406c-9b3a-e686bb4a074e	TCGA.BH.A0E6.01A-11D-A036-01	TCGA.BH.A0E6.01
TCGA.BH.A0WA.01	Stage IA	82	1	Stage I	372	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	372	0	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA.BH.A0WA.01	701	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-BH-A0WA	701	0	days	701	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					82	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.BH.A0WA.F34068	TCGA-BH-A0WA	TCGA.BH.A0WA.01A		Negative					Negative	Other			NA	NA	-30025	724	NA	0	701	NA	NA							Scheduled Follow-up Submission	2012-7-29	FEMALE						NA		NA	NA			No	NA	C50.9	8575/3	C50.9		YES		Fine needle aspiration biopsy	80	NO	Negative			3	Negative										NA											5	5	NA							NO	0	NA	true	No	M0	N0 (i-)	T1c	Stage I	TCGA-BH-A0WA.87E28DAE-5012-4A16-BE27-A9F0F3F30F5B.pdf	A0WA	TUMOR FREE										NO	Primary Tumor	1	segmental mastectomy	6th	NO	NO	YES	BH	Breast	A	LIVING	2008	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	35001085-6428-46a2-a1c7-a45970cac84f	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	35001085-6428-46a2-a1c7-a45970cac84f		TCGA.BH.A0WA.01A-11D-A10G-09		TCGA.BH.A0WA.01	TCGA.BH.A0WA.01A-11D-A10A-05			TCGA.BH.A0WA.01	TCGA.BH.A0WA.01A-11D-A10G-09		TCGA.BH.A0WA.01		TCGA.BH.A0WA.01A-11D-A10G-09,TCGA.BH.A0WA.01A-11D-A128-09	TCGA.BH.A0WA.01	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	TCGA.BH.A0WA.01	TCGA.BH.A0WA.01A-11D-A107-01		TCGA.BH.A0WA.01A-11R-A109-07	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	TCGA.BH.A0WA.01A-11D-A107-01	TCGA.BH.A0WA.01
TCGA.BH.A18G.01	Stage X	81	3	No_Conversion	61	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	61	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T1	T1	LIVING	0	TCGA.BH.A18G.01	149	0	days	Iq	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4		TCGA-BH-A18G	149	0	days	149	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					81	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA.BH.A18G.F64216	TCGA-BH-A18G	TCGA.BH.A18G.01A		Negative					Negative	Other			NA	NA	-29820	78	NA	0	149	NA	NA								2014-8-27	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.5	8500/3	C50.5		YES		Core needle biopsy	100	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											4	4	NA							NO	0	NA	true	No	M0	N0	T1c	Stage IA	TCGA-BH-A18G.7C92F144-4A84-4D9E-8A35-C059FD082150.pdf	A18G	TUMOR FREE						NO	YES			YES	Primary Tumor	1	right segmental mastectomy			NO	YES	BH	Breast	A	LIVING	2010	a8a7a335-8e21-4f24-b48b-8764caa21329	ee9101bf-b45d-41d3-bc63-16d9ca91e714	a8a7a335-8e21-4f24-b48b-8764caa21329	ee9101bf-b45d-41d3-bc63-16d9ca91e714	TCGA.BH.A18G.01A-21-A13F-20			TCGA.BH.A18G.01			7deb8368-b91a-4e0e-bd5c-5b6c93f12d8a	TCGA.BH.A18G.01	TCGA.BH.A18G.01A-11D-A12B-09	TCGA.BH.A18G.01A-11D-A12E-05	TCGA.BH.A18G.01	TCGA.BH.A18G.01			a8a7a335-8e21-4f24-b48b-8764caa21329		TCGA.BH.A18G.01A-11D-A12A-01	TCGA.BH.A18G.01	TCGA.BH.A18G.01A-11R-A12D-07	a8a7a335-8e21-4f24-b48b-8764caa21329	TCGA.BH.A18G.01A-11D-A12A-01	TCGA.BH.A18G.01
TCGA.C8.A1HJ.01	Stage II	53	1	Stage IIA	5	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	5	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.C8.A1HJ.01	5	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-C8-A1HJ	NA	NA	days	5	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right	Axillary lymph node dissection alone			TCGA-C8-A1HJ	TCGA.C8.A1HJ.01A		Negative					Negative	Other			NA	NA	-19629	121	NA	0	5	NA	NA			NO					2011-6-1	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	1070	NO	Negative			10	Negative	Peri (6-12 months since last menstrual period)									NA											5	5	NA								NA	NA	true	No	M0	N0	T2	Stage IIA	TCGA-C8-A1HJ.11F98715-1482-4D7D-9102-E362634806A7.pdf	A1HJ	TUMOR FREE							YES				Primary Tumor	1	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	c0dd6c33-008d-44e8-b20c-8089bc3e29a3	6275c0ff-efae-4d00-b3ae-123cbb90b4e2	c0dd6c33-008d-44e8-b20c-8089bc3e29a3	6275c0ff-efae-4d00-b3ae-123cbb90b4e2	TCGA.C8.A1HJ.01A-21-A17J-20	TCGA.C8.A1HJ.01A-11D-A13L-09		TCGA.C8.A1HJ.01	TCGA.C8.A1HJ.01A-11D-A13K-05		6528f6b1-d0f5-413c-a304-0fa218a132ac	TCGA.C8.A1HJ.01	TCGA.C8.A1HJ.01A-11D-A13L-09			TCGA.C8.A1HJ.01	TCGA.C8.A1HJ.01A-11D-A13L-09		c0dd6c33-008d-44e8-b20c-8089bc3e29a3		TCGA.C8.A1HJ.01A-11D-A13J-01	TCGA.C8.A1HJ.01		c0dd6c33-008d-44e8-b20c-8089bc3e29a3	TCGA.C8.A1HJ.01A-11D-A13J-01	
TCGA.D8.A142.01	Stage IIB	74	1	Stage IIB	425	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	425	0	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T3	LIVING	0	TCGA.D8.A142.01	425	0	days	High	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 3	mutation cluster 5	TCGA-D8-A142	425	0	days	425	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA.D8.A142.F13813	TCGA-D8-A142	TCGA.D8.A142.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-27313	212	NA	0	425	NA	NA							Scheduled Follow-up Submission	2011-6-20	FEMALE					2+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	490	NO	Equivocal	Negative		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA							NO	0	NA	false	No	M0	N0	T3	Stage IIB	TCGA-D8-A142.7D2C880F-6897-44A0-9470-5A5B5429A9C0.pdf	A142	TUMOR FREE		FISH					YES			NO	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	336577b1-b012-4346-936b-0502d0f8a597	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	336577b1-b012-4346-936b-0502d0f8a597	TCGA.D8.A142.01A-21-A13D-20	TCGA.D8.A142.01A-11D-A10Y-09		TCGA.D8.A142.01			d434b104-6d07-417e-9a84-c729c071cf14	TCGA.D8.A142.01	TCGA.D8.A142.01A-11D-A10Y-09	TCGA.D8.A142.01A-11D-A112-05	TCGA.D8.A142.01	TCGA.D8.A142.01	TCGA.D8.A142.01A-11D-A10Y-09		9f440cd6-d55f-4cb6-a433-637ef1f9d38f		TCGA.D8.A142.01A-11D-A111-01	TCGA.D8.A142.01	TCGA.D8.A142.01A-11R-A115-07	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	TCGA.D8.A142.01A-11D-A111-01	TCGA.D8.A142.01
TCGA.D8.A27F.01	Stage IIA	40	1	Stage IIA	227	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	227	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.D8.A27F.01	488	0	days	BRCA-LUAD+	C1-LUAD-enriched	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12		mutation cluster 12	TCGA-D8-A27F	488	0	days	488	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.D8.A27F.F29515	TCGA-D8-A27F	TCGA.D8.A27F.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-14731	166	NA	0	488	NA	NA			NO				Scheduled Follow-up Submission	2012-3-21	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	320	NO	Negative			11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	NA	NA							NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A27F.976C6F9E-DDCB-42F4-BD2C-A4D715396B47.pdf	A27F	TUMOR FREE							YES			YES	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	0a69935d-9552-4792-9b2e-1a630114691e	96972bfb-01a7-4731-aca8-43dc346feb10	0a69935d-9552-4792-9b2e-1a630114691e	96972bfb-01a7-4731-aca8-43dc346feb10	TCGA.D8.A27F.01A-21-A17K-20	TCGA.D8.A27F.01A-11D-A16D-09		TCGA.D8.A27F.01	TCGA.D8.A27F.01A-11D-A16G-05		7ce10802-b13b-47af-abe3-b8deaf2c64f4	TCGA.D8.A27F.01	TCGA.D8.A27F.01A-11D-A16D-09			TCGA.D8.A27F.01	TCGA.D8.A27F.01A-11D-A16D-09		0a69935d-9552-4792-9b2e-1a630114691e		TCGA.D8.A27F.01A-11D-A16C-01	TCGA.D8.A27F.01		0a69935d-9552-4792-9b2e-1a630114691e	TCGA.D8.A27F.01A-11D-A16C-01	
TCGA.D8.A27H.01	Stage IIA	72	1	Stage IIA	140	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	140	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.D8.A27H.01	397	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 3		mutation cluster 2	TCGA-D8-A27H	397	0	days	397	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Right Upper Outer Quadrant	No axillary staging		TCGA.D8.A27H.F29536	TCGA-D8-A27H	TCGA.D8.A27H.01A		Negative					Negative	Modified Radical Mastectomy		NO	NA	NA	-26588	84	NA	0	397	NA	NA			NO				Scheduled Follow-up Submission	2012-3-22	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	170	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	NA	NA							NO	NA	NA	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A27H.52D7E980-806C-499D-9DB9-40E1D651D9EB.pdf	A27H	TUMOR FREE							YES			NO	Primary Tumor	1		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	123725b8-4f66-4b97-9726-e0c70300d38e	e6674bdf-bebe-4c44-a6c1-36ce0ee121f7	123725b8-4f66-4b97-9726-e0c70300d38e	e6674bdf-bebe-4c44-a6c1-36ce0ee121f7	TCGA.D8.A27H.01A-21-A17K-20	TCGA.D8.A27H.01A-11D-A16D-09		TCGA.D8.A27H.01	TCGA.D8.A27H.01A-11D-A16G-05		54304e23-2f82-43d6-9ace-f054d7a0f410	TCGA.D8.A27H.01	TCGA.D8.A27H.01A-11D-A16D-09			TCGA.D8.A27H.01	TCGA.D8.A27H.01A-11D-A16D-09		123725b8-4f66-4b97-9726-e0c70300d38e		TCGA.D8.A27H.01A-11D-A16C-01	TCGA.D8.A27H.01		123725b8-4f66-4b97-9726-e0c70300d38e	TCGA.D8.A27H.01A-11D-A16C-01	
TCGA.E2.A158.01	Stage IIA	43	1	Stage IIA	450	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	450	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T1	T1	LIVING	0	TCGA.E2.A158.01	450	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A158	450	0	days	450	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.E2.A158.F18956	TCGA-E2-A158	TCGA.E2.A158.01A		Negative					Negative	Simple Mastectomy		NO	NA	NA	-15903	436	NA	0	450	NA	NA			NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-11-8	FEMALE			<10%		1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	200	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											5	5	NA							NO	1	NA	false	Yes	M0	N1mi	T1c	Stage IIA	TCGA-E2-A158.1CEBF20D-767A-4A19-AA41-B9EAFCF05176.pdf	A158	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			NO	Primary Tumor	1		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	43326f71-c61c-410b-af4b-c71a054e27c9	c75325af-6b3b-40b9-88a2-79754c120cae	43326f71-c61c-410b-af4b-c71a054e27c9	c75325af-6b3b-40b9-88a2-79754c120cae	TCGA.E2.A158.01A-21-A13E-20	TCGA.E2.A158.01A-11D-A12B-09		TCGA.E2.A158.01			cc34e050-b748-413b-a5ec-064c216e98c3	TCGA.E2.A158.01	TCGA.E2.A158.01A-11D-A12B-09	TCGA.E2.A158.01A-11D-A12E-05	TCGA.E2.A158.01	TCGA.E2.A158.01	TCGA.E2.A158.01A-11D-A12B-09		43326f71-c61c-410b-af4b-c71a054e27c9		TCGA.E2.A158.01A-11D-A12A-01	TCGA.E2.A158.01	TCGA.E2.A158.01A-11R-A12D-07	43326f71-c61c-410b-af4b-c71a054e27c9	TCGA.E2.A158.01A-11D-A12A-01	TCGA.E2.A158.01
TCGA.E2.A1LS.01	Stage IA	46	NA	Stage I	239	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	239	0	Basal		Negative		NA	NA	enrollment	T1	T1	LIVING	0	TCGA.E2.A1LS.01	1604	0	days		C4-BRCA/Basal	cluster 3	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14		mutation cluster 5	TCGA-E2-A1LS	1604	0	days	1604	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA.E2.A1LS.F70016	TCGA-E2-A1LS	TCGA.E2.A1LS.01A		Negative					Negative	Simple Mastectomy		NO	NA	NA	-16887	176	NA	0	1604	NA	NA			NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-2-9	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	100	NO	Negative		NO	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											3	NA	NA							NO	0	NA	false	No	M0	N0	T1c	Stage IA	TCGA-E2-A1LS.A514658A-FB29-4AA0-9451-2A960B3720C1.pdf	A1LS	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			NO	Primary Tumor	1		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	81239059-614b-46b7-a21e-224ec62e2939		81239059-614b-46b7-a21e-224ec62e2939		TCGA.E2.A1LS.01A-21-A17J-20	TCGA.E2.A1LS.01A-12D-A159-09		TCGA.E2.A1LS.01	TCGA.E2.A1LS.01A-12D-A161-05		9e7e3f34-faa6-4a3d-a0cb-d733c45b9b65		TCGA.E2.A1LS.01A-12D-A159-09			TCGA.E2.A1LS.01	TCGA.E2.A1LS.01A-12D-A159-09		81239059-614b-46b7-a21e-224ec62e2939			TCGA.E2.A1LS.01		81239059-614b-46b7-a21e-224ec62e2939		
TCGA.E2.A574.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.E2.A574.01	1179	0	days										TCGA-E2-A574	1179	0	days	1179	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left	Sentinel node biopsy alone		TCGA.E2.A574.F70296	TCGA-E2-A574	TCGA.E2.A574.01A		Negative					Negative	Lumpectomy		NO	NA	NA	-16195	429	NA	0	1179	NA	NA				Allred 0 = 0+0		2.8		2015-2-9	FEMALE			10-19%		2+	200	2.8	1	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Equivocal	Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)									NA											NA	NA	NA							NO	0	NA	true	No	M0	N0	T2	Stage IIA	TCGA-E2-A574.F3FAB505-03FF-4FAA-ABB6-96AD20F47871.pdf	A574	TUMOR FREE	Allred 0 = 0+0			Allred Score	Allred Score	YES	YES			YES	Primary Tumor	1		7th		NO	YES	E2	Breast	A	LIVING	2011	fec9b75b-9a91-4979-9056-ecdd852429d8	2df2ecf5-359b-4a32-a24f-e93f64828f7e	fec9b75b-9a91-4979-9056-ecdd852429d8	2df2ecf5-359b-4a32-a24f-e93f64828f7e				TCGA.E2.A574.01	TCGA.E2.A574.01A-11D-A29O-05		19a7926b-5288-4e60-b0a3-ebdb0ff58b1a	TCGA.E2.A574.01	TCGA.E2.A574.01A-11D-A29N-09			TCGA.E2.A574.01			fec9b75b-9a91-4979-9056-ecdd852429d8		TCGA.E2.A574.01A-11D-A29M-01	TCGA.E2.A574.01		fec9b75b-9a91-4979-9056-ecdd852429d8	TCGA.E2.A574.01A-11D-A29M-01	
TCGA.E9.A1N8.01	Stage IIA	48	1	Stage IIA	0	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	0	0	Basal				NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.E9.A1N8.01	1039	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E9-A1N8	1039	0	days	1039	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.E9.A1N8.F53518	TCGA-E9-A1N8	TCGA.E9.A1N8.01A		Negative								NO	NA	NA	-17652	66	NA	0	1039	NA	NA			NO				Scheduled Follow-up Submission	2013-12-12	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Tumor resection	680	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	5	NA							NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1N8.4F15F8D6-9F34-4A61-A006-E5E7A2E68207.pdf	A1N8	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	7d6b6a17-5f1e-4586-9316-195c0e96925c	0179d350-8a90-4269-8eee-a0b971d23cb8	7d6b6a17-5f1e-4586-9316-195c0e96925c	0179d350-8a90-4269-8eee-a0b971d23cb8	TCGA.E9.A1N8.01A-21-A17K-20	TCGA.E9.A1N8.01A-11D-A142-09		TCGA.E9.A1N8.01	TCGA.E9.A1N8.01A-11D-A145-05		8ea109e3-1e03-468c-b117-43cbd5c7571d	TCGA.E9.A1N8.01	TCGA.E9.A1N8.01A-11D-A142-09			TCGA.E9.A1N8.01	TCGA.E9.A1N8.01A-11D-A142-09		7d6b6a17-5f1e-4586-9316-195c0e96925c		TCGA.E9.A1N8.01A-11D-A141-01	TCGA.E9.A1N8.01		7d6b6a17-5f1e-4586-9316-195c0e96925c	TCGA.E9.A1N8.01A-11D-A141-01	
TCGA.E9.A244.01	Stage IIA	54	1	Stage IIA	20	NA		FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	20	0	Basal				NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.E9.A244.01	21	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9		mutation cluster 5	TCGA-E9-A244	21	0	days	21	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA.E9.A244.F31164	TCGA-E9-A244	TCGA.E9.A244.01A								Lumpectomy		NO	NA	NA	-19778	58	NA	0	21	NA	NA			NO				Scheduled Follow-up Submission	2012-4-24	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	310	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	NA	NA							NO	0	NA	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A244.4158FEAB-066B-4500-8FD2-3F197438DFB5.pdf	A244	TUMOR FREE							YES			NO	Primary Tumor	1		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	147d6ebb-7359-449a-9e6a-6c8443ebaa2e	4695c0f4-4d30-4604-84b3-81407bf980e8	147d6ebb-7359-449a-9e6a-6c8443ebaa2e	4695c0f4-4d30-4604-84b3-81407bf980e8	TCGA.E9.A244.01A-21-A17K-20	TCGA.E9.A244.01A-11D-A167-09		TCGA.E9.A244.01	TCGA.E9.A244.01A-11D-A16A-05		a6266eec-b341-4642-aed5-9c6cd44f14df	TCGA.E9.A244.01	TCGA.E9.A244.01A-11D-A167-09			TCGA.E9.A244.01	TCGA.E9.A244.01A-11D-A167-09		147d6ebb-7359-449a-9e6a-6c8443ebaa2e		TCGA.E9.A244.01A-11D-A166-01	TCGA.E9.A244.01		147d6ebb-7359-449a-9e6a-6c8443ebaa2e	TCGA.E9.A244.01A-11D-A166-01	
TCGA.EW.A1OW.01	Stage IIA	58	1	Stage IIA	463	NA	Negative	FEMALE	Negative	NA	NA	NA	Negative	M0	Negative	N0	463	0	Basal		Negative		NA	NA	enrollment	T_Other	T2	LIVING	0	TCGA.EW.A1OW.01	694	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8				TCGA-EW-A1OW	694	0	days	694	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA.EW.A1OW.F29117	TCGA-EW-A1OW	TCGA.EW.A1OW.01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES	NA	NA	-21465	444	NA	0	694	NA	NA			NO		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8090/3	C50.9		YES		Core needle biopsy	100	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	NA	NA							NO	0	0	true	No	MX	N0	T2	Stage IIA	TCGA-EW-A1OW.2153CBCE-6DA9-4E0F-9F41-B9F08FD50647.pdf	A1OW	TUMOR FREE							YES	<10%		YES	Primary Tumor	1		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	21cc5775-0987-4088-b19c-86bf43f09bb2	0941a978-c8aa-467b-8464-9f979d1f0418	21cc5775-0987-4088-b19c-86bf43f09bb2	0941a978-c8aa-467b-8464-9f979d1f0418	TCGA.EW.A1OW.01A-11-A17J-20			TCGA.EW.A1OW.01	TCGA.EW.A1OW.01A-21D-A145-05		a4d72446-5d9b-4b8d-af59-9add055da84e	TCGA.EW.A1OW.01				TCGA.EW.A1OW.01			21cc5775-0987-4088-b19c-86bf43f09bb2		TCGA.EW.A1OW.01A-21D-A141-01	TCGA.EW.A1OW.01		21cc5775-0987-4088-b19c-86bf43f09bb2	TCGA.EW.A1OW.01A-21D-A141-01	
TCGA.GI.A2C9.01		NA	NA		NA	NA				NA	NA	NA					NA	NA	Basal				NA	NA					0	TCGA.GI.A2C9.01	3342	0	days	High	C4-BRCA/Basal		BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4			TCGA-GI-A2C9	3342	0	days	3342	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA.GI.A2C9.F21663	TCGA-GI-A2C9	TCGA.GI.A2C9.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-21534	2979	NA	0	3342	NA	NA			NO				Scheduled Follow-up Submission	2012-5-8	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	MX	N0	T3	Stage IIB	TCGA-GI-A2C9.ADDE6090-5278-42D5-8E89-E0AB630A4C06.pdf	A2C9	TUMOR FREE							YES			YES	Primary Tumor	1		6th	YES	NO	YES	GI	Breast	A	LIVING	2003	b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	49f9eae1-6d7c-45a8-bcf1-b321f980a581	b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	49f9eae1-6d7c-45a8-bcf1-b321f980a581	TCGA.GI.A2C9.01A-21-A24A-20			TCGA.GI.A2C9.01	TCGA.GI.A2C9.01A-11D-A21R-05		179ce5cd-da63-4c2e-bf72-253129faf128	TCGA.GI.A2C9.01	TCGA.GI.A2C9.01A-11D-A21Q-09			TCGA.GI.A2C9.01			b5b8fdd8-c4df-4f79-aed5-23ac41f75f18		TCGA.GI.A2C9.01A-11D-A21P-01	TCGA.GI.A2C9.01		b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	TCGA.GI.A2C9.01A-11D-A21P-01	
TCGA.LL.A73Y.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.LL.A73Y.01	477	0	days										TCGA-LL-A73Y	477	0	days	477	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right|Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA.LL.A73Y.F67099	TCGA-LL-A73Y	TCGA.LL.A73Y.01A		Negative	3 Point Scale	3+	3 Point Scale		Negative	Simple Mastectomy		NO	NA	NA	-24647	55	NA	0	477	NA	NA								2014-10-30	FEMALE					3+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	60	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	MX	N0	T1c	Stage IA	TCGA-LL-A73Y.9A8F7726-D97C-44DE-B72F-6BF0FC2078F8.pdf	A73Y	TUMOR FREE						YES	YES			NO	Primary Tumor	1		7th		YES	NO	LL	Breast	A	LIVING	2013	535ab8cf-47a9-4541-b3ef-223bba76a13e	8e13bd29-de53-4cb0-991f-7ae7460cb548	535ab8cf-47a9-4541-b3ef-223bba76a13e	8e13bd29-de53-4cb0-991f-7ae7460cb548				TCGA.LL.A73Y.01	TCGA.LL.A73Y.01A-11D-A33F-05			TCGA.LL.A73Y.01				TCGA.LL.A73Y.01			535ab8cf-47a9-4541-b3ef-223bba76a13e		TCGA.LL.A73Y.01A-11D-A33D-01	TCGA.LL.A73Y.01		535ab8cf-47a9-4541-b3ef-223bba76a13e	TCGA.LL.A73Y.01A-11D-A33D-01	
TCGA.A2.A0ST.01	Stage IIA	62	1	No_Conversion	1643	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1643	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA.A2.A0ST.01	3017	0	days	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A2-A0ST	NA	NA	days	3017	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.A2.A0ST.F14035	TCGA-A2-A0ST	TCGA.A2.A0ST.01A		Negative					Negative	Lumpectomy		YES	NA	NA	-22922	2597	NA	0	3017	NA	NA							Scheduled Follow-up Submission	2011-7-14	FEMALE						NA		1.3	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Excisional Biopsy	210	NO		Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA							YES	3	0	true	No	M0	N1a	T1c	Stage IIA	TCGA-A2-A0ST.1E8B978E-3D1B-46E8-80EE-3A11EE571CEC.pdf	A0ST	WITH TUMOR										YES	Primary Tumor	1		6th	YES	NO	YES	A2	Breast	A	LIVING	2003	920e47c0-1b19-46e6-b1db-b5fd95e44df0	db464b40-f99f-4427-9d17-edd9af51b2c8	920e47c0-1b19-46e6-b1db-b5fd95e44df0	db464b40-f99f-4427-9d17-edd9af51b2c8	TCGA.A2.A0ST.01A-21-A13A-20	TCGA.A2.A0ST.01A-12D-A099-09		TCGA.A2.A0ST.01	TCGA.A2.A0ST.01A-12D-A10P-05		d662c746-aeee-4b37-b811-a236222583b8	TCGA.A2.A0ST.01	TCGA.A2.A0ST.01A-12D-A099-09		TCGA.A2.A0ST.01		TCGA.A2.A0ST.01A-12D-A099-09	TCGA.A2.A0ST.01	920e47c0-1b19-46e6-b1db-b5fd95e44df0	TCGA.A2.A0ST.01	TCGA.A2.A0ST.01A-12D-A087-01		TCGA.A2.A0ST.01A-12R-A084-07	920e47c0-1b19-46e6-b1db-b5fd95e44df0	TCGA.A2.A0ST.01A-12D-A087-01	TCGA.A2.A0ST.01
TCGA.BH.A0BW.01	Stage I	71	1	Stage I	355	NA	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	355	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA.BH.A0BW.01	2371	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-BH-A0BW	2371	0	days	2371	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left Lower Outer Quadrant			TCGA.BH.A0BW.F59127	TCGA-BH-A0BW	TCGA.BH.A0BW.01A		Negative					Negative	Other			NA	NA	-25974	1344	NA	0	2371	NA	NA			NO					2014-5-1	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO		Negative	NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											5	3	NA							NO	0	NA	true	No	M0	N0	T1c	Stage I	TCGA-BH-A0BW.14CE78F3-8FB4-476D-A09C-AE87F7919D77.pdf	A0BW	TUMOR FREE						YES	YES			YES	Primary Tumor	1	Segmental mastectomy	6th		NO	YES	BH	Breast	A	LIVING	2006	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	75a4c81e-50fb-4ea4-b973-9e6e666f0e19	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	75a4c81e-50fb-4ea4-b973-9e6e666f0e19	TCGA.BH.A0BW.01A-21-A13B-20	TCGA.BH.A0BW.01A-11D-A10Y-09		TCGA.BH.A0BW.01			a5fc2a17-0d67-4a6f-ae45-373d3cc91129	TCGA.BH.A0BW.01	TCGA.BH.A0BW.01A-11D-A10Y-09	TCGA.BH.A0BW.01A-11D-A112-05	TCGA.BH.A0BW.01	TCGA.BH.A0BW.01	TCGA.BH.A0BW.01A-11D-A10Y-09		7e84df9f-1da5-4add-a5e8-a9d9d8af409c		TCGA.BH.A0BW.01A-11D-A111-01	TCGA.BH.A0BW.01	TCGA.BH.A0BW.01A-11R-A115-07	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	TCGA.BH.A0BW.01A-11D-A111-01	TCGA.BH.A0BW.01
TCGA.EW.A3U0.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.EW.A3U0.01	532	0	days	High			Low purity c2	BRCA basal-like c6		miRNA cluster 4			TCGA-EW-A3U0	532	0	days	532	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA.EW.A3U0.F42032	TCGA-EW-A3U0	TCGA.EW.A3U0.01A		Negative					Negative	Other		NO	NA	NA	-22520	182	NA	0	532	NA	NA			NO					2013-4-9	FEMALE						NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative		NO	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	1	NA	true	No	M0	N1a	T3	Stage IIIA	TCGA-EW-A3U0.8652E026-9C4D-4AB6-AADE-29DA3345892E.pdf	A3U0	TUMOR FREE						YES	YES			YES	Primary Tumor	1	partial left mastectomy	7th		YES	NO	EW	Breast	A	LIVING	2011	4763b4dd-1eef-4503-9381-4baa57cc690f	f24585b7-37a2-47c7-91fd-e427fb1ff7d9	4763b4dd-1eef-4503-9381-4baa57cc690f	f24585b7-37a2-47c7-91fd-e427fb1ff7d9	TCGA.EW.A3U0.01A-21-A24A-20			TCGA.EW.A3U0.01	TCGA.EW.A3U0.01A-11D-A22B-05		0c52f4b2-07d9-4591-a6b7-e4700f8d476d	TCGA.EW.A3U0.01	TCGA.EW.A3U0.01A-11D-A228-09			TCGA.EW.A3U0.01			4763b4dd-1eef-4503-9381-4baa57cc690f		TCGA.EW.A3U0.01A-11D-A227-01	TCGA.EW.A3U0.01		4763b4dd-1eef-4503-9381-4baa57cc690f	TCGA.EW.A3U0.01A-11D-A227-01	
TCGA.LL.A441.01		NA	NA		NA	NA				NA	NA	NA					NA	NA					NA	NA					0	TCGA.LL.A441.01	996	0	days										TCGA-LL-A441	996	0	days	996	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA.LL.A441.F46386	TCGA-LL-A441	TCGA.LL.A441.01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES	NA	NA	-22772	37	NA	0	996	NA	NA								2013-8-7	FEMALE					1+	NA		NA	NA	Infiltrating Ductal Carcinoma		No	NA	C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)									NA											NA	NA	NA							NO	0	0	false	No	MX	N0	T1c	Stage IA	TCGA-LL-A441.1FFDD2E3-02D5-4C38-B6E9-1261EB57835A.pdf	A441	TUMOR FREE						YES	YES			YES	Primary Tumor	1		7th		YES	NO	LL	Breast	A	LIVING	2012	8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	4588244d-e5f9-4cad-9915-1c6f4c0f887c	8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	4588244d-e5f9-4cad-9915-1c6f4c0f887c				TCGA.LL.A441.01	TCGA.LL.A441.01A-11D-A244-05		76fc75d8-5131-4ccf-9c99-be1dac58876d	TCGA.LL.A441.01	TCGA.LL.A441.01A-11D-A243-09			TCGA.LL.A441.01			8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662		TCGA.LL.A441.01A-11D-A242-01	TCGA.LL.A441.01		8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	TCGA.LL.A441.01A-11D-A242-01	
